The effect of repeated early injury on reward-related processing in the adult rat by Low, L.A.
1
The effect of repeated early
injury on reward-related
processing in the adult rat
Lucie Alanna Low
University College London
2010
Thesis presented for the degree of
Doctor of Philosophy2
Declaration:
I, Lucie Low, confirm that the work presented in this thesis is my own.
Where information has been derived from other sources, I confirm that
this has been indicated in the thesis.
Lucie Low
April 20103
Abstract
Pain during early life can affect the developing central nervous system, leading to
altered neural function in the adult organism. In this thesis, I investigate the long-term
effects of repeated early pain on reward-related processing in the adult rat. I
hypothesised that the reward system was likely to be sensitive to early activation of pain
pathways, as the brain systems involved in both pain and reward overlap extensively,
and virtually all centrally acting analgesic drugs are also drugs of reward.
To begin, I investigate the extent to which the developing reward system is activated by
a classic analgesic and drug of abuse, morphine. Comparing neonatal and adult
activation of the dopaminergic system, results show that a single morphine challenge
activates neonatal reward pathways, but that there are qualitative differences in the
neonatal response to repeated morphine. Next, I show how reward-related behaviours of
adult animals repeatedly injured as neonates differ from those of uninjured littermates,
and finally propose the lateral hypothalamic orexin system as a biomarker reflecting this
behaviour. The results provide evidence that neonatal injury interferes with the normal
development of reward systems during a critical period of development, resulting in
characteristic changes in reward behaviour and cell signalling in the adult animal.4
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1 Introduction
The experiments presented in this thesis are designed to investigate the long-lasting
effects of repeated pain during early development on adult reward-related processing in
the rat. Human data has clearly shown that pain during childhood, particularly in very
young and premature neonates, can cause changes in sensory and nociceptive
processing in the older child that can persist into adulthood. Pain processing is
intricately linked with reward processing in a number of ways, and so the central
hypothesis tested in this thesis is that exposure to injury in infancy will alter CNS
reward processing in adult rats, and that this will be reflected in reward behaviours and
the neurobiological reward signalling in the adult brain.
1.1 The problem of early pain
Pain at any age is unpleasant, yet most adult humans have methods of treating this pain,
either by requesting or taking medication, or by engaging internal coping mechanisms
that can help diminish the emotional, affective components of pain. However, young
human infants do not have the abilities to either self-administer nor to engage executive
coping mechanisms. Pre-verbal infants cannot report an internal pain state, meaning the
responsibility for pain relief must come from the carer or clinician.
Over the past 20 years, there has been an increase in the incidence of premature birth
(Langhoff-Roos et al., 2006), and the technology to aid survival has meant that infants
as young as 24 weeks post-menstrual age (PMA) can survive and develop in the
neonatal intensive care unit (NICU). However, the NICU is a very different
environment to the womb, and premature infants are exposed to a mass of stressful
stimuli such as light, noise, tactile stimulation, surgery, medication, and maternal
separation that could feasibly affect development (see Grunau et al., 2006). Evidence
exists to show that very young neonates can respond to pain, and also that pain during
this vulnerable time of development can cause long-term alterations in pain processing,
extending well into childhood and adulthood (see Fitzgerald, 2005; Fitzgerald and
Walker, 2009; La Prairie and Murphy, 2010 for reviews).Introduction
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1.1.1 Pain management in neonates
Treatment of pain in neonates is a clinical challenge for a number of reasons. Firstly,
pre-verbal infants cannot report their pain experience, so surrogate measures of pain
must be taken in order to decide upon the appropriate treatment. In older infants, visual
analogue scales (VAS) and self-report measures can be used for pain measurement,
although these rely on a certain level of cognitive development for optimal usefulness
(see Howard, 2003).
Pain measures in pre-verbal neonates that are used in clinical practice are based upon
behavioural and physiological reactions to a noxious stimulus, and include monitoring
gross body movements, muscle and limb reflex withdrawal magnitude, heart rate and
blood pressure, cerebral haemodynamic responses, and facial grimacing (see Fitzgerald
and Walker, 2009). These measures are incorporated into assessment tools, and current
tools include the Premature Infant Pain Profile (PIPP), the Neonatal Infant Pain Scale
(NIPS), and the Behavioural Indicators of Infant Pain (BIIP), amongst others (Holsti
and Grunau, 2007; Shah and Ohlsson, 2007). Whilst pain scales have been validated for
older children (von Baeyer and Spagrud, 2007) and neonates (Grunau et al., 2006), there
is no ‘gold standard’ as yet for pain assessment in neonates. As there can be a robust
activation of the cerebral cortex after noxious stimulation, but no facial pain response at
all (Slater et al., 2008), this suggests that measures are best taken in conjunction with
each other to enable adequate treatment of vulnerable infants (see Howard, 2003).
Further difficulties in treatment arise through differences in CNS organisation and
synaptic organisation between neonates and adults: dosage, metabolism of medication,
efficacy and specificity of action are all affected by brain development (see Walker,
2008).
Current treatments to manage pain in neonates include systemic opioids such as
morphine, and use of epidural analgesia administration, delivered directly into the
cerebrospinal fluid surrounding the spinal cord, is often employed for post-operative
pain (Murat et al., 1987). In addition, morphine is used in the NICU to provide sedation
in neonates requiring mechanical ventilation, to improve tolerance of ventilation and
comfort of the infant, although further research on its use in this situation has beenIntroduction
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recommended (Bellú et al., 2008). Opioids are the most frequent form of analgesia used
in the NICU, with analgesia rarely given for non-surgical invasive procedures (Johnston
et al., 1997).
Regional nerve blocks with local anaesthetic can be used for minor procedures, as can
the application of topical local anaesthetics such as lidocaine, in combination with
opioids or paracetamol if necessary (Howard, 2003), but the efficacy and benefits of
non-steroidal anti-inflammatory drugs (NSAIDs) is unclear in neonates and infants less
than 3 months old so their use is not as widespread (see Fitzgerald and Walker, 2009).
The stress and/or pain of procedures such as heel lance (to take blood), which can be
performed multiple times a day, can be alleviated by comfort measures such as non-
nutritive suckling or sucrose given shortly before the procedure (Blass and Watt, 1999;
Stevens et al., 2004; Stevens et al., 2010), as can cuddling, swaddling, and tactile
stimulation (Howard, 2003; D'Apolito, 2006). In older children, distraction techniques
and teaching of coping skills can be helpful for pain management. For example, a recent
systematic review has indicated that cognitive behavioural therapy is effective in
treatment of headache in children and adolescents (see Eccleston et al., 2003).
1.1.2 Early pain in humans causes long-term alterations in pain
circuitry and sensitivity
Evidence suggests that repeated pain during the neonatal period and childhood can
cause long-lasting effects on sensory and pain processing (Grunau et al., 1994;
Oberlander et al., 2000; Grunau et al., 2001; Grunau et al., 2007). Effective pain
management in neonates therefore becomes important to minimise the consequences of
early pain experience. In a clinical setting, multiple painful procedures may be
performed daily for routine monitoring i.e. heel lance, to monitor blood oxygenation
levels of very young infants. Simons et al (2003) found that, during the first 14 days of
NICU admission, neonates were subject to an average of 14 potentially painful
procedures per day. A more recent study (Carbajal et al., 2008) confirmed these
findings, showing that neonates were exposed to an average of 16 painful and/or
stressful procedures, and that up to 80% of neonates were not given specific analgesia
for these procedures.Introduction
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Taddio and colleagues (1997) studied male infants that had been circumcised when they
were vaccinated at 4-6 months. Infants who had been treated with a topical anaesthetic
(EMLA cream) when circumcised showed a lower pain score than those who received
no anaesthetic, and the circumcised groups showed higher pain scores than
uncircumcised controls. This double-blind, randomised, controlled trial (RCT), together
with an earlier paper showing that parental ratings of pain sensitivity were lower at 18
months of age in infants born at extremely low birth weights (Grunau et al., 1994),
highlighted the potential consequences of early pain, and the importance of neonatal
analgesia.
Premature infants with NICU experience show lasting behavioural sensitivity to
mechanical stimuli that persists for at least the first year of life (Abdulkader et al.,
2007), and longitudinal studies find evidence for alterations in sensory processing in ex-
NICU children at school age (9-12 years)(Hermann et al., 2006; Hohmeister et al.,
2008). Buskila and colleagues (2003) showed ex-premature 12-18 year olds had
significantly more ‘tender points’ and lower tenderness thresholds than matched full-
term children, and Walker et al (2009a) recently presented data from a cohort of
extremely preterm infants born at less than 26 weeks PMA in 1995 (the UK EPICure
cohort); quantitative sensory testing (QST) in these children showed that ex-premature
children had decreased sensitivity to thermal stimuli, but no differences in mechanical
sensitivity when tested at the thenar eminence (at the base of the thumb). Decreases in
mechanical and thermal sensitivity were found adjacent to neonatal thoracotomy scars,
although no differences between ex-premature and term children were seen in current
pain experience or pain coping styles. This decrease in baseline sensitivity both globally
and at the site of scarring is replicated by evidence in children aged 9-12 who had
undergone neonatal cardiac surgery (Schmelzle-Lubiecki et al., 2007). Local sensitivity
changes are proposed to be due to altered peripheral pain processing, and global
changes in thermal and mechanical sensitivities due to centrally-mediated alterations in
nociceptive pathways (Walker et al., 2009a).Introduction
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1.1.2.1 Effects are mediated by alterations in central nociceptive
processing
Evidence for centrally-mediated alterations in pain processing after neonatal injury is
provided by studies investigating pain responses to noxious stimuli, or a new injury, in
post-premature or post-NICU children. Hermann and colleagues (2006) showed that
post-NICU premature infants had decreased thermal sensitivity and enhanced perceptual
sensitisation to a prolonged heat stimulus when tested at 9-12 years of age, compared to
non-hospitalised control children. Furthermore, these children were more likely to
catastrophise (exaggerate the negative aspects of the pain experience) and did not show
increased pain thresholds when in the presence of their mothers, unlike full-term control
children with no NICU experience (Hohmeister et al., 2008).
Major surgery to infants within the first three months of life caused an increase in pain
sensitivity when infants underwent subsequent surgery in either the same or a different
dermatome (an area of skin supplied by a single spinal nerve) at a later date (Peters et
al., 2005). In this study, pain sensitivity was measured by noradrenaline plasma
concentrations and anaesthetic demand during surgery, and observation and self-report
measures plus morphine intake post-surgery. Anaesthetic and analgesic demand was
highest in children with later surgery in the same dermatome, but was also higher when
surgery was performed in a different dermatome compared to infants with no surgical
history, suggesting changes in both spinal and supraspinal processing following
neonatal surgery.
However, the severity and type of injury during infancy can produce differing long-term
effects. Deep somatic and visceral noxious stimulation, such as that described by Peters
et al (2005), may lead to sensitisation of pain responses, but acute inflammatory types of
neonatal noxious stimulation, such as heel lance, may lead to reduced nociceptive
responsiveness (see La Prairie and Murphy, 2010). To illustrate, heel lancing led to
dampened behavioural responses in infants at 32 weeks’ post-conceptional age, with a
larger degree of hypo-responsiveness in neonates with a greater number of previous
invasive procedures (Grunau et al., 2001). A dampened response, as seen by decreased
facial responsiveness to immunisation and blunted nociceptive sensitivity to everyday
bumps, has also been seen in older infants at 4, 8, and 18 months of age in ex-pretermIntroduction
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neonates compared to full-term controls (Oberlander et al., 2000; Grunau et al., 1994).
This dichotomy is also illustrated by a study of school-age children (9-16 years) who
had suffered moderate or severe burn injuries in infancy (6-18 months of age)
(Wollgarten-Hadamek et al., 2009). Moderately burned infants showed increased
mechanical pain sensitivity, whereas severely burned neonates showed elevated thermal
pain thresholds.
Taken together, the effects of early surgery, prematurity and resulting length of NICU
stay can all affect the type and degree of later effects. Invasive early procedures such as
surgery may decrease sensitivity to pain at baseline, but a re-injury to a previously
injured infant, especially to an area served by the same spinal innervation, leads to
increased hypersensitivity compared to controls (Peters et al., 2005).
1.1.2.2 Prematurity can affect the stress response
Premature birth is also proposed to lead to alterations in generalised stress-arousal
systems. Premature infants are, as already mentioned, subject to many stressors such as
light, noise, maternal separation and noxious procedures. Grunau and colleagues (2006)
propose that these early stressors could increase the ‘allostatic load’ of the neonate.
‘Allostasis’ refers to the cumulative effects of exposure to repeated stressors, and is the
process by which an organism will strive to maintain homeostasis (bodily equilibrium),
for example via the hypothalamic-pituitary-adrenal (HPA) axis, which regulates the
stress response (see McEwen, 1998). Long-term, repeated stress exposure causes an
increased ‘allostatic load’, which will lead to an elevation of stress responses mediated
by the HPA axis (see McEwen, 2004). Evidence for this comes from studies showing
that cortisol levels (a stress hormone released on HPA axis activation) were higher in
ex-premature infants at 8 months when exposed to novel toys (Grunau et al., 2005), and
higher at baseline in infants born extremely premature (23-28 weeks PMA) when tested
at 3, 6, 8 and 18 months (Grunau et al., 2007). The authors propose that the stress
response systems are ‘reset’ by the stressful NICU experience, and that this could
contribute to the increased pain reactivity in older infants.
1.1.2.3 NICU experience can alter long-term cognitive development
Prematurity, and the associated necessary healthcare, are also linked to problems with
cognitive development. A large proportion of ex-NICU preterm infants show cognitiveIntroduction
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impairments later in development (Wood et al., 2005), and up to half will require some
form of educational support in childhood (Rivkin, 2000), with a high incidence of
behavioural disorders reported in post-premature adolescents (Indredavik et al., 2004).
Further, a meta-analysis of 227 studies showed that ex-premature infants were more at
risk from attention deficit disorders, and the earliest pre-term infants showed the most
cognitive deficits when tested at school age (Bhutta et al., 2002). Attempts to find an
anatomical substrate for these deficits has used imaging techniques to study brain
morphology in previously premature infants. Magnetic resonance imaging (MRI)
studies have demonstrated abnormalities in the size and/or growth rate in the cerebral
cortex, cerebellum and basal ganglia (Ajayi-Obe et al., 2000; Dyet et al., 2006;
Boardman et al., 2006), and diffusion tensor imaging (DTI), which can be used to assess
brain connectivity, has shown abnormalities in white matter tracts in the ex-premature
brain, which could help explain the increased incidence of cognitive difficulties in ex-
premature infants (Counsell et al., 2007; Berman et al., 2005; Dubois et al., 2006).
1.1.3 Animal models provide information on the development of
nociceptive processing
The data from humans on the effects of neonatal pain clearly show that injury during the
early life period can cause changes in sensory and nociceptive processing that can last
into adulthood. However, elucidation of the mechanisms of these changes relies
critically on modelling pain in animals. Animal models of neonatal pain identify cellular
mechanisms that would be impossible to study in humans, and provide researchers with
novel drug targets for the development of new pharmaceutical agents for pain
management. In addition, animal models are used as preclinical screening systems,
where potential new drugs are tested for efficacy and toxicity.
The gestational period for a rat is 21.5 days, and the development of the CNS over the
first 7-10 days of life in the rat is approximately equivalent to that of an infant from 24
through to 40 weeks of gestation (see Fitzgerald and Walker, 2009; McCutcheon and
Marinelli, 2009 for reviews). This comparability means that study of the development of
spinal nociceptive circuits and brain connectivity in animals can inform researchers on
the developmental stage of premature infants.Introduction
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1.1.3.1 Nociceptive transmission pathways
Pain is transmitted from the periphery to the brain via the spinal cord. Primary afferent
nociceptors at the periphery are activated upon intense, potentially damaging stimuli,
and action potentials within these nerve fibres are transmitted to the spinal cord.
Primary afferent fibres are divided into those that are myelinated (Aβ and Aδ fibres) and 
those that are not (C fibres). Myelinated A fibres are involved in transmitting
mechanical information, and unmyelinated C fibres in transmitting thermal information,
with  Aδ  and  C  fibres  implicated  in  pain  processing.  Cell  bodies  of  all  fibre  types 
constitute the dorsal root ganglion (DRG)(Wall and Melzack, 2005). The terminals of
the nociceptors are located in specific spinal layers (laminae), and when activated, the
primary afferents release peptides and glutamate, which activate second order neurons.
Dorsal horn neurons of the spinal cord relay the nociceptive signal to the contralateral
side of the spinal cord, and from there the spinothalamic tract, consisting of ascending
projection fibres, conveys the signal to the brainstem and thalamus (see Figure 1-1)
(Wall and Melzack, 2005). From here, the nociceptive signal is passed to a variety of
nuclei and cortical areas, which mediate different aspects of the pain experience. The
intensity of a noxious stimulus is coded for by the firing rate of pain transmission
neurons (Julius and Basbaum, 2001).
Figure 1-1 – A schematic diagram to
illustrate the afferent projections from the
dorsal horn of the spinal cord to supraspinal
areas, via the spinothalamic tract (consisting
of the spinoreticular (SRT) and
spinomesencephalic (SMT) tracts).
Nociceptive stimuli are transduced by
primary afferent nociceptors at the
periphery and transmitted to the spinal cord,
from where the signal ascends to the
thalamus and is then passed onto higher
cortical areas for processing. Adapted from
Fields (2004).
However, nociception and the sensation of pain are modulated by a number of
mechanisms at different sites, and the brain exerts a large descending modulatory
influence on spinal cord nociceptive processing, depending on both external stimuli and
the motivational state of the organism (Scholz and Woolf, 2002; Fields, 2004). TheIntroduction
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periaqueductal grey (PAG) of the midbrain receives direct input from the hypothalamus
(which has a role in maintaining the internal homeostatic state of an organism) and
limbic forebrain, which consists of a collection of cortical and subcortical structures that
are implicated in memory and emotional processing, and includes the hippocampus and
amygdala. From the PAG, descending modulatory signals are sent to the rostroventral
medulla (RVM) of the brainstem, which transmits either excitatory or inhibitory signals
to the nociceptive neurons of the dorsal horn of the spinal cord, with a net effect to
either increase or decrease ascending nociceptive signals (see Figure 1-2).
Figure 1-2 – A schematic diagram to
illustrate the descending pathways that can
modulate nociceptive processing. The
anterior cingulate cortex (ACC),
hypothalamus (H), thalamus (T) and
amygdala project to the periaqueductal grey
(PAG), which can indirectly control pain
transmission in the dorsal horn of the spinal
cord through the rostroventral medulla
(RVM). Excitatory modulation is shown in
red, inhibitory in green. The yellow pathway
represents a separate control channel via
serotonergic neurons in the RVM. Ascending
transmission is shown in purple. Adapted
from Fields (2004).
1.1.3.2 Spinal nociceptive processing develops over the first few weeks
of an animal’s life
The spinal cord is not mature at birth in the rat, and undergoes considerable change over
the first 2-3 weeks of life (see Fitzgerald, 2005). In the adult, both Aδ and C fibres 
regulate nociceptive processing, and the Aβ fibres are involved in mechanosensation. 
However, in the neonatal rat, differences in the developmental rate of penetrance of the
afferents from the dorsal root ganglia mean that nociceptive reflexes are predominantly
mediated by Aβ and Aδ fibres, rather than by the C fibres, as in the adult. This is 
because myelinated afferents enter the spinal cord earlier than unmyelinated C fibres
during embryogenesis (Ozaki and Snider, 1997; Jackman and Fitzgerald, 2000), and C
fibre innervation is not present in lamina II until embryonic day (E) 18-19 (Fitzgerald,
1987). In addition, Aβ fibres grow terminal arbors that are larger than they will be in Introduction
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adulthood, extending across spinal cord laminae that will not be innervated by these
fibres in later life (Beggs et al., 2002; Granmo et al., 2008). Destroying developing C
fibres with capsaicin, or blocking cell activity with NMDA receptor antagonists show
that the dendritic withdrawal process is dependent on cell signalling between A and C
fibres within the spinal cord (Torsney et al., 2000; Beggs et al., 2002).
The immaturity of dendritic projections of Aβ fibres in the developing spinal cord is 
likely to contribute to increased receptive field size (the area of the body that produces a
response in a specific neuron when stimulated) of dorsal horn neurons (Fitzgerald and
Jennings, 1999), and an overlap of A and C fibre signalling. This in turn leads to reflex
withdrawal from normally innocuous stimuli and disorganised reflex responses to
noxious stimuli (Jennings and Fitzgerald, 1996; Levinsson et al., 1999; Holmberg and
Schouenborg, 1996; Waldenstrom et al., 2003). Indeed, in rats, a focal heat source
directed to the tail will produce reflex withdrawals both towards and away from the
stimulus, which becomes more organised over time (Waldenstrom et al., 2003). The fact
that disordered withdrawal reflexes are also seen in young infants (Andrews et al.,
2002) suggests that similar developmental spinal mechanisms are present in the human.
The enhanced, less organised spinal withdrawal responses in the neonate compared to
the adult is also likely to be due to an immature balance between excitatory and
inhibitory signalling (see Fitzgerald, 2005). Excitatory transmission is mediated by
glutamatergic synapses in the spinal cord, and excitatory postsynaptic receptors such as
AMPA  (α-amino-3-hydroxy-5-methyl-4-isoxazole  proprionic  acid)  and  NMDA  (N-
methyl-D-aspartate) receptors are found at higher levels in the neonate than the adult
(Jakowec et al., 1995; Gonzalez et al., 1993). In addition, the composition of receptor
subunits changes over development, which will alter the relative permeability of these
receptors to calcium ions (Burnashev et al., 1992; Wang et al., 1994). Inhibitory
modulation by glycine and GABA (γ-aminobutyric acid) is not mature at birth, and high 
levels of chloride ions within the cell (due to a developmental lag in expression of the
KCC2 transporter protein that regulates these ions within the cell) mean that GABA
receptor activation in the neonate can be excitatory, instead of inhibitory (Ben-Ari,
2002). Spinal GABAergic and glycinergic inhibition is functional in neonatal rats, but
undergoes significant maturation over the first days of life (Baccei et al., 2003; Ririe et
al., 2008).Introduction
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1.1.3.3 Descending inhibitory control from the brainstem is not mature
in the neonatal rat
The brainstem plays a major role in modulation of ascending excitatory signalling from
the spinal cord (Basbaum and Fields, 1984; Ren and Dubner, 2002), and modulation by
the periaqueductal grey (PAG) and rostroventral medulla (RVM) is channelled down
descending fibres via the dorsolateral funiculus (DLF) to the spinal cord (Basbaum and
Fields, 1984; Sandkuhler, 1996) (see Figure 1-2). This descending inhibition does not
reach maturity in the rat until 3 weeks of age (postnatal day (P)21) (Fitzgerald and
Koltzenburg, 1986; Boucher et al., 1998).
Furthermore, the RVM undergoes a developmental shift beginning at around P21, from
an exclusively facilitatory role in spinal pain transmission, to a biphasic role, both
facilitating and inhibiting ascending spinal input (Hathway et al., 2009). PAG
stimulation will not produce analgesia until 3 weeks of age, further suggesting that the
brainstem nuclei involved in descending inhibition are not functional until the third
postnatal week (Van Praag and Frenk, 1991b).
Together, this evidence demonstrates that pain processing is immature in the neonatal
rat, and that before P21, excitatory spinal processing predominates, leading to enhanced
responses to noxious and non-noxious stimuli. This excitability and lack of descending
control may be an important factor in allowing central plasticity following early pain
and injury.
1.1.3.4 Long-term effects of neonatal noxious stimuli in rodents
As in humans, interference with the neonatal rodent CNS causes long-term alterations in
nociceptive responses. Similar to neonatal humans, animals cannot report their pain, but
behavioural responses can be measured and monitored, and drug effects and
physiological mechanisms investigated.
The consequences of neonatal injury in rodents depend, as in humans, on the type of
injury (e.g. nerve damage or inflammation), and the sensory modality being investigated
(e.g. heat or mechanical sensitivity). Inflammation induced by repeated paw prick
(much like a human heel lance) causes thermal hyperalgesia (an exaggerated response toIntroduction
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a painful stimulus) in rat pups that lasts from several weeks up to adulthood (Anand et
al., 1999; Walker et al., 2003a). Neonatal inflammation lasting up to 7 days, induced by
injection of Complete Freund’s adjuvant (CFA), results in enhanced spinal neuronal
responses to paw pinch in the adult, as well as increased primary afferent nerve fibre
innervation of the dorsal horn (Ruda et al., 2000), suggesting that the hypersensitivity
exhibited after both short- and long-term inflammation may be mediated by spinal
circuits.
Further evidence for spinal circuitry mediating later hypersensitivity comes from studies
of skin wounds to neonatal rat pups. Wounds caused drops in mechanical withdrawal
thresholds and increases in dorsal horn receptive field size long after the wound had
healed (Reynolds and Fitzgerald, 1995; Torsney and Fitzgerald, 2003). Tissue injuries
such as skin wounding cause release of nerve growth factors, and this increase in
growth factors causes hyper-innervation of the skin, leading to the increased sensitivity
to noxious stimuli seen in later life (De Lima et al., 1999). This is consistent with
human studies showing hypersensitivity after injury in children, especially those with
previous surgical history (Taddio et al., 1997; Andrews and Fitzgerald, 2002; Peters et
al., 2005).
As in humans, global hypoalgesia in adult rats can also result from pain experience as
pups, and is proposed to be mediated by changes in descending modulation (La Prairie
and Murphy, 2009) or alterations in the stress response to injury (see Fitzgerald, 2005).
Bhutta et al (2001) found that repeated formalin injections to the rat pup hindpaw within
the first week of life caused decreased thermal sensitivity in the adult, the effect of
which was decreased by pre-treatment with morphine. Daily foot-shock to rat pups from
birth until P21 produced adult animals with a marked reduction in thermal sensitivity
(Shimada et al., 1990), and the authors also found that morphine analgesia in adulthood
was increased in the foot-shocked rats. The preventative role of analgesia in the long-
term effects after this type of injury is also seen in mice (Sternberg et al., 2005) and
humans (Taddio et al., 1997; Taddio and Katz, 2004).
Ren et al (2004) modelled both the baseline adult hypoalgesia after neonatal injury, and
hypersensitivity after re-injury, by injecting carrageenan (which causes short-term
inflammation lasting ~24 hours) to the rat hindpaw within the first two weeks of life.Introduction
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When mechanical and thermal thresholds were tested at baseline in adulthood (P120-
125), significant hypoalgesia was seen in both the ipsilateral (same) and contralateral
(opposite) paws, an effect replicated by La Prairie and Murphy (2007). When the adults
were given a further carrageenan challenge, however, hypersensitivity to noxious
stimuli was seen only in the ipsilateral paw. The authors suggest that the local
hypersensitivity is mediated by spinal segmental changes after neonatal inflammation,
i.e. alterations in the developmental connectivity of the spinal cord and/or sprouting of
nerve fibres at the skin, resulting in an increased nociceptive response. The hypoalgesia
they attribute to alterations in descending inhibitory tone or alterations in stress
regulation, support for which comes from studies showing that early stress alters later
nociceptive processing (Pieretti et al., 1991; Coutinho et al., 2002). Similar baseline
hypoalgesia after neonatal CFA and hypersensitivity to re-inflammation was shown by
Lidow and colleagues (2001).
1.1.3.5 Critical periods in development and long-term effects
Consistent with evidence on the maturation of spinal nociceptive processing, plus
human studies showing that pre-term infants experience lasting effects of noxious
stimulation but that full-term infants do not (Taddio et al., 1997; Walker et al., 2009a), it
would appear that it is stimulation during a ‘critical period’ of development which
predicts long-term changes (La Prairie and Murphy, 2010). Critical periods are defined
as time windows within which an organism develops in a particular way. Interference
with development during this window will cause long-lasting changes, yet outside of the
critical period, the same stimulation will not lastingly affect development. Critical
periods have been described in a variety of modalities, including vision, hearing, the
stress response (see Hensch (2004) for a comprehensive review), and more recently pain
(La Prairie and Murphy, 2007; Walker et al., 2009b).
The concept of a critical period is demonstrated by the effect of nerve injury on
neonates at different stages of development. In adults, peripheral nerve damage causes
significant allodynia (a withdrawal response to a previously innocuous stimulus) and
neuropathic-like pain behaviours that last for weeks to months (Decosterd and Woolf,
2000). However, the same nerve damage to rat pups performed within the first three
weeks of life produces only transient increases in sensitivity. If, however, surgery is
performed at P33, lasting allodynia is produced (Howard et al., 2005). ThisIntroduction
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phenomenon is consistent with human data showing that brachial plexus damage, which
injures the nerves innervating muscles and skin of the arm and upper torso, does not
cause chronic pain in neonates as it does in adults (Anand and Birch, 2002).
From the evidence discussed above, long-term alterations in nociceptive processing
only occur within certain critical periods. In the rat, this is within the first three weeks of
life. In the human neonate, long-term effects occur mainly in post-premature infants,
born between 24 and 38 weeks PMA. As the first two weeks of the rat’s life correspond
approximately to the final trimester in human gestation, this strongly suggests that the
critical periods are the same for both species, and means that the developmental
mechanisms described in the rat that mediate nociceptive processing (i.e. development
of spinal cord connectivity, maturation of spinal neuronal responses, and appearance of
descending inhibition) are likely to be similar to those in the human. This, in turn, could
help inform clinical practice in the treatment of preterm infants in the NICU.
1.2 Pain and reward processing are linked
The experience of pain is unpleasant – indeed, the International Association for the
Study of Pain (IASP) define pain as “an unpleasant sensory and emotional experience
associated with actual or potential tissue damage, or described in terms of such
damage”. This definition inherently accepts that pain is a subjective emotional
experience, but also that the relief from pain will be the opposite of unpleasant, i.e.
pleasurable, or rewarding. The main groups of analgesics in use in clinical practice,
such as opioids, are also intensely rewarding and subject to addiction and abuse
(Franklin, 1989), and there is a huge overlap in brain areas involved in pain and reward
processing (see Borsook et al., 2007; Leknes and Tracey, 2008 for reviews).
Furthermore, many drugs of abuse have analgesic actions, such as cocaine,
amphetamine, nicotine, ketamine, and alcohol (Franklin, 1989).
1.2.1 Areas of the brain involved in pain and reward processing
overlap
Rewarding and painful (i.e. aversive) stimuli are positive and negative reinforcers of
behaviour in animals, and the dopaminergic and opioidergic systems of the brain are
critical for both types of reinforcer, as they provide both the ‘pleasure’ of rewards and
are involved in antinociception and analgesia (see Borsook et al., 2007). HumanIntroduction
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imaging studies have shown that the same areas activated by reward are also activated
by pain (Becerra et al., 2001; Seymour et al., 2005; Scott et al., 2007) and much data
now suggests that rewarding and aversive stimuli affect similar pathways in the CNS,
leading to a robust demonstration that pain and reward processing involves many
overlapping areas. These areas include the hypothalamus, amygdala, RVM, PAG,
hippocampus, prefrontal cortex, anterior cingulate cortex (ACC), insular cortex, ventral
tegmental area (VTA), and nucleus accumbens (NAcc) (see Leknes and Tracey (2008)
for a comprehensive review).
To illustrate the overlapping regions in brain pain and reward, brief evidence is
presented for dual processing roles in three structures: the nucleus accumbens,
amygdala and anterior cingulate cortex.
1.2.1.1 NAcc
The NAcc is particularly well-situated to mediate pain and reward processing. It
receives direct input from dopaminergic neurons in the mesolimbic dopamine system
and injection of opioids directly into the NAcc, which activates reward pathways,
induces analgesia (Dill and Costa, 1977). Opioid antagonism by accumbal injection of
naloxone attenuates the analgesic effect of morphine (Gear and Levine, 1995), and two
distinct regions of the NAcc shell have been identified: one that mediates pleasure, and
one that causes a negative shift in affect (Reynolds and Berridge, 2002). Dopamine
analgesia is mediated through the NAcc (Altier and Stewart, 1998; 1999).
1.2.1.2 Amygdala
The amygdala is part of the descending pain modulatory system (see Figure 1-2) is
activated in humans during both acute and chronic pain (Becerra et al., 2001; Harris et
al., 2007a), and is associated with the emotional reactivity to pain (see Finn et al., 2003;
Neugebauer et al., 2004). The amygdala also shows activation following both rewarding
and aversive stimuli (Breiter et al., 1997), possibly due to its role in orienting to
motivationally salient stimuli (see Rolls, 2000).
1.2.1.3 Anterior cingulate cortex
The ACC is critical for learning aversive teaching signals i.e. the cue that predicts when
an animal will receive a noxious stimulus (Johansen et al., 2001; Johansen and Fields,Introduction
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2004), and human imaging studies have shown that the ACC is implicated in aberrant
pain signalling in chronic pain patients (Apkarian et al., 2001). Furthermore, lesions of
the ACC decrease the physical perception of pain, implicating a role in analgesia
(Wilkinson et al., 1999). Shidara and Richmond (2002) showed that ACC neurons in
monkeys code for reward expectancy, illustrating a role for the ACC in reward
processing.
1.2.2 Analgesia and relief from pain are rewarding
As pain is potentially damaging to an organism, a pain state is one that an organism will
work to avoid. Conversely, a reward is something that an organism will work to
achieve, and includes pain relief, i.e. analgesia. As pain is a deviation from the standard
internal state, the motivation for pain relief can be thought of in terms of the animal
striving to regain homeostasis as it would for other systems, i.e. hunger and thirst.
Together, this leads to conceptualisation of pain and reward as opposite ends of the
same spectrum, with homeostatic balance being striven for. In general, the reward value
of a stimulus increases the more effective that stimulus is at restoring homeostasis (see
Craig, 2003), which would mean that analgesics which are most effective in reducing
pain are those with the highest reward value. That analgesia is rewarding is supported
by several lines of evidence, as detailed below.
1.2.2.1 Termination of a pain stimulus is rewarding
Firstly, termination of a painful stimulus is rewarding (Seymour et al., 2005; Leknes
and Tracey, 2008). For example, Leknes and colleagues (Leknes et al., 2008) performed
a human psychophysical experiment into the pleasantness of pain relief. A noxious
thermal stimulus of varying intensity (ranging from pain threshold to intense pain, as
rated by self-report using a visual analogue scale) was briefly applied to the arm.
Subjects were asked to self-report the maximal relief felt when the stimulus was
terminated. The authors found a strong positive correlation (r=0.81) between the pain
intensity and sensation of relief (see Figure 1-3), showing that the termination of the
noxious stimulus was more rewarding when the pain intensity was higher. These
findings are consistent with data showing that relief from other unpleasant states such as
hunger activates reward processing areas in the brain (Kringelbach et al., 2003), as does
expectation of pain relief (Seymour et al., 2005). In addition, psychophysical data has
shown that pain perception increases as stimulus intensity increases (Price, 1999),Introduction
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therefore directly linking stimulus intensity, pain sensation, and reward upon pain
cessation.
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Figure 1-3 - A schematic illustration of the positive correlation found by Leknes et al, whereby
subjective relief upon pain cessation increases as pain intensity increases. Adapted from Leknes et
al (2008).
1.2.2.2 The placebo effect relies on reward processing
The placebo effect occurs when patients perceive benefit from treatment, despite it
having no genuine therapeutic effect. The effect therefore relies on expectation of pain
relief, and is mediated by opioidergic mechanisms, as similar brain areas are activated
by opioid agonists and placebo analgesia (Levine et al., 1978b; Petrovic et al., 2002;
Benedetti et al., 2005). Human imaging (fMRI) studies over the past decade have
implicated crucial brain areas involved in the placebo response, most of which are
classically implicated in reward processing. For example, the release of endogenous
opioids and dopamine from mesolimbic reward areas such as the nucleus accumbens
and ventral striatum has been shown during placebo analgesia (Zubieta et al., 2005;
Scott et al., 2008). In addition, the magnitude of the placebo effect is predicted by the
release of dopamine from the nucleus accumbens (Scott et al., 2007) and grey matter
density in brain reward processing areas (Schweinhardt et al., 2009). Dopamine-related
personality traits (such as sensation-seeking and reward responsiveness) are also linked
to the extent of placebo analgesia (Schweinhardt et al., 2009).
1.2.2.3 Rewarding stimuli induce analgesia
Analgesia can also result from a variety of classically rewarding stimuli, such as
pleasurable music, odours, images, and sexual behaviour (Leknes and Tracey, 2008).
Palatable food can also induce analgesia. A classic study by Dum and Herz (1984)Introduction
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showed that thermal nociceptive withdrawal thresholds of rats are raised when they are
expecting a chocolate reward, as the animals took longer to move off a hot-plate when
they had previously received a chocolate reward under the same conditions. This effect
was reversed by naloxone (an opioid antagonist), and is therefore opioid-mediated. As
discussed previously, sucrose can be used as an analgesic in neonatal care (see Stevens
et al., 2010). The fact that sucrose is not a ‘classic’ analgesic i.e. does not directly
influence pain transmission (Fitzgerald, 2009), suggests that sucrose may be acting via
supraspinal reward pathways in the neonate, evidence for which comes from the fact
that sucrose analgesia in animals is blocked by naloxone (Blass et al., 1987).
1.2.2.4 Chronic pain states reduce reward responses
Whilst opioids are highly rewarding, chronic pain patients do not show the same levels
of addiction to opioids as non-patients (Noble et al., 2010). In both inflammatory and
nerve injury pain states, morphine loses its rewarding effects (Suzuki et al., 1996). The
mechanisms for this are thought to involve dysregulation of mu opioid receptor function
in the VTA via an ERK-mediated signalling pathway, caused by continuous release of
endogenous opioids caused by nerve injury (Ozaki et al., 2002; Ozaki et al., 2004;
Niikura et al., 2008). The loss of the rewarding effects of opioids in an inflammatory
pain state is also due to sustained activation of the kappa opioidergic system, which is
anti-analgesic (Narita et al., 2005).
1.2.3 Endogenous opioids modulate pain and reward
As many of the above studies show, opioids are essential for modulation of both pain
and reward (Fields, 2007). Exogenous opioids, such as morphine, are potent analgesics
and drugs of abuse, and endogenous opioids, produced and released internally, are
critically involved in the descending modulatory control of nociceptive processing (see
Fields, 2004). The analgesic effect of opioids are produced by direct action on spinal
cord nociceptive circuits, and supraspinal disinhibition of brain reward areas, which
leads to increased dopamine release in the forebrain, and results in the rewarding effects
of opioids.
There is robust evidence for the importance of endogenous opioids in nociception.
Opioid receptors are found throughout the brain, but particularly in areas involved in
both nociceptive and reward processing such as the RVM, PAG, and ventral striatumIntroduction
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(see Le Merrer et al., 2009). Injection of opioid receptor agonists produces analgesia,
particularly in the PAG (Yaksh et al., 1976), and electrical stimulation of areas rich in
opioid receptors such as the PAG produce increases in nociceptive withdrawal
thresholds in animals (Mayer and Liebeskind, 1974) and analgesia in humans
(Hosobuchi et al., 1977). Antagonism of opioidergic signalling in the PAG and RVM
blocks analgesia (Kiefel et al., 1993). Furthermore, the brain releases endogenous
opioids in response to painful stimuli, suggesting an internal anti-nociceptive circuit is
being activated (Zubieta et al., 2001).
However, descending modulation of pain can excite or inhibit pain responses due to
specific subsets of cells within the PAG and RVM exerting opposite effects on spinal
cord nociceptive signalling. RVM stimulation can both inhibit or facilitate nocifensive
behaviours and dorsal horn neuronal responses (Urban et al., 1999; Zhuo et al., 2002).
The two classes of neurons responsible for this opposite signalling are termed ON and
OFF cells, with a third class of serotonergic neurons classified as NEUTRAL cells,
which have a variable response to noxious stimuli (Potrebic et al., 1994) (see Figure
1-2).
ON cells are characterised by a burst of activity that begins just before a nociceptive
withdrawal reflex, and OFF cells show a pause in firing that begins just prior to the
withdrawal reflex (Heinricher et al., 1989). Both classes of cells project to specific
laminae of the spinal cord that relay nociceptive signals (Fields et al., 1995), and firing
rates are affected by opioid receptor agonists, which cause continuous OFF cell firing
and silence ON cells (Heinricher et al., 1994). The net activity of one set of neurons
over the other is thought to rely on the behavioural state of the animal, as activity is
controlled by the higher order brain areas reciprocally connected to the PAG and RVM,
such as the amygdala, hippocampus and frontal cortices, which assimilate information
from multiple areas to control behaviour (see Fields, 2004).
1.2.4 Motivation-decision model
The systems controlling the facilitation or inhibition of spinal cord nociceptive
processing are best understood when looking at pain as a behavioural motivator, in that
escape from painful stimuli and seeking of relief from pain are highly motivating drives.
The motivation-decision model, as put forward by Fields (2004; 2006), states thatIntroduction
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anything that is potentially more important for survival than pain should exert anti-
nociceptive effects. For example, if an animal is subject to a mild pain state in order to
gain a reward such as food or sex, the pain state will be ignored as the reward exerts an
anti-nociceptive effect. Conversely, if the tissue damage, or threat of damage, is severe
enough to threaten the animal’s survival, any reward will be ignored as the animal
engages in self-protective strategies such as escape, avoidance, and guarding behaviour
of any injury site. Fields (2006) states that the control over the reward or survival
behaviours is mediated by cortical brain structures involved in reward and decision-
making, and signals sent via the biphasic descending opioid modulatory system.
Evidence for this model comes from a variety of sources. Animal studies have shown
that rewards elicit an increased tolerance of pain, and that this is mediated by
endogenous opioid release, as shown by Dum and Herz (1984). Stimuli that elicit innate
(i.e. predator-driven) and conditioned (i.e. learnt) fear block pain responses via opioid
release, indicating that the blockade of pain responses is in order to protect the organism
against a greater immediate threat to survival (Fanselow, 1986). Indeed, animals
conditioned to receive a foot-shock show longer withdrawal latencies upon presentation
of the conditioned stimulus, which relies on endogenous mu opioid signalling in the
amygdala, PAG and RVM (Bellgowan and Helmstetter, 1998; Foo and Helmstetter,
1999). This phenomenon, termed stress-induced analgesia, has been the subject of much
research, and is modulated by the descending inhibitory pain pathway in both animals
and humans (Willer et al., 1981; Butler and Finn, 2009).
In humans, further evidence for the motivation-decision model comes from findings that
the anticipation of pain activates descending inhibitory pathways. Keltner et al (2006)
showed that pain expectation affected the activation of classic nociceptive areas such as
the thalamus and somatosensory cortices, and that this modulation converged on the
nucleus cuneiformis, a brainstem region that receives input from the PAG and projects
to the RVM. Fairhurst et al (2007) also found that pain anticipation caused increased
activation of the PAG, and that actual receipt of the pain activated the PAG, RVM and
ventral tegmental area. The authors proposed that the anticipatory activity in the PAG
was to activate descending inhibitory pathways to help modulate the pain. Supporting
this, the anticipation of a reward or pain relief, as already shown, causes release of
endogenous opioids in the human brain (Zubieta et al., 2005).Introduction
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Becerra et al (2001) provided a potential neurobiological substrate for the ‘decision’
aspect of the motivation-decision model. The authors showed that noxious thermal
stimuli activated both classical reward and pain areas, but that an early phase of
activation was seen in ‘reward’ structures such as the nucleus accumbens and ventral
tegmental area, and a later phase of response was seen in ‘pain’ areas such as
somatosensory and anterior cingulate cortices, thalamus and insula. Fields (2006)
proposes that this early phase activation is when the response ‘decision’ is made, taking
into account salient external factors and motivational drives. This proposal fits well with
evidence that dopaminergic signalling in brain reward areas is involved in incentive
salience (i.e. how important a stimulus is to an organism), valence (i.e. whether a
stimulus is positive or negative in nature) and behavioural motivation (see Wise, 2004;
Schultz, 2007). Once the ‘decision’ is made, the late phase activation of ‘pain’ areas
seen by Becerra and colleagues controls the behavioural response, as higher cortical
areas such as the anterior cingulate, amygdala and prefrontal cortex send output to the
midbrain structures that biphasically modulate spinal cord nociception.
1.2.5 Does early pain lead to altered reward processing in later life?
The evidence presented above shows that pain during a critical period of development
causes long-lasting changes in pain responses, but the effects of early pain on alternative
modalities is an area of much research.
Studies have shown the long-term effects of repeated neonatal pain and stress on the
adult stress response, in terms of the responsiveness of the HPA axis. Infants with prior
NICU experience show alterations in stress responsivity later in childhood (Grunau et
al., 2005; Grunau et al., 2007), and animal studies have investigated the impact of
stressors such as maternal deprivation and repeated handling on the organism’s
neurobiology and later adult behaviours (Pieretti et al., 1991; Coutinho et al., 2002;
Champagne and Meaney, 2006; Lippmann et al., 2007; Enthoven et al., 2008). Meaney
et al (2001) studied the impact of early maternal deprivation on dopaminergic
processing, explicitly linking early stress and reward, and found changes in dopamine
transporter proteins and adult response to cocaine and amphetamine. As pain is
inherently stressful, this strongly suggests that neonatal pain could alter reward
processing in the adult.Introduction
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Maternal style in rats and humans also impacts upon later responses to stress, novelty
and pain, (Meaney, 2001; Champagne et al., 2003; Champagne and Meaney, 2007;
Clinton et al., 2007; de Medeiros et al., 2009), the effects mediated by epigenetic
influences on gene expression and translation (Weaver et al., 2004; Fagiolini et al.,
2009). Furthermore, evidence from rodent, primate and human studies suggests that the
infant-parent attachment is rewarding for both mother and infant, and that this bond is
mediated by opioidergic and dopaminergic systems (Moles et al., 2004; Barr et al.,
2008; Noriuchi et al., 2008), both of which are critically involved in pain and reward
processing. Due to the large overlap between pain and reward processing, we
hypothesise that pain during early life will lead to alterations in reward processing in the
adult animal, and this hypothesis forms the basis of this thesis.
There have been suggestions in the literature that early pain can affect later reward-
related processing, although to date no published literature exclusively investigating this
question. Studies into the long-term effects of early pain on adult pain processing have
shown changes in preference for alcohol as adults (Bhutta et al., 2001) or alterations in
opioid tone (La Prairie and Murphy, 2009). However, these studies are investigating
pain, gender and the effects of early analgesia, and do not discuss their results in terms
of reward processing. They do, however, provide intriguing suggestions that early pain
may affect the opioid-mediated descending modulation of pain, which, as discussed
above, shares common brain regions with areas involved in reward processing.
1.3 The aims of this thesis
To summarise the above evidence, it is known that early pain causes long-term effects
on pain processing, and that pain and reward processing are neurobiologically linked.
We therefore hypothesise that repeated painful experience will affect reward processing
in the adult.
This thesis will investigate this question in three main ways:
1) To test the feasibility of the hypothesis that early life pain can interfere with
developing reward pathways, we needed to establish the functionality of reward
pathways in the neonate. Chapter 2 will therefore investigate the functionality ofIntroduction
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reward pathways in the neonate using a classic analgesic and drug of abuse,
morphine, to activate the system.
2) To test the hypothesis that early pain experience can alter adult reward
behaviour, Chapter 3 will investigate the effect of repeated neonatal pain on
adult reward behaviours, using a model of neonatal injury designed to mimic
clinical procedures. Reward behaviour will be investigated using a conflict
paradigm that places an animal’s motivation for reward in competition with its
drive for safety and survival.
3) Finally, to test the hypothesis that early pain experience can alter adult reward
cell signalling in the CNS, Chapter 4 will investigate whether early pain
experience alters the activation of the orexin system of the lateral hypothalamus
during reward behaviours. The orexin system impacts upon opioid and
dopaminergic transmission and is strongly implicated in reward processing.Chapter 2
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2 Chapter 2 – Investigating the effect of morphine on
neonatal reward pathways
2.1 Introduction
The aim of this chapter is to investigate the function of the neonatal mesolimbic
dopaminergic system and how it differs from that of the adult, using morphine to
stimulate and activate the system. Activity of the dopaminergic cells of the ventral
tegmental area (VTA) of the rat midbrain have been used to investigate the functional
role of dopaminergic pathways after acute and chronic morphine administration in
young rats. Morphine is not only a potent analgesic but also a drug of abuse, and is
well-known to activate the reward pathways in the adult brain (see Le Merrer et al.,
2009).
The response of the adult dopaminergic system to rewarding stimuli is well-
documented, but the development in the neonatal system is less well-known. As the
overall hypothesis of this thesis is that pain and reward processing overlap, and that pain
during early life affects later reward-related processing, then it is important to see to
what extent the early dopaminergic reward system can be activated in the newborn.
Morphine is a useful and classical method of testing this.
In addition, it is important to understand the central effects of morphine in the newborn,
as this is a critical period for the development of the pain system and morphine is
frequently prescribed in neonatal intensive care units (NICU) to sedate premature
infants and provide analgesia for some procedures (see Anand, 2007).
2.1.1 Dopamine (DA)
Dopamine is a catecholamine and, as well as being an important neurotransmitter in its
own right, it is also the precursor to adrenaline and noradrenaline. Dopamine-releasing
cells are located mainly in the substantia nigra pars compacta (SNpc), the
hypothalamus, and ventral tegmental area (VTA) and dopamine is broken down by the
enzymes monoamine oxidase (MAO) and catechol-O-methyl transferase (COMT).
Figure 2-1 shows the biosynthetic pathway for dopamine:Chapter 2
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Figure 2-1 – the biosynthetic pathway for dopamine, showing precursors and enzymes
Dopamine acts on D1 to D5 G protein-coupled receptors (GPCRs). D1 and D5 are
classified as ‘D1-like receptors’ and D2, 3 and 4 as ‘D2-like receptors’. The two groups
are similar in terms of structure and pharmacological profile, but differ in terms of
localisation within the brain and relative distribution. Furthermore, ‘D1-like’ receptors
couple to the Gs GPCR, stimulating adenylate cyclase to activate protein kinase A
(PKA), whereas ‘D2-like’ receptors couple to the Gi GPCR signalling pathway, which
inhibits PKA (see Rho and Storey, 2001). The D1 and D2 receptors are most strongly
implicated in reward and addiction, as shown by animal (Maldonado et al., 1997; Pruitt
et al., 1995) and human imaging studies (see Volkow et al., 2009).
Tyrosine hydroxylase (TH) is the rate-limiting enzyme in DA production from its
precursor (see Figure 2-1). It is widely-used as a dopaminergic cell marker the
expression of TH has been used in this investigation to map dopaminergic cells of the
ventral tegmental area at different ages (Narita et al., 2004a; Berhow et al., 1996).
2.1.1.1 Dopamine in the brain
The dopaminergic system has been the subject of a huge number and variety of
experiments and various controversies over the years, and is now known to be involved
in a variety of brain systems. In the basal ganglia, dopamine cells are crucial in the
initiation of movement (see Lewis and Barker, 2009). Imbalances of dopamine in the
prefrontal cortex can lead to psychosis, and a lack of dopamine has been linked to
depression (see Totterdell, 2006). It also has a major role in reward and motivational
processing, via the mesolimbic dopaminergic system (see Wise, 2004).
Tracing and lesion studies of dopaminergic projections have elucidated the anatomy of
connections well, showing that dopaminergic fibres project to many areas of the brain in
both rats (Deutch et al., 1988) and man (Haber and Knutson, 2009).
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Figure 2-2 - a schematic to show the nigrostriatal and mesocorticolimbic projections in the rat (left) and
human brain (right). In the human brain schematic, the green pathway is the nigrostriatal projection and the
purple the mesolimbic projections from the VTA to the ventral striatum and prefrontal cortex (left: adapted
from http://homepage.psy.utexas.edu/homepage/class/Psy332/Salinas/Neurotransmitters/Slide08.GIF; right:
adapted from http://openlearn.open.ac.uk/mod/resource/view.php?id=192954).
Many addictive drugs, including many analgesics, affect the dopaminergic system. They
increase dopamine levels in the brain by a variety of methods. Cocaine and
amphetamine block the dopamine reuptake transporter (Giros et al., 1996), which allows
DA to remain in the synaptic cleft for longer. Nicotine acts on presynaptic cholinergic
receptors to increase DA release, and mu opioids inhibit GABAergic interneurons that,
at basal levels, inhibit the DA cells of the VTA.
Dopaminergic drugs also have analgesic potential. In contrast to the opioids, which
cause sedation, dopaminergic drugs increase alertness whilst having a similar efficacy to
opioids in the relief of suffering. Combinations of opioids and dopaminergic drugs have
been suggested as an effective therapeutic avenue, as dopaminergic drugs such as
amphetamine are stimulatory, and can counteract opiate-induced respiratory depression.
There is some reluctance to include dopaminergic drugs in clinical practice, perhaps as
it has been argued that the analgesia they produce is mediated through the rewarding
effects of the drugs, and their abuse potential when combined with opioids for maximal
analgesia, is too high (see Franklin, 1989; 1999).
Clinically, dopamine antagonists are often used as anti-psychotics and indirect agonists
(i.e. cocaine) as psychostimulants. As DA cannot cross the blood-brain barrier, its
precursor, L-DOPA, is given as a form of medication for diseases where dopaminergic
function is lost i.e. Parkinson’s disease.Chapter 2
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Reinforcement, reward, incentive motivation, conditioned reinforcement, and anhedonia
are all thought to depend upon the function of dopamine in the brain and these proposals
are all supported and refuted by a massive body of literature spanning 60 years. The
evidence for a critical role for dopamine in reward processing, however, is very strong,
as discussed below (see Wise, 2004).
2.1.2 Mesolimbic dopaminergic system
Dopaminergic neurons can be broadly subdivided into two groups that form two
pathways. One originates in the zona compacta of the substantia nigra (SNc) and gives
rise to the nigrostriatal pathway, which is crucial for the control of movement,
orchestrating a delicate balancing act between the nuclei of the basal ganglia to produce
and refine movement.
The second pathway originates in the ventral tegmental area (VTA) and is comprised of
two interlinked and overlapping pathways; the mesolimbic and mesocortical pathways,
thought to be important for motivational functioning. The mesolimbic pathway runs
from the VTA to the nucleus accumbens (NAcc) and olfactory tubercle, further
innervating the septum, amygdala and hippocampus. Medial VTA cells project to
medial prefrontal, cingulate and perirhinal cortices and this projection is known as the
mesocortical pathway. Because there is large overlap between the VTA cells that
project to these various targets, the pathways are collectively referred to as the
‘mesocorticolimbic’ dopamine system.
The mesocorticolimbic system has been the subject of many investigations over the
years. Olds and Milner (1954) first found that intracranial electrical stimulation of the
hypothalamus and associated mesolimbic structures can be a rewarding stimulus for an
animal, and later studies have shown that animals trained to stimulate themselves
electrically in areas through which dopaminergic neurons are known to pass will
repeatedly stimulate themselves, above other motivational factors such as food and sex
(Franklin, 1978; Liebmann and Butcher, 1974).
Blocking dopaminergic signalling via receptor antagonism, using neuroleptic drugs, can
reduce the effect of rewarding stimuli and self-stimulation (Fouriezos et al., 1978; Wise
et al., 1978) and ablation through the administration of 6-OHDA, an excitotoxicChapter 2
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dopamine agonist, can abolish certain reward-seeking behaviours (Berridge et al.,
1989).
2.1.2.1 Genetic manipulation of the DA system
The use of genetically modified mice where different dopamine receptor subtypes have
been deleted highlight their varying roles in reward processing (see Holmes et al.,
2004).
The rewarding effects of cocaine are lost in mutant mice where the dopamine D1
receptor has been knocked out (Xu et al., 1994; Drago et al., 1996). Mutant mice
lacking the D2 receptor have severe motor problems (Baik et al., 1995) and show a
decreased response to cocaine (Caine et al., 2002). These D2 knockout mice do not self-
administer morphine nor learn morphine-cued conditioned place preference (Maldonado
et al., 1997), and they also show abnormal responses to ethanol and cocaine (see
Holmes et al., 2004).
Deleting the gene that codes for tyrosine hydroxylase produces dopamine-deficient
(DD) mice, of which 90% will die during gestation unless DA signalling is rescued by
maternal L-DOPA administration. Once born, they are indistinguishable from wild-type
litter-mates until around P10, but will die by P15 without DA rescue (by L-DOPA
injection), as they will not feed enough to survive (Zhou et al., 1995). If reared to
adulthood by repeated L-DOPA administration, DD mice can learn place preferences,
but appear apathetic and show minimal interest in their environment, and do not seem to
engage in goal-oriented behaviour i.e. nesting or exploratory behaviours, suggesting a
lack of motivational drive (see Palmiter, 2008). Dopamine also has a role in fear
conditioning via the amygdala. Adult DD mice do not learn fear conditioning in a fear-
potentiated startle paradigm, suggesting a role for dopamine in reward and aversion
learning (Fadok et al., 2009).
2.1.3 Ventral Tegmental Area
The ventral tegmental area (VTA) is located in the midbrain (mesencephalon) and
neurons in the VTA are reciprocally connected to almost all of the areas to which they
project, including the nucleus accumbens, substantia nigra, limbic structures such as theChapter 2
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amygdala, and cortex. It contains the dopaminergic cells that give rise to the
mesocorticolimbic system (see Figure 2-2 and Figure 2-4 for localisation of the VTA).
2.1.3.1 Firing properties of VTA DA cells
Dopamine cells fire at two different frequencies – tonic and phasic (Grace, 1991; Grace
et al., 2007) Tonic firing is spontaneous, low frequency activity of ~4Hz that releases
low levels of dopamine steadily into the synaptic cleft (Brischoux et al., 2009). Phasic
firing is the burst of activity that occurs after a stimulus and releases large amounts of
dopamine transiently into the synaptic cleft, thus activating post-synaptic receptors.
Phasic firing typically occurs in bursts of around 5 spikes, at frequencies above 12Hz
(Ungless et al., 2004), starting with an interspike interval (ISI) of less than 80msecs and
finishing with an ISI of 120msecs (Brischoux et al., 2009). Phasic and tonic firing are
proposed to be inversely related, such that an increase in tonic extracellular DA levels
attenuates subsequent phasic firing (see Wood, 2006).
The work of Schultz on awake monkeys (Schultz et al., 1998; 2001; 2007) has
suggested that dopaminergic neurons of the VTA encode reward, showing that VTA
cells will fire on receipt of an unexpected reward, and are inhibited when the expected
reward does not appear. Cells in the rat VTA will also respond to aversive stimuli i.e.
footshock (Mirenowicz and Schultz, 1996; Guarraci and Kapp, 1999). Originally, these
cells (3-49% of VTA cells recorded) were declared non-dopaminergic (Ungless et al.,
2004) but later research has confirmed the existence of dopaminergic cells that fire for
both rewarding and aversive stimuli (Brischoux et al., 2009).
Recent suggestions help resolve the debate by putting forward the view that there are
two functionally and anatomically distinct dopamine systems in the VTA (Ikemoto,
2007). An important paper by Brischoux et al (2009) shows that dorsal VTA
dopaminergic cells are inhibited by noxious footshock, consistent with their role in
reward processing, as a non-rewarding stimulus inhibits cell firing. However, ventral
VTA cells are phasically excited by footshock, suggesting that dopaminergic signalling
is involved in both rewarding and aversive events. The suggestion that there are two
functionally and anatomically discrete cell populations in the VTA that signal either
rewarding or aversive stimuli fits well with data showing that the amygdala, an areaChapter 2
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receiving input from the ventral VTA, is implicated in noxious processing and is
involved in the learning of aversive stimuli (Barr et al., 2009).
Taken together, electrophysiological research has led to ideas that the DA neurons of
the VTA fire according to the expectation and receipt of a reward (reward error-
prediction) (Schultz, 2007; Berridge and Robinson, 2003; Robinson and Berridge, 1993;
McClure et al., 2003) and also the incentive salience of a stimulus, i.e. how important it
is to the organism, as seen by studies showing the rewarding and aversive signalling
properties of DA neurons (Ungless, 2004)
2.1.3.2 Behavioural studies
Many studies have investigated the effect of dopamine modulation in the nucleus
accumbens, which receives input from the VTA (Di Chiara and Bassareo, 2007).
However, experiments in mice and rats studying at the effect of intracranial self-
administration (ICSA) and intracranial place conditioning (ICPC) have proven that the
VTA itself is a crucial site for reward processing (see McBride et al., 1999). ICSA
involves implantation of a cannula into the brain which delivers a drug when the animal
completes a particular response i.e. nosepoke, whilst in the ICPC paradigm, a drug is
infused and the place preference measured in animals after infusion. Experiments have
shown that animals will self-administer morphine into the VTA and that the effect is
blocked by a morphine antagonist, demonstrating that the effect is mu receptor-
mediated (Bozarth and Wise, 1981; Devine and Wise, 1994). Morphine infusion into
the VTA also causes the induction of place preference (Phillips and LePiane, 1980;
Bozarth, 1987).
2.1.3.3 Human imaging studies
Human imaging studies have confirmed an important role of the VTA in reward
processing. Functional magnetic resonance imaging (fMRI) studies have shown an
increase in BOLD (blood oxygenation level-dependent) signal in the VTA after
administration of rewarding drugs (Breiter et al., 1997; Sell et al., 1999) and a decrease
with noxious heat application (Becerra et al., 2001). This supports electrophysiological
studies suggesting that the VTA processes both rewarding and aversive stimuli, and
adds weight to the theory that the VTA DA system has a role in incentive salience.Chapter 2
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Future imaging research may focus on investigating the detailed functional connectivity
of the VTA and its role in reward networks (see Camara et al., 2009).
2.1.4 Ontogeny of the dopaminergic system
The adult dopaminergic system has been well-characterised, but the development of this
system and the effect of neonatal interference on adult dopaminergic function has also
been an active area of research over the last 50 years.
2.1.4.1 Cell differentiation
Dopamine cell differentiation and localisation is driven by specific gene pathways early
in embryonic life. The transcription factors sonic hedgehog (Shh) and fibroblast growth
factor 8 (Fgf8) induce mesolimbic dopamine cell differentiation in the ventral midbrain
(later giving rise to the substantia nigra and VTA) at E10.5 to E13 in the mouse. The
survival of the DA cells and enzymes regulating their activity (i.e. tyrosine hydroxylase)
depend on transcription factors such as Nurr1, Pitx3, and Lmx1b for cell survival and
maintenance throughout the lifetime of the animal (see Alavian et al., 2008).
2.1.4.2 Monoamine levels and receptor expression
Dopamine and its receptors appear between E10 and E15 in the rat (Voorn et al., 1988;
Schambra et al., 1994) and reach adult concentrations at around P50 (Loizou and Salt,
1970). The dopamine transporter protein (DAT), which regulates the amount of
dopamine present in the synaptic cleft, increases in density from E18 to P28, when it
reaches adult levels and remains stable thereafter (Galineau et al., 2004). The enzymes
that catalyse degradation of dopamine are present at near adult levels in the neonate
(Karki et al., 1962).
Reports on the development of dopamine receptor expression have been inconsistent in
the literature (see Rho and Storey, 2001; McCutcheon and Marinelli, 2009). In general
however, autoradiography and immunohistochemical studies have shown that receptor
expression increases during development, peaking during adolescence and then
decreasing over adulthood. For example, in the rat striatum (including the VTA), DA
receptor levels peak between P28 and P40 (Noisin and Thomas, 1988) and decrease
after that, stabilising by 4 months of age (Andersen et al., 2000).Chapter 2
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However, the expression of DA receptors in prefrontal areas does not peak until P60
(Tarazi and Baldessarini, 2000). This is in line with the general delayed maturation of
this area, which is involved in executive functions such as planning and goal-directed
behaviour in both animals and humans.
2.1.5 Opioids
The opium poppy, Papaver somniforum, has given rise to some of our most potent
analgesic drugs, but has also been the cause of widespread drug abuse that blights many
lives, due to its dual properties as pain-relieving and rewarding.
Opioids are peptides which act on the G-protein-coupled opioid receptors, mu (µ),
kappa  (κ)  or  delta  (δ).    Endogenous  opioids  are  divided  into  three  categories  – 
endorphins, enkephalins and dynorphins. These have agonist activity at all three
receptors, but each receptor displays distinct ligand sensitivity and there is much
crosstalk of opioid signalling, possibly due to receptor heterodimerisation (Sora et al.,
1997; Ikeda et al., 1999). The endogenous opioids arise from three precursor proteins
that can code for more than 20 different endogenous opioids – pro-opiomelanocortin,
prepro-enkephalin, and preprodynorphin (see Vaccarino and Kastin, 2001). Exogenous
peptides are well-known as powerful analgesics and also drugs of abuse – i.e. heroin,
codeine and morphine and their various analogues; all derivatives of opium.
The three types of opioid receptor, and the more recently discovered ‘orphanin’
receptors (‘orphan’ receptors that share a high structural homology to classical opioid
receptors) are widespread throughout the nervous system. In the spinal cord, the mu
opioid receptor (MOR) is the most numerous, accounting for ~70% of receptors seen in
the substantia gelatinosa (layers I and II) of the dorsal horn of the spinal cord (Kar and
Quirion, 1995).
Supraspinally, mu, kappa and delta receptors (MOR, KOR and DOR) are widespread
and found in the locus coeruleus, rostroventral medulla (RVM), periaqueductal grey
(PAG), ventral tegmental area (VTA), thalamus, amygdala, hippocampus and cortex
(Atweh and Kuhar, 1977). Outside of the central nervous system, they are expressed by
peripheral nociceptors, cardiac and skeletal muscle, the myenteric plexus (the major
nerve supply to the gastrointestinal tract) and various white blood cells.Chapter 2
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2.1.5.1 Morphine
So-named after Morpheus, God of Dreams, morphine is the opioid which acts on mu
opioid receptors and was isolated in 1806, having been used in its natural form for
hundreds of years as a painkiller. It is coded for by the Oprm gene, which codes at least
six splice variants of the MOR (Pan et al., 2005).
Morphine is an important analgesic and, at the level of the spinal cord, mainly acts on
presynaptic C fibre terminals, decreasing neurotransmitter release and so decreasing the
ascending afferent nociceptive signal (Dickenson et al., 1987). Low doses of opioids
applied directly to the spinal cord (epidurally) can produce clinically effective and
localised analgesia and this fact has been exploited for pain relief during childbirth
(Saeki and Yaksh, 1993).
Supraspinally, morphine acts on many areas of the brain, including the periaqueductal
grey (PAG), rostroventral medulla (RVM), and VTA, and causes an increase in the
descending inhibition mediated by these areas, thereby decreasing pain sensation.
Injections of morphine directly into the PAG and RVM will inhibit spinally-mediated
nociception, an effect which can be blocked by the MOR antagonist naloxone (Cheng et
al., 1986; Moreau and Fields, 1986; Fang et al., 1989). Naloxone administration will
also enhance pain sensation when given alone or after oral surgery (Levine et al.,
1978a).
Once morphine has bound to the receptor, it acts by initiating signalling cascades via the
G proteins that are liberated by agonist binding to the receptor. Morphine predominantly
acts via the Gi/o signalling pathway, which acts by inhibiting production of cyclic AMP
(cyclic adenosine monophosphate), a second messenger molecule important in many
biological processes.
In the VTA, morphine binds to MORs on inhibitory GABAergic interneurons, causing
chloride ion influx and hyperpolarisation. This lifts the baseline inhibition of the DA
cells and activates the mesolimbic DA pathway (Johnson and North, 1992; Bonci and
Williams, 1997; Garzón and Pickel, 2001). Therefore morphine has its rewarding effects
via disinhibition of the dopaminergic system.Chapter 2
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MOR signalling is terminated by phosphorylation of the receptor by GRKs (G protein-
coupled receptor kinases) which is then internalised into the cell by β arrestins. Chronic 
morphine use leads to cellular tolerance of the system which reduces the effect of opioid
drugs by a number of mechanisms. These include shifts in coupling of the GPCR from
Gi/oto Gs, downregulation of the number of MORs on the cell surface, and upregulation
of glutamate and other opioid-opposing pathways (see Borgland, 2001; Christie, 2008;
Ueda and Ueda, 2009 for comprehensive reviews).
2.1.5.2 The developmental regulation of MOR expression and
morphine function
2.1.5.2.1 Ontogeny of MOR expression
In the first week of the neonatal rat’s life, mu and kappa are the predominant opioid
receptors, shifting to a predominance of mu and delta receptors in the adult (Leslie et
al., 1982). Delta receptor expression appears after the first postnatal week (McDowell
and Kitchen, 1987) and the appearance of DOR subtypes is linked to the onset of
weaning (Kitchen et al., 1995).
MOR mRNA has been found in the E13 rat and is isolated to the striatum by E18
(Georges et al., 1998). Receptors are present in the rat spinal cord from E16 (Kirby,
1981) and show an initial decline at birth, then a sharp rise over the first two postnatal
weeks to adult levels (Spain et al., 1985). Endogenous opioid peptides are present in
mouse brain at E11.5 and rat brain at E18 (Ruis et al., 1991; Pickel et al., 1982) and
increase to adult levels by P25 (Bayon et al., 1979).
2.1.5.2.2 Binding to opioid receptors is seen prenatally
Opioid receptor binding, seen by in vitro quantitative receptor autoradiography studies,
is shown from embryonic day (E) 12 onwards in the striatum, and has been shown to
increase during early postnatal life to peak at 3 weeks after birth (Kent et al., 1981;
McDowell and Kitchen, 1987). In the spinal cord, MOR binding sites are diffuse
throughout the cord in neonatal rats, but become mainly localised to more superficial
laminae by adulthood. In addition, the density of binding sites peaks at P4, and declinesChapter 2
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to adult levels by P21 (Kar and Quirion, 1995). This shows that both the presence and
functionality of MORs changes dramatically during the first few weeks of life.
2.1.5.2.3 Morphine analgesia in the neonate
Morphine analgesia is more efficacious in human neonates than in adults (see Nandi and
Fitzgerald, 2005), and when administered epidurally, morphine has a greater analgesic
effect in rat pups than adult animals (Marsh et al., 1999a; Marsh et al., 1999b). Animals
lacking the MOR show no morphine-induced analgesia, but no overt behavioural
abnormalities or major compensatory changes elsewhere in the opioid system,
emphasising the importance of the MOR in analgesia (Matthes et al., 1996; Kitchen et
al., 1997).
The effect of morphine is shown to increase with age, increasing by 40-fold between P3
and P14 (Giordano and Barr, 1987), with the analgesic potency of morphine proposed to
reach adult levels by P14 (Barr and Lithgow, 1986). This changing efficacy, in addition
to the proliferation of receptors that occurs during development, could also in part be
due to changing ratios of morphine metabolites during development. Morphine is
metabolised into morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G),
which are anti-analgesic, and analgesic, respectively. Therefore the analgesic efficacy of
morphine partly depends on this metabolism-defined ratio, which is different in
prematurely-born neonates, and matures with age (Hartley et al., 1994). The increased
potency of morphine in young animals could also be partially due to a blood-brain
barrier with higher permeability than that of the adult (Kupferberg and Way, 1963).
2.1.5.2.4 Chronic morphine administration in the neonate alters opioid
signalling
Chronic morphine, administered from P1 to P4, results in a decrease in brain MOR
density, which gradually recovers to control levels by P14 (Tempel et al., 1988), and
alters opioid receptor numbers and sensitivity, desensitising animals to opiate analgesia
throughout life (Thornton and Smith, 1998). Morphine administration during the first
week of life also causes increased MOR binding and decreased hot plate latencies in
adulthood (Handelmann and Quirion, 1983; Handelmann and Dow-Edwards, 1985).Chapter 2
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Similar to the effects of exogenously applied morphine, administration of the
endogenous endorphin beta-endorphin also showed a decrease in opiate receptors in the
brain in adults (Zadina et al., 1985). Furthermore, prenatal morphine administration to
pregnant dams caused reduced adult morphine analgesia (Johannesson and Becker,
1972; O'Callaghan and Holtzman, 1976). Together, these experiments show that
prenatal and early morphine/opioid exposure to the neonatal rat causes long-term
alterations in brain opiate receptors. This effect is sexually dimorphic, with opposite
morphine analgesic responses seen in adult males and females after 7 days of repeated
morphine exposure within the first week of postnatal life (Arjune and Bodnar, 1989).
2.1.5.2.5 Modulation of opioid signalling by external influences
The opioid system is sensitive to perturbance during development by factors such as
stress, injury, and exposure to opioid antagonists. Footshock and recurrent testing on the
hot plate test have both shown a later decrease in opioid sensitivity, as reflected by an
increased latency to response on the hot plate test, and decreased naloxone binding after
repeated hot plate stress (Bardo et al., 1981; Torda, 1978). Juvenile isolation between 4
and 5 weeks of life will induce stress, and alters opioid binding in the brain and opioid
release after later social interactions (Van den Berg et al., 1999a; Van den Berg et al.,
1999b). Blocking opioid signalling (with the opioid antagonist naltrexone) during
development can affect dendritic spine development in the cortex and hippocampus,
showing that opioid signalling is in part responsible for neuronal development (Hauser
et al., 1989). This evidence suggests roles for opioid signalling in brain development
and social behaviours, in addition to its more well-known roles in analgesia and reward.
2.1.5.3 Morphine is rewarding
In humans, morphine is rewarding, due to its ability to induce euphoria and relaxation
and morphine and the morphine derivative, heroin, are both drugs of abuse. A large
body of evidence has confirmed that morphine is rewarding in the VTA of animals. Rats
will self-administer morphine and morphine agonists directly into the VTA, and MOR
antagonists i.e. naloxone prevent this behaviour (Bozarth and Wise, 1981; Self and
Stein, 1993; David and Cazala, 1994a). Injection of morphine and the MOR agonist
DAMGO ([D-Ala2, NMPhe4, Gly(ol)5]enkephalin) into the VTA causes conditioned
place preference (CPP) and morphine-induced CPP is now used as an animal model for
drug-taking, withdrawal and relapse (Lin et al., 2010).Chapter 2
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A large body of evidence accumulated over the years has shown that the mu receptors
of many areas of the brain, including the nucleus accumbens, hypothalamus and
amygdala, contribute to the rewarding effects of opiates (see Le Merrer et al., 2009).
Knocking out the Oprm gene in mice that codes for the MOR causes alterations in both
analgesia and reward behaviours. Matthes et al (1996) showed that MOR KO mice lose
morphine-induced analgesia, cannot learn conditioned place preference, and do not
develop physical dependence. Later papers studying genetically engineered animals that
lack the MOR have shown deficits in reward behaviours, therefore confirming its
essential role in reward processing (Sora et al., 1997; Kieffer and Gaveriaux-Ruff,
2002).
Morphine fails to induce rewarding effects in animals that have inflammatory or nerve
injuries, and DA release in the VTA is markedly attenuated in these pain models
(Suzuki et al., 1996; Ozaki et al., 2002). This is suggested to be due to a sustained
reduction in the ERK signalling pathway in DA cells in neuropathic animals (Ozaki et
al., 2004) and could provide a reason why patients that use morphine as an analgesic do
not tend to get addicted to it (Fields, 2007).
2.1.5.4 Morphine and dopaminergic signalling
The rewarding effects of morphine are due to the disinhibition of the DA system.
Evidence for this arises from a number of studies looking directly at the effect of one
upon the other. For example, morphine’s rewarding effects are blocked by dopamine
antagonism in rats (Suzuki et al., 1995), while D2 receptor KO mice do not exhibit the
rewarding effects of opiates (Maldonado et al., 1997) and the MOR antagonist naloxone
can block the motivational effects of dopamine signalling (Shippenberg and Herz,
1988). Recent work has shown that morphine will activate the dopaminergic cells of the
VTA (as seen by expression of the immediate early gene Fos) regardless of the presence
of a noxious stimulus (formalin injection into the hindpaw), emphasising that morphine
will activate dopaminergic circuits, even in stressful situations (Bajic and Commons,
2010).
In humans, dopamine D2 receptors are crucial in reward and addiction (see Volkow et
al., 2009) and endogenous opioids can modulate DA reward systems (see Fields, 2004).Chapter 2
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Placebo may involve endogenous opioid systems (Benedetti et al., 2005), and a PET
study using a specific MOR tracer shows that placebo activates MOR-mediated
neurotransmission (Zubieta et al., 2001).
2.1.6 Reward processing in the neonate – the role of dopamine
Dopamine also has a critical role in reward processing in the neonate. Amphetamine and
cocaine, which both increase DA levels, induce place preference in the neonate rat (P3
to P10) (Barr and Lithgow, 1986) and rats in the first week of life can learn to nudge a
lever to receive electrical stimulation of dopaminergic sites in the brain (Moran et al.,
1981; Lithgow and Barr, 1984). Preweanling mice (<P21) can also exhibit conditioned
place preference to a compartment previously paired with cocaine (Laviola et al., 1992).
D1 and D2 receptor antagonism during development shows that the receptors contribute
to reward behaviours with a differing developmental profile. Using conditioned place
preference as a measure of reward-related behaviour, D1 receptor antagonism blocks
place preference to the same extent as it would in the adult, whereas D2 receptor
antagonism affects CPP in the P10 but not the P17 rat (Pruitt et al., 1995), showing that
the relative balance of dopamine receptor subtype alters during development.
2.1.6.1 Bonding behaviour is mediated by dopaminergic pathways
The process of an animal bonding, or attaching, to its mother is crucial for survival.
John Bowlby (1958; 1978; 1988) developed modern attachment theory –the idea that an
infant will learn to form a bond to its primary caregiver, who protects, feeds and
supports it. This attachment has been proposed to be rewarding for both offspring and
mother and it is thought that bonding behaviour is in part dopaminergically mediated
(see Insel, 2003), and that attachment learning, as well as fear learning, relies on
dopaminergic signalling in the amygdala (Barr et al., 2009).
Neonates can learn and show preference for a lactating over a non-lactating nipple
(Kenny and Blass, 1977) and the dopamine system is critical for this (Becker and
Smotherman, 1996). Knock-out studies show that a lack of dopamine during the first
two weeks of neonatal life is not fatal (Zhou et al., 1995), but it is nevertheless a critical
period during which disturbances of the maternal bond can have long-lasting effects on
the DA system. Maternal deprivation alters patterns of dopamine receptors, dopamineChapter 2
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release and dopaminergic cell number in the VTA and NAcc in adulthood (Meaney et
al., 2001), and postnatal exposure to glucocorticoid stress hormones causes an increase
in the number of dopaminergic cells in both the VTA and the substantia nigra pars
compacta (SNpc) (McArthur et al., 2005).
Attachment behaviour also relies on activation of the DA reward pathways in the
mother. Human fMRI studies have shown that the BOLD signal in the VTA is increased
in mothers when they viewed video clips of their infants (Noriuchi et al., 2008) and Dbh
knockout mice (that lack the gene to produce dopamine β-hydroxylase) fail to nurture 
their offspring (see Palmiter, 2008). Dopamine is released upon pup exposure and VTA
or NAcc lesions interrupt maternal care (see Insel, 2003). Taken together, these data
suggests that dopamine is important for learning attachment in the neonate and for
maternal behaviour in the parent animal.
2.1.7 Morphine is rewarding in the neonate
Many papers have shown that morphine can induce reward behaviours in young
animals, and that chronic morphine administration can cause tolerance to its analgesic
effects, similar to the adult. Morphine or met-enkephalin (an opioid peptide that acts on
MORs) administered directly into the VTA of the P4 and P5 rat caused odour-cued
place preference, whereby the neonate associates a place where they received the
morphine to a specific odour i.e. oranges, and will then return to the orange-smelling
box when given the choice (Barr and Rossi, 1992; Kehoe and Blass, 1986c). Analgesic
tolerance to opioids can develop in both neonatal humans, as seen by an increase in
dosage needed to reduce pain behaviours and maintain sedation (Taddio and Katz,
2004) and, to a lesser extent, animals (Van Praag et al., 1993; Van Praag and Frenk,
1991a).
Studies investigating morphine withdrawal have shown that the neonatal rat exhibits
withdrawal behaviours after chronic morphine treatment (>5 days). Shaking,
vocalisations, escape behaviour and hypersensitivity to noxious stimuli are seen, which
are the same as those seen in the adult (Ceger and Kuhn, 2000; Jones and Barr, 1995;
McPhie and Barr, 2000; Gong et al., 2010; Zhang and Sweitzer, 2008). Furthermore,
withdrawal from chronic morphine in the neonate sees activation (as measured by c-Fos
expression) of the same brain regions that are active during withdrawal in the adult,Chapter 2
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including the periaqueductal grey, locus coeruleus, and nucleus accumbens (McPhie and
Barr, 2009).
Related to the rewarding effects of maternal attachment, mu opioid receptor KO mice
show deficits in attachment behaviours. They do not show a preference towards their
mother’s cues and do not exhibit distress responses to maternal deprivation (Moles et
al., 2004), lacking the motivational drive to seek maternal care. The authors suggest that
the rewarding effect of attachment is lost in these animals.
2.2 Hypotheses
The evidence presented above shows that morphine activates dopamine pathways, and it
has therefore been chosen as a trigger for the DA system in this set of experiments.
While it is evident that dopaminergic pathways are active in the first days of life in
learning and maternal attachment, we wished to explore the integrity of dopaminergic
reward pathways in the newborn. This is an important predicate of the hypothesis that
early injury can affect reward processing in the adult, due to the overlap of the pain and
reward systems. The aim here was to perform a quantitative comparison of the
activation of the dopaminergic system in young and adult rats with morphine. The
activation of dopaminergic cells in the VTA was measured using pERK expression
following systemic morphine administration.
We hypothesised that:
 The dopaminergic system in the VTA is functional in the newborn rat.
 Administration of a rewarding stimulus, morphine, will activate the DA cells of
the VTA in the newborn.
 The effect of morphine on DA cell activation in the VTA will not alter
significantly with postnatal age.
2.3 Methods
Sprague-Dawley male and female rats were used at postnatal days (P) 7, P21 and adult
(>P50). Five groups were designated (see Table 2-1):Chapter 2
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Treatment group Number per
group
Baseline (no injection) 3-4
Single subcutaneous (s.c.) saline
dose 3-4
Repeated s.c. saline dose 4
Single s.c. morphine dose 4
Repeated s.c. morphine dose 4
Table 2-1 – A table to show the treatment groups and numbers of animals per group.
2.3.1 Timeline
The diagram below is a schematic of the experimental design.
Figure 2-3 – A schematic diagram to illustrate the time-line of the experiment. Animals either
received a single (top row) or repeated dose (lower row) of morphine or saline. The single dose was
administered on one day only. The repeated dose regime began 5 days prior to sacrifice so that the
animals in each age group were sacrificed on the same day.
Animals were killed on day 5, 30 minutes after the final morphine/saline injection, by
intraperitoneal (i.p.) injection of an overdose of pentobarbital, and transcardially
perfused with 4% paraformaldehyde (PFA). Brains were dissected out, post-fixed in 4%
PFA for 4 hours, then transferred to a 30% sucrose and azide solution (see Solutions)
and stored at 4°C.
Repeated
injection
Single
injection
Day 1
(P3 or P17)
Day 2 Day 3 Day 4 Day 5
(P7 or P21)Chapter 2
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2.3.2 Morphine administration
2.3.2.1 Ages
 Morphine was administered subcutaneously (s.c.) in 0.9% saline solution to the
neonate (<P7), preweanling (P21) and adult (>P50, >180g). Control animals
received saline only injections.
 The ages were chosen to reflect key periods of development for the animal. The
first three weeks of life are a time of great developmental plasticity in the rat
CNS (see Fitzgerald, 2005) and the literature on dopaminergic development
during this time suggests that changes in receptor expression and subtype as well
as maturation of functional reward pathways are taking place over this period
(see McCutcheon and Marinelli, 2009).
 These time points also correspond to the ages used later in this thesis to test the
effect of pain in early life on later reward processing (see Chapters 3 and 4).
2.3.2.2 Single dose of morphine:
 In this group of experiments, animals received one s.c. morphine injection only,
as shown in Figure 2-3.
 The dosage and volume used are detailed in Table 2-2:
Age Dose Volume of
injectate
P7
P21
Adult
5mg/kg
10mg/kg
10mg/kg
100µl
200µl
200µl
Table 2-2 - A table to show the ages, doses and volume of injectate in the single morphine injection
group
2.3.2.3 Repeated dose:
 In this group of experiments, animals were injected s.c. once daily for 5 days, as
shown in Figure 2-3.
 Repeated injections over 5 days was chosen as the literature suggests that this is
long enough to allow tolerance to morphine to occur (see Ueda and Ueda, 2009;
Christie, 2008).Chapter 2
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 For repeated injection, dosage and volume used are detailed in Table 2-3
(below):
Age Dose Volume of
injectate
P3 to P7
P17 to P21
Adult
5mg/kg
10mg/kg
10mg/kg
100µl
200µl
200µl
Table 2-3 - a table to show ages, doses and volume of injectate in the repeated morphine injection
groups
2.3.2.4 Rationale for dosage
 As this experiment was to investigate reward processing, it was important to
choose a dosage that was known to activate the reward pathways.
 Analgesic doses are lower than those used in the reward/addiction literature and
in the neonate range from 0.1mg/kg to 5mg/kg (McKelvy and Sweitzer, 2009;
Abbott and Guy, 1995; Marsh et al., 1997).
 The reward literature uses higher doses of opioids to stimulate the supraspinal
dopaminergic system. Doses range from 5mg/kg up to 20mg/kg (Barr and
Wang, 1992; Narita et al., 2004a; Jones and Barr, 1995; Ceger and Kuhn, 2000).
For the purposes of this experiment, a dose of 10mg/kg was chosen. As
morphine causes respiratory depression, this dose was halved for animals <P7,
to 5mg/kg. This prevented respiratory depression or hypothermia.
 Behavioural responses (sedation and analgesia) were tested following morphine
administration using loss of righting reflex and increased threshold to noxious
mechanical stimulation (using von Frey hair).
2.3.3 Immunohistochemistry
Tyrosine hydroxylase (TH) is present in all dopaminergic cells and so was chosen as a
DA cell marker in this experiment. Phosphorylated ERK (pERK) was chosen as a
marker of cell activation in the dopaminergic cells. Other studies have shown the
activation of the DA system by co-localisation of TH and pERK in the VTA (Ozaki et
al., 2004), and shown that morphine specifically upregulates pERK in the DA cells of
the VTA (Berhow et al., 1996).Chapter 2
61
The following protocol was used for immunostaining:
1. 40µm sections of the ventral tegmental area were cut on the freezing microtome
and placed into wells containing 5% sucrose in azide (see Appendix 1:
Solutions).
2. Sections were transferred to Röhren tubes (Sarstedt, Leicester, UK) 6 sections
per tube, each at a distance of 240µm from each other, and blocked in 3% goat
serum for 1 hour (see Appendix 1).
3. Phosphorylated ERK antibody (Cell Signaling Technology, MA, USA) was
placed onto the sections at a 1:250 dilution (4µl per ml) in TTBS (see Appendix
1). The tubes were incubated overnight at room temperature.
4. Sections were washed with 0.1M PB (see Appendix 1), 3 times, for 10 minutes
per wash.
5. The pERK secondary antibody was placed onto the sections. This was
biotinylated anti-rabbit, raised in goat (Vector Laboratories Inc., CA, USA), at a
1:500 dilution (2µl per ml) in TTBS. Sections were incubated for 90 minutes at
room temperature.
6. Sections were washed as above.
7. The avidin-biotin protocol was used to amplify the signal. Using the Vectastain
ABC kit (Vector Laboratories Inc., CA, USA), 4µl of ‘A’ and 4µl of ‘B’ per ml
TTBS were stirred for 30 minutes.
8. Avidin-biotin solution was placed onto the sections for 30 minutes at room
temperature.
9. Sections were washed, as above.
10. Biotinylated tyramide (Perkin Elmer Life Sciences, MA, USA) was diluted with
the amplification diluent 1:75 (13.3µl per ml) and placed onto the tissue for 7
minutes.
11. Sections were washed.
12. FITC avidin (Vector Laboratories Inc., CA, USA) was placed onto the tissue at a
concentration of 1:600 (1.67µl per ml) in TTBS for two hours. Sections were
kept in the dark to prevent bleaching of the fluorophore.
13. Sections were washed.Chapter 2
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14. The tyrosine hydroxylase primary antibody (Chemicon, MA, USA) was placed
onto the tissue at a concentration of 1:1000 (1µl per ml) in TTBS and was kept
in the dark to incubate overnight at room temperature.
15. Sections were washed.
16. The tyrosine hydroxylase secondary antibody was placed onto the sections. This
was the fluorophore 594-alexa anti-rabbit, raised in chicken (Invitrogen Ltd.,
Paisley, UK) at a dilution of 1:500 (2µl per ml) in TTBS. Sections were
incubated in the dark for 2 hours at room temperature.
17. Sections were washed and transferred to 0.01M PB and mounted onto
gelatinised slides, kept in the dark as much as possible to prevent bleaching of
the fluorophores.
18. Slides were dried in the dark overnight at room temperature and coverslipped
with Fluoromount (Sigma-Aldrich, Dorset, UK).
2.3.3.1 Immunohistochemistry controls
Four control tubes of sections were prepared to check for the effects of non-
specific binding of the antibodies (where the antibody binds to the tissue at
random instead of to the protein of interest). The control tubes underwent the
same washing and staining as the experimental tubes at all stages of the protocol,
except the sections were not exposed to the antibody at the relevant stage of the
protocol, and were placed into 0.1M PB instead.
The tubes were prepared under one of the four following conditions:
1. The pERK primary antibody was absent
2. The pERK secondary antibody was absent
3. The TH primary antibody was absent
4. The TH secondary antibody was absent
These sections are not shown as the background levels of fluorescence were so
low that the tissue is not visible.
2.3.4 Definition of the ventral tegmental area
 The co-ordinates of the VTA, as defined by the stereotaxic atlas of Paxinos and
Watson (2004) are as follows:Chapter 2
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From Bregma:
Anteroposterior: -5.5mm
Dorsoventral: -9.6mm
Mediolateral: +0.5mm
 However, the neonatal brain is smaller than the adult brain, so these co-ordinates
need to be scaled accordingly and change during development. To overcome this
problem and enable consistent identification of the VTA for counting purposes,
the entire ventral part (see black dotted box, figure below) of sections of adult
and neonate tyrosine hydroxylase staining (see bottom panel) were compared to
identify common cytoarchitectural features.
Figure 2-4 - A diagram to show the VTA as defined by the atlas of Paxinos and Watson (2004),
highlighted by the white and black oblongs in the top two panels. The black dotted section on the
left panel represents the same area that is shown in the bottom panel. The bottom panel illustrates
the pattern of tyrosine hydroxylase staining (red fluorescence) in the adult rat. The dotted white
line delineates the ventral boundary of the tissue. The white oblong highlights the area defined as
the VTA.
200μmChapter 2
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 As there was no difference in the characteristic pattern of tyrosine hydroxylase
staining over the three ages, the same features of TH staining were used as
landmarks across all three age groups.
2.3.5 Visualisation of sections
 Slides were visualised using a fluorescent microscope (Leica DMR). The
tyrosine hydroxylase secondary antibody (alexa-594) fluoresces at an optimal
wavelength of 594nm and appears red under the appropriate filter, and the
phosphorylated ERK tertiary antibody (FITC) fluoresces optimally at 488nm
and appears green under the appropriate filter.
 The left VTA of each section was visualised first under the relevant wavelength
filter to see fluorophore excitation and a photograph taken of the VTA at x20
magnification. The filter was then changed to visualise pERK staining and
another image of the same area captured. Photographs were taken using a
Hamamatsu camera linked to the microscope. Images were visualised using
OpenLab 4.0.4 software (Improvision Openlab).
2.3.6 Cell counting
 Once images were captured, the number of TH cells and then the number of
pERK cells per image were counted within the defined region. The images were
then merged using the image software and the number of co-expressing cells
(appearing yellow) per image counted.
 The VTA was photographed bilaterally in each section.
 5 sections were analysed per animal, with 4 animals in each group.
2.3.7 Analysis of cell counts
 From raw cell counts, the percentage of tyrosine hydroxylase-positive cells that
co-expressed pERK was calculated.
 To control for the change in cell density with age, which could confound the
comparisons of cell counts across age groups, estimates of cell density were
performed in the VTA at each age from Nissl stained sections.
 Briefly, tissue was collected and slides produced as previously described. Once
slides were dry, they were placed into a toluidine blue (Nissl) stain to mark all
cells for 10 minutes, then dehydrated and coverslipped with DPX.Chapter 2
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 Nissl stained slides were visualised with light microscopy and all stained cells
(neurons and glia – see Figure 2-5) counted under the same conditions as the
fluorescent sections at the three ages studied (P7, P21 and adult) to give total
cell counts per unit area.
Figure 2-5 – A representative picture of adult Nissl cell staining of the VTA, showing neurons and
glia.
 These counts were then multiplied by the area counted (calculated as 0.53mm
2)
to give cell density/mm
2.
 Once the total cell density was calculated, a one-way ANOVA (GraphPad Prism
v.4) compared total cell numbers across ages, and a comparative ratio defining
the adult as the standard of ‘1’ was calculated (see Results). Cell counts from P7
and P21 animals were then scaled accordingly.
 Using the scaled data, averages within animal were calculated, and then group
averages calculated.
 One- or two-way ANOVAs were performed (using GraphPad Prism v4) to
check for group differences, depending on which test was suitable. For one-way
ANOVA, Tukey’s Multiple Comparisons post-hoc tests were performed to find
the direction of any differences. For two-way ANOVA, Bonferroni’s post-tests
were performed for the same reason.
 ANOVA is a parametric method of analysis, so all data was checked for a
normal distribution (D’Agostino and Pearson omnibus normality test) prior to
analysis. Any non-normal data was analysed using the appropriate non-
parametric test i.e. the Kruskal-Wallis test for a one-way ANOVA.Chapter 2
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2.4 Results
2.4.1 Baseline data
The data presented in this chapter is the result of counts of subpopulations of cells in the
ventral tegmental area after various treatments at different ages. Therefore to begin, data
are presented on the change in cell density in the VTA with age from Nissl stained
sections, and the change in relative populations of dopaminergic and pERK-positive
cells.
2.4.1.1 Total cell density in the VTA changes with postnatal age
The number of cells per unit area in the VTA decreases during development. Cell
density was calculated by counting the total number of cells per unit area (0.53mm
2) in
VTA sections from the Baseline treatment group (n=3) per age to provide cells per mm
2
(see Analysis of cell counts section in Methods). Table 2-4 and Chart 2-1 (below) show
the total number of cells per mm
2at each age and the bar chart of this data.
P7
(n=3)
P21
(n=3)
Adult
(n=3)
Mean 998.9 896.5 755
SD 63.6 100.6 23.1
SEM 36.7 58.1 13.4
Table 2-4 – A table to show the average total cell counts at each age. 5 sections were counted from 3
different animals in the Baseline group at each age. Animal, then group, averages were calculated.
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Chart 2-1 – A bar chart to illustrate the total
cell density at each age point. *p<0.05; One-
way ANOVA with Tukey’s Multiple
Comparisons post-tests.
Chart 2-1 shows that there is a statistically significant fall in cell density in the VTA
with age (p<0.05; One-way ANOVA, Tukey’s Multiple Comparisons post-tests). The
density of cells is greater in the P7 (at ~1000/mm
2), and declines over development to a
density of 755/mm
2 in the adult rat.Chapter 2
67
2.4.1.2 Ratio of total cell density
To adjust for this fall in density with age, a ratio was calculated that could be applied to
all DA cell counts. Using the adult data as the baseline of ‘1’, the comparative ratio
below was calculated:
P7 P21 Adult
1.323 1.187 1
Table 2-5 – A table to show the comparative ratio calculated with Adult data as the baseline of ‘1’.
To allow for the change in density with age, cell counts were adjusted using the above
ratio.
2.4.2 The baseline relative number of dopamine cells in the VTA
does not differ across different developmental ages
Average dopamine (i.e. TH-positive) cell counts from each animal in all groups (n=3-4
animals in 5 treatment groups giving an n of 17-20 at each age) were calculated. The P7
and P21 counts were scaled to allow for the overall change in cell density that occurs
with age. Table 2-6 and Chart 2-2 illustrate the data:
P7
(n=20)
P21
(n=19)
Adult
(n=17)
Mean 60.7 53.3 61.2
SD 10.2 12.2 9.6
SEM 2.2 2.8 2.3
Table 2-6 – a table to show the adjusted mean TH+ cell counts in each age group.
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Chart 2-2 shows that the relative density of dopaminergic tyrosine hydroxylase-positive
cells per mm
2 does not differ significantly with age (p>0.05; One-way ANOVA).Chapter 2
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2.4.2.1 The overall percentage of dopamine cells in the VTA at baseline
is between 13 and 15%
The dopaminergic (TH+) counts were also expressed as a percentage of total cells
counted and in this case no adjustment for cell density was required. Figure 2-6
illustrates how calculating percentages can circumvent (and hide) underlying
developmental changes in cell density.
Figure 2-6 – A figure to illustrate how cell density may decrease with age, but relative density of
cells of interest i.e. DA cells, does not. The percentage of DA cells stained in the lower panel is the
same across all three ages – 50% - therefore the relative density remains the same.
The percentage of DA cells did not change with age, remaining between 13.3 and
15.31% of the total cell population (one-way ANOVA). Table 2-7 and Chart 2-3
(below) show this data:
P7
(n=20)
P21
(n=19)
Adult
(n=17)
Mean 15.2 13.3 15.3
SD 2.5 3.0 2.4
SEM 0.6 0.7 0.6
Table 2-7 – a table to show the average percentage of DA cells out of the total number of cells at
each age point.
P7 P21 Adult
Total cells
DA cells
50% 50% 50%
Relative
densityChapter 2
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Chart 2-3 – A bar chart to illustrate the
percentage of dopamine cells of the total cell
number at each age.
Whilst the total cell density may decrease with age, the relative percentage of
dopaminergic cells does not differ.
2.4.3 The baseline relative density of pERK-positive cells decreases
in the VTA during development
Average pERK-positive cell counts from each animal in all groups (n=3-4 animals in 5
treatment groups giving an n of 17-20 at each age) were calculated. Data was then
converted to cell density (per mm
2) and the P7 and P21 data scaled according to the
ratio of cell density. Table 2-8 and Chart 2-4 illustrate these data:
P7
(n=20)
P21
(n=19)
Adult
(n=17)
Mean 52.9 47.5 29.9
SD 26.1 24.8 12.5
SEM 5.7 5.7 3.0
Table 2-8 – a table to show the average pERK-positive cell density at each age point
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Chart 2-4 – A bar chart to illustrate the
density of pERK-positive cells in each age
group.
Chart 2-4 shows that the relative density of pERK-positive cells at baseline in the VTA
decreases during development from 52.9/mm
2 in the P7 animals to 29.9/mm
2 in the
adult. This is a significant decrease (p<0.01; One-way ANOVA, Tukey’s Multiple
Comparison’s post-tests).Chapter 2
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2.4.3.1 The percentage of pERK-positive cells in the VTA at baseline
does not change with age
This reduction in density of pERK cells with age is reflected in the percentage
calculations but in this case, it is not significant. The percentage of pERK-positive cells
of the total cell number in the VTA is 5.3% in both the P7 and P21 animals, and 4% in
the adult, as shown in Chart 2-5 (below). There is no significant difference between
ages (p>0.05, One-way ANOVA).
P7
(n=20)
P21
(n=19)
Adult
(n=17)
Mean 5.3 5.3 4.0
SD 2.6 2.8 1.7
SEM 0.6 0.6 0.4
Table 2-9 – a table to show the mean percentage of pERK-positive cells of the total number of cells
at each age point.
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percentage of pERK-positive cells out of the
total number of cells at each age.
To summarise, the data presented above show that, at baseline, the cell density of the
VTA decreases over development but the total percentage of DA and pERK-positive
cells does not change. Adjusting cell counts to give a relative density at each age shows
that the density of DA cells does not change with age, but the density of pERK-positive
cells decreases over development.
2.4.4 The effect of morphine on activation of dopamine cells at
different ages
The aim here was to investigate the activation of DA cells in the VTA in response to
morphine at different ages. Activation of DA cells was measured by pERK expression.
Therefore in control animals (baseline and saline-injected) and in morphine-treated
animals, the adjusted cell counts of TH+, pERK+ and the percentage of co-expressing
cells were calculated and the results compared across different treatment groups. TheChapter 2
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data are initially presented within each age group. Representative pictures of cell
staining at each age are presented at the end of the section. Table 2-10 is a reminder of
the five treatment groups in each age group:
Treatment group Number per
group
Baseline (no injection) 3-4
Single subcutaneous (s.c.)
saline dose
3-4
Repeated s.c. saline dose 3-4
Single s.c. morphine dose 4
Repeated s.c. morphine dose 4
Table 2-10 – A table to show the treatment groups and number of animals per group.
2.4.4.1 Morphine activation of dopamine cells at P7
All results presented below have been adjusted to account for the differences in total
cell density across age groups. Table 2-11 (below) gives the adjusted average cell
counts of dopamine (TH+), activated (pERK+) and co-expressing cells in each of the 5
treatment groups. The final column on the right shows the percentage of TH+ cells that
also express pERK. Chart 2-6 illustrates the data presented in the table.
Table 2-11 – A table to show the average cell counts (±SEM) in each treatment group in the P7 age
group.
P7 TH+ pERK+ Co-expressing Percentage
of TH+ cells expressing pERK
Baseline (n=4) 69 ± 6.0 32 ± 10.4 7 ± 1.6 11.5 ± 2.8
Single saline
(n=4)
75 ± 6.3 22 ± 3.0 2 ± 0.5 3.3 ± 1.0
Repeated
saline (n=4)
82 ± 8.5 37 ± 6.8 7 ± 1.0 9.3 ± 2.3
Single
morphine (n=4)
82 ± 3.6 46 ± 8.7 24 ± 6.1 30.0 ± 8.1
Repeated
morphine (n=4)
94 ± 4.8 47 ± 11.2 23 ± 7.5 23.0 ± 6.3Chapter 2
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Chart 2-6 – A bar chart to illustrate the percentage of TH+ cells co-expressing pERK in each
treatment group in the P7 age group.
These results show that both single and repeated morphine injection significantly
(p<0.05) increase TH+ cell activation (as measured by pERK expression) above saline
control group levels. A single morphine injection causes an increase (p<0.05) in
activation from 3.31% in the single saline group to 30% in the single morphine group.
There is a significant (p<0.01) increase in activation between the repeated saline group
(9.25%) and both the single (30%) and repeated morphine (23%) groups (One-way
ANOVA, Tukey’s Multiple Comparison’s post-tests). Therefore morphine activates the
dopaminergic cells in the P7 animal when administered both singly and repeatedly over
5 days.
2.4.4.2 Morphine activation of dopamine cells at P21
All results presented below have been adjusted to account for change in total cell
density across age group. Table 2-12 (below) gives the adjusted average cell counts of
dopamine (TH+), activated (pERK+) and co-expressing cells in each of the 5 treatment
groups. The final column on the right shows the percentage of TH+ cells that also
express pERK.Chapter 2
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P21 TH+ pERK+ Co-
expressing
Percentage of TH+
cells expressing pERK
Baseline (n=3) 45 ± 4.3 18 ± 1.3 4 ± 1.0 9.3 ± 2.1
Single saline (n=4) 68 ± 7.8 25 ± 11.0 4 ± 1.3 5.5 ± 1.6
Repeated saline
(n=4)
74 ± 4.8 37 ± 13.3 3 ± 1.1 4.3 ± 1.2
Single morphine
(n=4)
60 ± 5.8 35 ± 6.5 15 ± 4.4 24.3 ± 5.5
Repeated
morphine (n=4)
72 ± 4.0 36 ± 4.4 13 ± 3.6 19.8 ± 4.5
Table 2-12 – a table to show the average cell counts (±SEM) in each treatment group in the P21 age
group.
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Chart 2-7 – A bar chart to illustrate the percentage of TH+ cells expressing pERK in each
treatment group in the P21 age group.
Chart 2-7 shows that a single morphine injection significantly increases the percentage
of TH+ cells that also express pERK above baseline and saline control group levels
(p<0.05; One-way ANOVA, Tukey’s Multiple Comparison’s post-tests).
A repeated morphine injection also significantly increases the percentage of TH+ cells
that express pERK above saline control group levels (p<0.05; One-way ANOVA,
Tukey’s Multiple Comparison’s post-tests). These data show that morphine increases
the activation of the dopaminergic cells in the P21 animal when administered both
singly and repeatedly over 5 days.Chapter 2
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2.4.4.3 Morphine activation of dopamine cells in the adult
Table 2-13 (below) gives the adjusted average cell counts of dopamine (TH+), activated
(pERK+) and co-expressing cells in each of the 5 treatment groups. The final column on
the right shows the percentage of TH+ cells that express pERK.
Adult TH+ pERK+ Co-
expressing
Percentage of TH+ cells
expressing pERK
Baseline (n=3) 58 ± 3.8 16 ± 0.8 3 ± 0.4 5.6 ± 0.4
Single saline
(n=3)
58 ± 3.2 12 ± 1.1 3 ± 0.5 5.5 ± 0.5
Repeated saline
(n=3)
65 ± 2.0 10 ± 1.5 2 ± 0.4 3.3 ± 0.7
Single
morphine (n=4)
51 ± 4.0 25 ± 2.4 12 ± 3.0 26.6 ± 6.6
Repeated
morphine (n=4)
71 ± 4.2 15 ± 2.8 5 ± 1.1 7.4 ± 1.2
Table 2-13 – a table to show the average cell counts (±SEM) in each treatment group in the adult
age group.
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Chart 2-8 – a bar chart to illustrate the percentage of TH+ cells expressing pERK in each treatment
group in the adult age group.
These results show that a single morphine injection significantly increases the
percentage of TH+ cells that express pERK above all other treatment groups (p<0.01;
One-way ANOVA, Tukey’s Multiple Comparison’s post-tests). Repeated morphine
injection, however, does not significantly increase the percentage of TH+ cells that
express pERK above control group levels.Chapter 2
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These data show that of the five treatment groups, only a single morphine injection
activates dopaminergic cells in the adult animal, and that in contrast to the effects at P7
and P21, repeated morphine injection does not activate dopamine cells above control
group levels.
2.4.5 Comparing control groups across ages
2.4.5.1 Control group data does not differ between groups or across
the ages
Comparing control groups to each other and across the ages shows that the percentage
of TH+ cells expressing pERK does not change significantly with age (2-way ANOVA
with Bonferroni post-tests, all values p>0.05). These data are shown in Chart 2-9
(below).
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Chart 2-9 – A bar chart to illustrate that the percentage of TH+ cells expressing pERK in the three
control groups across ages.
These data also show that injection of saline does not increase the pERK expression in
TH+ cells above baseline levels, and also that an injection per se does not affect the
percentage of TH+ cells expressing pERK.
2.4.6 Comparing the effects of morphine across age groups
Chart 2-10 shows the percentage of TH+ cells that express pERK after either single or
repeated morphine, plus control data, at each age. Control data was pooled from the
baseline, single and repeat saline injection groups.Chapter 2
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Chart 2-10 – a bar chart to show the percentage of TH+ cells expressing pERK after single and repeated
morphine injection in each age group. Both single and repeat morphine injections are above control levels in
the P7 and P21 groups (solid curves). Only the single morphine injection produces an increase in activation in
the adult (dashed curve). *p<0.05, **p<0.01, ***p<0.001; 2-way ANOVA with Bonferroni’s post-tests.
2.4.6.1 Single morphine injection
Chart 2-10 (above) illustrates that a single morphine injection activates dopaminergic
cells to 25-30% at P7, P21 and in the adult, significantly above control levels (p<0.01 or
p<0.001; 2-way ANOVA with Bonferroni’s post-tests). There is no significant
difference between ages (p>0.05; Two-way ANOVA with Bonferroni’s post-tests).
These data show therefore that the DA systems of young animals react to a single
morphine challenge to the same extent as that of the adults.
2.4.6.2 Repeated morphine injection
In the P7 and P21 animals, a repeated morphine injection activates DA cells
significantly above control levels (p<0.05 or p<0.01; 2-way ANOVA with Bonferroni’s
post-tests). In the adult only, there is significantly less DA cell activation after repeated
morphine injections compared to a single morphine injection (p<0.01; Two-way
ANOVA with Bonferroni’s post-tests – dashed curve in Chart 2-10) and no difference
compared to control levels (p>0.05; 2-way ANOVA with Bonferroni’s post-tests).
There is also a trend for cell activation in the chronic morphine condition to decrease
over development (p=0.08; Two-way ANOVA, Bonferroni’s post-tests).
Taken together, this suggests that repeated morphine injections given over 5 days have a
different effect upon dopaminergic cell activation in the adult compared to that of the
younger animals.Chapter 2
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2.4.7 Representative images
2.4.7.1 Baseline control
Figure 2-7 - A representative image of
tyrosine hydroxylase (red) and
phosphorylated ERK (green) staining of an
adult VTA section in the baseline treatment
group. A single co-expressing cell, marked by
a blue arrow, appears orange/yellow.
2.4.7.2 Single saline control
Figure 2-8 – A representative image of TH
(red) and pERK (green) staining of an adult
VTA section in the single saline injection
treatment group. There are no co-expressing
cells.
2.4.7.3 Repeated saline control
Figure 2-9 – A representative image of TH
(red) and pERK (green) staining of an adult
VTA section in the repeated saline injection
group. A single co-expressing cell, marked by
a blue arrow, appears yellow.Chapter 2
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2.4.7.4 Single morphine injection at P7, P21 and adult
2.4.7.4.1 P7
Figure 2-10 – A representative image of TH
(red) and pERK (green) staining in VTA of
the P7 animal. Co-expressing cells, examples
indicated by blue arrows, appear
orange/yellow.
2.4.7.4.2 P21
Figure 2-11 – A representative image of TH
(red) and pERK (green) staining in the VTA
of the P21 animal. Co-expressing cells,
examples indicated by blue arrows, appear
orange/yellow.
2.4.7.4.3 Adult
Figure 2-12 - A representative image of TH
(red) and pERK (green) staining in the VTA
of the adult animal. Co-expressing cells,
examples indicated by blue arrows, appear
orange/yellow.Chapter 2
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2.5 Discussion
2.5.1 Summary of results
2.5.1.1 Cell density in the VTA decreases over postnatal development
The results show that the density of total cells per mm
2 decreases over development.
This is not surprising in view of the increase in cell size, length, and complexity of
dendritic arbors over development (see McAllister, 2000), the proliferation of glial cells
(Nixdorf-Bergweiler et al., 1994), and also the increase in myelination of nerve fibres
that occurs during the first few weeks of an animal’s life (Butt and Berry, 2000),
pushing cell bodies further apart. This decrease in density means that raw cell counts of
populations of neurons in a fixed area of brain tissue are potentially misleading. What
might appear as a decrease in TH+ve cell number, for example, may simply be
reflecting the ‘spreading out’ of all cells in this region. To circumvent this problem two
approaches were used. One was to calculate the change in overall cell density, and thus
calculate a ratio to adjust TH+ve and pERK+ve counts at each age. The other was to
express the counts as a percentage of the total cell count in the area at each age. These
calculations gave consistent data that could be compared across ages.
2.5.1.2 Single morphine injection
A single morphine injection caused dopamine cell activation in the VTA above control
group levels at all ages, raising the percentage of activated DA cells from 5-10% in
control animals to 26-30% in morphine-injected animals. This shows that the P7 and
P21 dopaminergic system responds to a single morphine injection in much the same
way as the adult, fulfilling one hypothesis of this experiment.
The two other hypotheses of this chapter are also fulfilled – that the dopaminergic
system of the VTA is functional in the newborn rat, and that morphine, a rewarding
stimulus, will activate this system. Overall, these results are consistent with the
literature which has shown that morphine activates reward pathways in the neonate to
the same extent as the adult (Kehoe and Blass, 1986a; Kehoe and Blass, 1986b; McPhie
and Barr, 2000).Chapter 2
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2.5.1.3 Repeated morphine injection
Repeatedly injecting morphine over a 5 day period causes different effects in the
preweanling animals compared to the adults. Adults appear to develop neurobiological
tolerance over five days of morphine treatment, shown by a decrease of DA cell
activation to baseline levels.
In the P7 and P21 groups, however, dopamine cell activation is still high compared to
saline control groups after 5 days. Indeed, there are no differences in DA cell activation
between single and repeated morphine injections at these ages, suggesting that the
preweanling animals are not developing tolerance to morphine. Other investigators have
shown that the neonate does not develop analgesic tolerance to morphine (Rozisky et
al., 2008; Van Praag and Frenk, 1991a). These results are not in line with the hypothesis
that the effect of morphine will not differ significantly with age.
2.5.2 Technical considerations
2.5.2.1 Immunohistochemical staining
Whilst every effort is taken when processing and counting immunohistochemically-
treated slides, there are a number of points at which methodological processes can
potentially confound the results. A perfusion that does not circulate the
paraformaldehyde as successfully as another, due to an incorrect or less-than-optimal
placement of the needle into the heart, can affect the quality of tissue that is later
visualised under the microscope. For example, blood vessels can also be stained with
the pERK antibody in badly fixed tissue, making cell counting more difficult. To partly
overcome this problem, the shape and size of every spot of staining had to be carefully
considered to ensure neurons only were being counted. Using the TSA (tyramide signal
amplification) method to amplify the pERK signal also reduced the signal-to-noise ratio
and reduced the risk of identifying false positives.
The immunohistochemical process itself is not without problems. Antibodies may bind
more or less specifically depending on the quality of the tissue or on the amount of
washing comparative between experiments, and the background levels of antibody
binding may confound later cell counts. To control for these confounds, control slides
are produced that give images of the background levels of staining that prove theChapter 2
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antibody is binding correctly. For these experiments, negative control slides produced
without the primary or secondary antibodies proved that the antibodies used were
specific and showed low background levels of staining.
2.5.2.2 Gender
A potential confound in these experiments was the lack of separation for gender in the
preweanling animals. Males alone were used in adulthood. Despite research showing
gender variations in response to morphine (Cicero et al., 1996; McKelvy and Sweitzer,
2009), we hypothesised that as the preweanling animals had not yet begun to enter
sexual maturity, there should not be any differences in morphine response due to
hormonal variation between genders.
2.5.2.3 Morphine dosage
The dosage of morphine was different between the youngest P7 group and the P21/adult
animals. A dose of 10mg/kg was originally chosen, as this dosage had been used in the
literature when investigating morphine reward (Jones and Barr, 1995; Barr and
Goodwin, 1997). However, to check the effects of this high dosage (which is higher
than that needed for analgesia) on young animals, a pilot study was carried out to
determine the effect of a 10mg/kg dose on a single P6 animal. Morphine is well-known
as a respiratory depressant (Takita et al., 1997), and morphine at this dosage produced
considerable respiratory depression and hypothermia in the P6 animal, which, if applied
to all groups of <P7 animals in this experiment, would have meant continuous
monitoring of animals was necessary over the 30 minute post-injection period before
sacrifice to prevent suffocation or trampling by the dam. A dose that produced sedation
and analgesia, but not significant hypothermia or respiratory depression, was found to
be 5mg/kg, so this dosage was selected as appropriate for the youngest animals. All
pups displayed clear sedation (as seen by loss of righting reflex) and analgesia (as seen
by lack of response to tail pinch).
This need for a lower dosage in younger animals is in line with the literature showing
that morphine is more efficacious in the neonate, due to higher MOR levels, an
increased permeability of the blood-brain barrier, and slower metabolism of morphine
(Giordano and Barr, 1987; Nandi et al., 2004; Hartley et al., 1994).Chapter 2
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Despite the technical considerations discussed, overall the methods are sufficiently
robust to enable significant differences and firm conclusions to be drawn.
2.5.3 Development of tolerance to morphine
Tolerance to morphine is defined as the need for ever-increasing concentrations over a
period of chronic treatment to produce the original effect, and can occur at a cellular and
systems level. The mechanisms of many aspects of tolerance are not yet fully
understood, but there are a number of molecules and signalling pathways implicated in
tolerance to chronic opioids.
2.5.3.1 Analgesic tolerance is not seen in young neonates
Analgesic tolerance to morphine is seen in adults, but not seen in neonates until at least
P8 (Barr and Lithgow, 1986; Van Praag and Frenk, 1991a; Rozisky et al., 2008). This is
earlier than previous studies had reported, and does not mirror the increase in number of
receptors that occurs up to P15 (Zhang and Pasternak, 1981; Auguy-Valette et al.,
1978), but could be due to masking effects of rapidly proliferating opioid receptors
during the first two postnatal weeks, which will see an increase in receptor expression
during the time that repeated morphine dosages induce cellular tolerance mechanisms
(Van Praag and Frenk, 1991a). It is unlikely that a lack of receptors causes the lack of
tolerance seen in the neonates and P21 animals, as MOR expression has reached adult
levels by P15, so it would be expected that P21 animals would display the same
tolerance as adults.
However, the dosages used in this experiment were significantly higher than the
dosages used to induce analgesia, and analgesic tolerance was not specifically measured
in these animals. Tail pinch or suprathreshold von Frey hair application qualitatively
showed that analgesia was still apparent after 5 days of repeated morphine injection in
all ages. Perhaps if sensitive quantitative tests of nociceptive withdrawal thresholds had
been measured, analgesic tolerance would have been clear.Chapter 2
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2.5.3.2 Acute receptor desensitisation and internalisation after
morphine binding does not explain the lack of tolerance in
neonates
Agonist binding causes the MOR to become activated, by dissociation of the Gα and 
Gβγ subunits, which both trigger the Gi/o inhibitory intracellular signalling cascades.
Desensitisation of the receptor by phosphorylation occurs rapidly after the agonist has
bound, and can occur via a number of kinases i.e. G-protein receptor kinase (GRK),
protein kinases A and C (PKA/PKC) and calcium/calmodulin-dependent protein kinase
II (CaMKII), all of which have been implicated in morphine tolerance (see Ueda and
Ueda, 2009; Zhang et al., 2009).  After phosphorylation, β arrestin binds to the MOR 
and uncouples the MOR from its signalling pathways. Endocytosis of the MOR from
the cell surface then occurs via the scaffold protein clathrin, internalising the MOR.
Once the MORs are internalised into the cell, 20% are degraded by lysosomes, and 80%
de-phosphorylated then recycled back onto the cell surface membrane. This process
occurs rapidly within ~30 minutes (see Christie, 2008), resulting in a fast turnover of
receptors.
MOR agonists such as DAMGO are efficient at the internalisation and resensitisation of
the MOR as described above, but morphine itself does not cause receptor internalisation
to the same extent (see Borgland, 2001; Bailey and Connor, 2005). Therefore tolerance
to chronic morphine may occur due to receptor desensitisation rather than via
internalisation, perhaps via an alteration in the activity of the regulatory proteins that
would normally internalise and recycle the receptor, i.e. PKC, GRK, or β arrestin (see 
Christie, 2008). Finn and Whistler (2001) propose that the MOR may remain
phosphorylated at the cell surface membrane, is not internalised and recycled, and may
continue to signal in a chronic morphine condition, providing an explanation as to the
continuing action of morphine in younger animals.
Dang and Williams (2004) showed that desensitisation by phosphorylation of the MOR
is faster, and receptor internalisation is slower after chronic morphine treatment (5
days), suggesting that chronic morphine can influence the kinetics of the rapid effects
described above, but this alone is not likely to account for the long-term changes seen
over days and weeks of morphine administration.Chapter 2
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2.5.3.3 Chronic morphine treatment leads to cellular tolerance
Chronic and excessive stimulation of MORs over a long time period can lead to
homeostatic (‘allostatic’) adjustment of downstream signalling systems (see Le Moal
and Koob, 2005) and these signals may directly affect neural excitability, potentially
contributing to tolerance. An example of this is the adenylyl cyclase (AC)-cyclic AMP-
PKA cascade.
Chronic morphine treatment causes ‘superactivation’ of the AC signalling cascade (see
Bailey and Connor, 2005; Martini and Whistler, 2007). Acutely, opioids inhibit AC
activity, which causes a decrease in cAMP (3’,5’-cyclic adenosine monophosphate)
levels. However, after chronic morphine treatment, there is an increase in AC and
therefore cAMP in the continued presence of the agonist, resulting in a compensatory
homeostatic recovery to baseline levels of cAMP, and therefore tolerance of the system
to morphine (Avidor-Reiss et al., 1996). This changing level of cAMP may affect
transcription factors such as CREB (cAMP response element binding protein) and
ΔfosB further down the signalling pathway, having a knock-on effect on cellular
responses.  Both  CREB  and  ΔfosB have been heavily implicated in the molecular
mechanisms of drug addiction (see Nestler, 2004).
Other molecules that couple to signalling cascades and are directly affected by the MOR
include the MAP kinases (mitogen-activated protein kinases) and PI3
(phosphoinositide-3) kinase. One MAPK, ERK (extracellular-signal-regulated kinase) is
activated by the liberation of the MOR Gβγ subunit and has been implicated in receptor 
desensitisation (see Christie, 2008). PI3 kinase is also activated by Gβγ subunits, and 
could stimulate PKC signalling, which itself may have a role in receptor desensitisation,
as described above.
2.5.3.4 Tolerance of neural systems results from chronic morphine
treatment
Changes in neuronal firing, synaptic strength and chemical balance may all be altered
by chronic morphine, causing knock-on effects within the whole network. These kinds
of changes are complex and not well understood at this time.
2.5.3.4.1 ‘Anti-opioid’ systemsChapter 2
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Networks that are functionally antagonistic to endogenous opioid signalling have been
proposed that may be disturbed under chronic morphine conditions. The κ-opioidergic 
system and its ligands (the dynorphins) may be organised in a functionally antagonistic
manner to µ opioid signalling (see Shippenberg et al., 2007) and other suggested anti-
opioid systems include the nociceptin, orphanin, neurokinin-1, neuropeptide FF and
cholecystokinin-mediated systems (see Ueda and Ueda, 2009; King et al., 2001).
A further proposed anti-opioid system revolves around NMDA receptor signalling (Mao
et al., 1995; Mao, 1999). Antagonising the NMDA-R blocks opioid tolerance and
dependence (Trujillo and Akil, 1991; Mendez and Trujillo, 2008), and mice lacking the
NMDA receptor (NR)2A subunit do not develop analgesic tolerance. Electroporation of
the receptor back into the VTA restores analgesic tolerance in these animals (Inoue et
al., 2003). These data suggest that the NMDA receptor may be involved in the
development of tolerance at the systems level, perhaps through synaptic plasticity and
long-term potentiation, as mentioned below.
2.5.3.4.2 Glial function and tolerance
Astrocytes and microglia activate in response to chronic morphine treatment, and there
is evidence that this activation may influence neural excitability and synaptic plasticity,
perhaps playing an important role in tolerance and dependence to opioids (Narita et al.,
2004b; Watkins et al., 2005). Glia also produce growth factors and cytokines which can
affect synaptic plasticity i.e. via cAMP/CREB activation in the locus coeruleus
(Akbarian et al., 2002).
2.5.3.4.3 Synaptic plasticity
Opioids can affect synaptic plasticity after a single morphine injection, so it is likely
that chronic opioids will also affect the balance of cell signalling, perhaps via long-term
potentiation (LTP) and long-term depression (LTD) mechanisms (Ungless et al., 2001;
Christie, 2008). Acute morphine administration causes imbalances in excitatory AMPA
and NMDA receptors in the dopaminergic cells of the VTA (Ungless et al., 2001) and
also causes decreased LTP induction at GABAergic synapses onto these dopaminergic
cells (Nugent et al., 2007). This strongly suggests that long-term changes would occur
in synaptic plasticity with chronic morphine treatment.Chapter 2
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2.5.4 Potential explanations for the lack of tolerance in the neonate
as compared to the adult
The results of the experiments in this chapter showed that neonates do not develop
cellular tolerance to repeated morphine injection, as seen by the fact that the activation
of the DA cells did not decrease to baseline levels after 5 days of injection, unlike the
adults. This is unlikely to be due to a lack of functional morphine receptors, as these
have been found in the newborn animals in both spinal cord and brain, and both
analgesic and addictive behaviours are seen in animals in the first week of postnatal life
(Abbott and Guy, 1995; Jones and Barr, 1995; Barr and Goodwin, 1997; Barr et al.,
2003).
The delay in development of tolerance is also unlikely to be due to a lack of functioning
dopamine neurons, as these are present in the VTA at birth (see Alavian et al., 2008),
and the DA neurons of the VTA will respond to morphine challenge in the P4 rat (Barr
and Rossi, 1992). However, the numbers of DA receptors in the VTA do not peak until
P28 (Noisin and Thomas, 1988), and the relative importance of D1 and D2 receptor
signalling changes during the first 17 days of life (Pruitt et al., 1995). Dopamine
receptors in the prefrontal cortices, which are reciprocally connected to the VTA, do not
reach adult levels until around P60 (Tarazi and Baldessarini, 2000). This suggests that
within the first two weeks of life, dopaminergic signalling within the VTA and its
projections to prefrontal areas is not yet mature, and the lack of tolerance seen may be
partly due to this immaturity.
To illustrate, in the adult the VTA is reciprocally connected to the medial prefrontal
cortex (mPFC), which sends excitatory glutamatergic output to the DA cells of the
VTA, acting preferentially on NMDA receptors (Taber and Das, 1995; Wang and
French, 1993). Lesions of the mPFC deprive DA cells of one of their major sources of
excitation, and the mPFC is implicated in the induction of the behavioural sensitisation
seen after chronic morphine (Hao et al., 2007). If this single area is implicated in
addictive behaviours, it is likely that other prefrontal areas are also involved in the
response to chronic drug administration in the adult.Chapter 2
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However, in the neonate, this connectivity may not be functional. Studies have shown
that the prefrontal cortex shows a delayed maturation in comparison to midbrain areas,
and that dopaminergic signalling in the adult can be qualitatively different to the
neonate (see McCutcheon and Marinelli, 2009). Therefore the lack of tolerance seen in
the neonates could be due to immature connectivity to brain areas involved in the
expression of tolerance in the adult. This immature connectivity could perhaps be due to
a lack of a number of factors: mature neurons in prefrontal areas; interneurons to
connect neurons in different areas; functional synapses between the areas; and/or white
matter to connect the areas. This explanation would fit with the result that the P21
animals did not develop tolerance, as the prefrontal cortex is not functionally mature
until at least P45 (Tseng and O'Donnell, 2007).
A further hypothesis to account for a lack of tolerance in the neonate could involve the
NMDA receptor and its role in synaptic plasticity. As described above, systems
tolerance could be partly controlled by action of an ‘anti-opioid’ NMDA-mediated
system (see Mao, 1999; Ueda and Ueda, 2009). In line with data from the adult, Zhu
and Barr (2003) found that NMDA receptor antagonists block the development of
morphine tolerance. However, this only occurs after 14 days of age and not at all in
animals in the first week of life, which the authors speculate is due to an immature
composition of NMDA receptor subunits that does not mature until the third week of
life. This would suggest that the neonate cannot develop cellular tolerance, which is in
line with the data presented in this chapter.
2.6 Conclusions
The results presented in this chapter suggest that the reward pathways in the VTA of the
neonate are functionally mature, as morphine will activate the mesolimbic dopaminergic
pathways in the youngest animals, as measured by pERK expression in DA cells. This
is in line with literature showing that morphine is rewarding in the neonate, i.e. it will
induce conditioned place preference (Kehoe and Blass, 1989), and symptoms of
withdrawal will appear on cessation of morphine administration (Jones and Barr, 1995;
Ceger and Kuhn, 2000).Chapter 2
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The results also show that P7 and P21 animals do not develop cellular tolerance to 5
days of morphine administration, but that the adult does. These results are in line with
the literature that shows that adults develop cellular tolerance, but that neonates do not
(Rozisky et al., 2008). These animals may not develop cellular tolerance in the
dopaminergic cells studied due to an immaturity of NMDA receptor composition,
and/or a lack of functional connectivity to the medial prefrontal cortex. The lack of
tolerance is unlikely to be due to immature opioid receptor expression, as the levels of
opioid receptors are mature by the end of the second postnatal week (Auguy-Valette et
al., 1978). Nor are the morphine or dopaminergic systems immature at P21, as both are
sensitive to reward in the neonate (Lithgow and Barr, 1984; Barr and Rossi, 1992).
These results are encouraging for rest of this thesis, as they provide a solid basis for the
further experiments in this thesis which will look at the long-term effects of injury
during the neonatal period on adult reward processing. The results presented here prove
that the reward pathways during the neonatal period are viable, and so it is possible that
pain during this period has the potential to impact upon reward processing, much as
pain in adulthood can affect reward processing.Chapter 3
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3 Chapter 3 – The effect of neonatal injury on adult
reward behaviours
3.1 Introduction
This chapter addresses the fundamental question of this thesis: if pain processing can be
affected by early life injury, then can other modalities of cognitive processing also be
affected? The hypothesis presented in this thesis is that interfering with the developing
nociceptive system will shift processing in the reward systems of the brain in adulthood.
The experiments presented in this chapter are aimed at investigating the long-term
effects of neonatal experience of foot wound on reward-related behaviour in adult life.
To do this, preweanling animals were repeatedly injured, and the sensory and affective
alterations in behaviour studied when the animals were mature.
3.1.1 Injury during early life
As discussed in the introduction to this thesis, there is much evidence in the literature
that neonatal pain can cause long-term alterations in pain processing in the older and
adult organism (Ren et al., 2004; Lidow et al., 2001; Walker et al., 2009b). This is
particularly relevant for informing clinical practice in human neonates, as many of the
procedures performed that are necessary for survival can cause long term changes in
nociceptive processing that can affect the child later in life (Buskila et al., 2003; Grunau
et al., 2006; Walker et al., 2009a).
3.1.1.1 Modelling the heel lance in humans
In this chapter, rats that were repeatedly injured as neonates are to be studied in
adulthood for sensory changes, and also for subtle changes in behaviour towards a
reward. To make this investigation as relevant to human clinical practice as possible, the
model of injury chosen was designed to reflect the heel lance procedure routinely
performed in the neonatal intensive care unit (NICU): the plantar skin incision model.
On the NICU, blood must be gathered from infants to monitor blood oxygenation levels.
However, particularly in preterm infants, veins are not mature enough to cope with
repeated venepuncture, so to overcome this problem, blood is collected via heel lance.Chapter 3
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In this procedure, the foot is warmed to stimulate blood flow, the heel is punctured with
a small blade, and the foot squeezed to cause bleeding and allow blood collection.
Whilst neonates on the NICU do not experience only heel lance, it is the most common
invasive procedure performed in the NICU (Johnston et al., 1997), causes behavioural
responses i.e. facial distortion and limb withdrawal, and activates cortical
somatosensory processing areas (Slater et al., 2006). The fact that heel lance is
processed by both the spinal cord and brain in infants makes it a relevant procedure to
model in animals where adult cognitive processing is being investigated. Other papers
have modelled heel lance by repeated needle prick (Walker et al., 2003a) or insertion of
a needle completely through the paw (Anand et al., 1999), but in this chapter, the
plantar skin incision model of post-operative pain was chosen to mimic the neonatal
repeated heel lance procedure.
The plantar skin incision model, or ‘foot wound’ as it will be referred to hereafter, was
developed by Brennan and colleagues (1996). It was developed to model surgical injury
and its effect both peripherally and centrally has since been thoroughly described
(Brennan et al., 2005). It has also been used in neonates and shown to produce acute
thermal and mechanical hypersensitivity (Ririe et al., 2003) and to alter spinal
nociceptive processing (Ririe et al., 2008).
Recently, Walker and colleagues (2009b) have shown that a single neonatal foot wound
causes enhanced sensitivity to mechanical stimuli upon re-injury two weeks later,
compared to animals with no neonatal foot wound. Furthermore, this effect is not
apparent when the original foot wound was performed in older animals (postnatal days
(P)10, 21 or 40), suggesting a critical period within the first week of postnatal life for
the development of heightened sensitivity after re-injury. This paper is important for the
experiments in this chapter, as it shows that a single neonatal foot wound can have long-
lasting effects on pain sensitivity after the wound has healed, and that re-injury to the
same site can exacerbate the resulting hypersensitivity.
Methodologically, the foot wound model has a number of advantages. Firstly, it is a
short, simple, non-invasive surgical procedure. Therefore, animals are only briefly
anaesthetised and possible confounding effects upon adult behaviour due to anaestheticChapter 3
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administration are minimised. Also, like the heel lance, an incision is made into the
foot/paw, meaning similar physiological response mechanisms are involved in both i.e.
inflammatory responses in a particular dermatome and the associated peripheral and
central nervous system changes. Another advantage is the reproducibility of the foot
wound surgery, allowing accurate comparisons at different ages after the same stimulus.
As Figure 3-1 shows, the anatomical landmarks of the rat hindpaw are clear, and these
do not change over development. This reproducibility is important when comparing
animals which will all display different patterns of individual differences.
Figure 3-1- A schematic diagram of the rat
hindpaw, showing footpads. The relative
location of these on the paw does not change
throughout the lifetime of the animal.
Adapted from Walker et al (2009b).
3.1.2 Measuring reward behaviours
A reward is something that inspires the motivational incentive to seek it. In simple
terms, it is something that an organism will work for. Rewards can be almost anything,
from basic reinforcers such as food, sex and drugs, to complex social behaviours, such
as friendship and teamwork. Reward responses in animals and humans have been a
massive area of research over the past 100 years – to help understand the motivations
that drive drug abuse, and also to help ameliorate the symptoms of withdrawal.
In animals, reward behaviour can be measured in a variety of ways. Some paradigms are
relatively simple, and based on operant conditioning principles, where an animal learns
to perform a behaviour to receive a conditioned reward. Other paradigms are more
complex, and the animal has to learn to perform, or withhold, a particular set of
responses within a specific time-frame to receive the reward. These more complex
paradigms can often take into account other outcome measures, such as anxiety
behaviours, impulsivity and anhedonia (the loss of ability to experience pleasure).
To investigate reward behaviours in animals, a number of considerations have to be
taken into account. Which paradigm would be most appropriate to use? Should an
existing paradigm be modified to make it appropriate for these sets of experiments?Chapter 3
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Should a pharmacological drug or something more naturalistic be used as the rewarding
stimulus? These questions are considered below.
3.1.2.1 Classical conditioning
Many reward paradigms are based on extensions of classical conditioning principles,
first detailed by Pavlov in his experiments with salivating dogs (1927). In a classical
conditioning paradigm, at baseline an animal naturally associates an unconditioned
stimulus (UCS) i.e. food, with an unconditioned response (UCR) i.e. salivation. During
conditioning, another stimulus presented with the food (i.e. a bell) becomes associated
with the salivatory response. After conditioning, the bell becomes a conditioned
stimulus (CS), where the sound of it alone can cause salivation, now termed as the
conditioned response (CR).
3.1.2.2 Operant conditioning
Operant conditioning is an extension of classical conditioning, and is learning that
occurs through rewards and punishments, as the animal learns to associate performance
of a particular behaviour with a certain outcome. Skinner first used the term ‘operant’ to
refer to any “active behaviour that operates upon the environment to generate
consequences” (Skinner, 1953) and his behaviourist ideas have shaped the study of
animal behaviour over the last 5 decades. Operant conditioning takes into account both
reward and punishment, the former increasing the frequency of the specific behaviour
and the latter decreasing the frequency.
3.1.2.2.1 Progressive ratio measurement
Progressive ratio testing is a reward-sensitive procedure based on operant conditioning
principles. In this procedure, an animal receives a reward i.e. sweetened condensed
milk, upon lever press or nose-poke. The number of lever presses/pokes required to
produce the reward continually increases until the animal stops responding, at which
point the ‘break point’ is determined. Weaker rewards are shown to have lower break
points (Hodos, 1961). A brief search of the literature shows that within the last year,
rewards given on a progressive ratio schedule have included ethanol (Li et al., 2010b),
heroin (Wang et al., 2009b), cocaine (Wang et al., 2009a), and food (Sharf et al., 2010)
amongst many others, showing how it is a widely used experimental tool.Chapter 3
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3.1.2.2.2 Conditioned place preference
3.1.2.2.2.1 Principles of Conditioned Place Preference
Conditioned place preference (CPP) is another behavioural paradigm based on operant
conditioning principles and has been used hundreds of times in rodents over the course
of the last 20 years, generally to investigate the rewarding properties of drugs of abuse
(see Tzschentke, 1998).
CPP paradigms normally consist of two chambers with differing characteristics i.e.
vertical versus horizontal stripes, different odours etc., although square open fields with
differing characteristics between each quadrant have also been used successfully
(Vezina and Stewart, 1987).
To run the experiment, the animal is placed into one of the two chambers and either
administered with the drug under investigation or exposed to the reward in question (in
the case of drug injection, administration occurs immediately prior to placement in the
chamber) on a certain number of conditioning days prior to testing. On the test day, the
animal is placed into either the non-conditioned chamber, or a neutral chamber attached
to both conditioning chambers, and the amount of time the animal spends in the
conditioned chamber is measured. The animal will spend more time in the chamber with
which it associates the rewarding stimulus. It is said that if a stimulus has been
rewarding, it will demonstrate CPP (see Tzschentke, 1998).
3.1.2.2.2.2 Applications of conditioned place preference
The literature overwhelmingly shows that CPP is a reliable indicator of a reward’s
motivational properties (see Tzschentke (1998) and (2007) for comprehensive reviews).
CPP has been shown to result from a huge array of drugs, often mediated by the
mesolimbic dopaminergic system; Amphetamine, cocaine, heroin and morphine, which
all increase DA levels, and various combinations of these with other drugs, all induce
CPP. Conversely, CPP is blocked by dopaminergic antagonists. Other rewarding drugs
that induce CPP have included ethanol; nicotine; benzodiazepines such as diazepam
which enhance GABAergic transmission; MDMA (3,4-
methylenedioxymethamphetamine, commonly known as Ecstasy); LSD (lysergic acidChapter 3
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diethylamide); phencyclidine (PCP, or ‘angel dust’); various cannabinoids; and some
hormones, amongst many others. Natural reinforcers such as food, sucrose-sweetened
water, social play, home cage odours and the presence of pups in maternal rats have also
been shown to induce CPP. Clearly, it is a powerful test of whether or not a stimulus is
rewarding.
CPP has also been used to investigate the effect of lesions on reward behaviours,
helping to show which specific areas of the brain are involved in reward processing.
Lesions by 6-hydroxydopamine (6-OHDA), which selectively ablates dopaminergic and
noradrenergic neurons, have shown that the nucleus accumbens shell and ventral
pallidum are necessary for morphine-induced, diazepam-induced and novelty-induced
CPP (Shippenberg et al., 1993; Spyraki and Fibiger, 1988; Pierce et al., 1990)
Excitotoxic lesions (by ibotenic acid or kainic acid) of the NAcc, ventral pallidum,
amygdala and medial PFC, amongst many others, have been shown to be necessary for
induction and learning of CPP (Olmstead and Franklin, 1996; Hiroi and White, 1993;
Brown and Fibiger, 1993; Tzschentke and Schmidt, 1998). Finally, electrolytic lesions,
caused by driving a large current through brain tissue and destroying it, cause CPP loss,
as do radiofrequency lesions and knife-cut lesions (see Tzschentke, 1998).
Studies of different strains of rats and mice have shown inherent differences in drug
response, as shown by CPP. Conditioned place preference has even been used in non-
mutated animals to breed separate strains. Rats that showed naturally strong or weak
cocaine-induced CPP, paired over three generations, produce discrete strains with
differences in cocaine sensitivity (Schechter, 1992). Testing of genetically manipulated
mice has also confirmed the role of a number of molecules in drug reward i.e. mu opioid
receptor (MOR) and dopamine D2 receptor knock-out mice will not develop morphine-
induced CPP (Matthes et al., 1996; Maldonado et al., 1997).
3.1.2.2.2.3 Conditioned Place Avoidance
A modification of the CPP paradigm, conditioned place avoidance (or aversion), is
based on the same principles as CPP, but is used as a way to measure the aversive, or
punishing properties of a stimulus. Animals are exposed to an aversive stimulus (e.g.
footshock or a dopamine antagonist) that is paired to one of the two conditioning
chambers, and time spent in that chamber upon post-conditioning testing is lowerChapter 3
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compared to pre-conditioning baselines. Therefore the animal has learnt to avoid the
chamber in which the aversive stimulus occurred.
Pain is both an aversive stimulus and state for an animal to be in, and pain research is
beginning to use CPA as a way of modelling the affective components of pain. For
example, Hummel et al (2008) showed that animals in neuropathic and inflammatory
pain states will show aversion to a previously neutral chamber in which the injured paw
was repeatedly mechanically stimulated during 5 days of conditioning. Other studies
have shown that injection of inflammatory agents such as carrageenan and complete
Freund’s adjuvant (CFA) into the hindpaw, and also nerve injury, will induce CPA
when the injured paw/nerve territory is mechanically stimulated during conditioning
(LaBuda and Fuchs, 2000; van der Kam et al., 2008). In the studies above, morphine
analgesia delivered concomitantly to conditioning either attenuated or abolished CPA
induction.
3.1.2.2.2.4 Intracranial place conditioning
Another modification of the classic CPP paradigm, intracranial place conditioning
(ICPC), is a useful paradigm for investigating the brain regions that are involved in
signalling reward. By implanting cannulae into different regions implicated in reward
processing, the effects of drug agonists and antagonists can be closely linked to specific
areas.
Intracranial administration of the drug is given in association with one of the CPP
chambers during conditioning, and place preference measured on test days. This is a
non-operant test with no learning of behaviour needed to elicit drug reward.
ICPC studies have shown that dopaminergic drugs in a variety of brain regions will
induce CPP. Morphine injection into the VTA induces CPP, as do endogenous opioid
peptides and mu and delta opioid receptor agonists (Phillips and LePiane, 1980; Phillips
and LePiane, 1982; Bals-Kubik et al., 1993). Neurotensin, which modulates
dopaminergic signalling, injected into VTA also causes CPP (Glimcher et al., 1984).
Other areas implicated after dopaminergic drug injection include the nucleus accumbens
(NAcc), in particular the shell section, medial prefrontal cortex (mPFC), dorsal
hippocampus, periaqueductal grey, and lateral hypothalamus (see McBride et al., 1999).Chapter 3
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All the above examples rely on DA signalling, but ICPC has shown other
neurotransmitter systems are involved in reward processing. For example, injection of
the cholinergic agonist cytosine into the VTA causes CPP (Museo and Wise, 1994) and
substance P, which is closely implicated in serotonergic signalling, injected into the
ventral pallidum and nucleus basalis magnocellularis (NBM) induces CPP (Hasenohrl et
al., 1998). Taken together, ICPC can show a myriad of regions responsible in part for
reward signalling.
ICPC can be used in conditioned place avoidance paradigms as well. Johansen and
Fields (2004) showed that the anterior cingulate cortex (ACC) is involved in learning
the aversive component of pain. Excitotoxic lesions, performed by microinjection of
ibotenic acid, prevented the expression of formalin-induced CPA if the area was
lesioned before, but not after, conditioning. Furthermore, stimulation of the ACC with
excitatory amino acids, in the absence of pain, also produced CPA. These data, together
with an earlier paper from the same laboratory (Johansen et al., 2001) show that the
ACC encodes a teaching signal for aversive stimuli.
However, ICPC can be problematic. The implantation of a cannula into the brain is an
invasive procedure, and post-surgery animal recovery must be carefully monitored. The
diffusion extent of drugs that are being infused into the brain must be well characterised
to minimise spread into other nearby structures, and the neurotoxicity of the drug in
question must also be well known to prevent local damage that could influence results
for confounding reasons. Finally, localisation of the cannula must be scrutinized after
the experiments are concluded to check that it has been placed in the correct area –
incorrect placement of cannula could negate any results from that particular animal. In
brain regions such as the ventral tegmental area (VTA), this is particularly important, as
the VTA is small and bordered by many areas such as the substantia nigra that could
affect experimental results greatly (see Figure 3-2).Chapter 3
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Figure 3-2 – A schematic diagram of a coronal section of the brain, with the ventral tegmental area
highlighted by the black circle. It is small and has borders with many other areas. Adapted from
Paxinos and Watson (2004).
A major weakness of the ICPC procedure is that the animal has no control over the
administration of the agent, meaning that whilst associative learning is displayed, the
motivational aspect of drug-seeking is largely lost (see McBride et al., 1999).
3.1.2.2.3 Summary of place preference paradigms
CPP has been popular with researchers for a number of reasons: it is cheap and easy to
set up, does not require large amounts of training, and it can produce reliable and
reproducible drug effects.
However, the lack of CPP induction with a certain stimulus does not automatically
mean that a drug will not be rewarding or potentially addictive. The testing apparatus is
a highly artificial construct, especially where external drug administration is concerned,
and it can be argued that, whilst sensitive to pharmacological manipulation, CPP is not
representative of an environment that an animal may encounter in its natural habitat.
3.1.2.2.4 Intracranial self-stimulation (ICSS) and intracranial self-
administration (ICSA)
Intracranial self-stimulation or self-administration are other useful methods of
investigating drug reward in animals, delivering rewarding stimuli directly into the
brain. They involve placement of an electrode or cannula into a specific brain region,
and the animal will learn to perform certain behaviours i.e. lever pressing or nose-poke,
to receive electrical stimulation or a drug infusion in response. The main advantage of
ICSS/ICSA is that the animal is in charge of its own electrical impulse/drugChapter 3
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administration, and in this way it is an operant conditioning paradigm, whereas in CPP
the animal has little or no control over access to the rewarding stimuli and displays
simple associative learning to an environment. Rewards can be administered in a linear
fashion, with a single lever press/nose-poke resulting in a single ‘shot’ of the reward, or
on a progressive ratio schedule to examine reward magnitude, break points, and the
effects of withdrawal directly in the brain regions implanted with the electrode or
cannula.
3.1.2.2.4.1 Electrical intracranial self-stimulation (ICSS)
Olds and Milner (1954) first found that animals will keep returning to an area of testing
apparatus in which they had received electrical stimulation of certain brain regions, and
that the animals could then be trained to self-stimulate by pressing a lever. Olds and
Milner concluded that electrical stimulation could serve as a positive reward in operant
conditioning. Since these discoveries, ICSS has been demonstrated in all species that
have been tested, and even in humans, with electrodes in the caudate nucleus, amygdala,
intralaminar thalamic nuclei and middle hypothalamus mapping intensities of
stimulation necessary for the sensation of ‘rewarding’ and ‘aversive’ properties (Bishop
et al., 1963). Both animals and humans will choose to forgo food, even to the point of
starvation or exhaustion in animals, in order to continue the lever-pressing that delivers
the electrical stimulation. Aversive stimuli, such as footshock, will also be better
tolerated or ignored altogether when there is the option of self-stimulation (Olds, 1958).
Electrical ICSS paradigms can be carefully manipulated to deliver controlled and
reproducible stimuli. The magnitude of the reward, and therefore how motivated the
animal is to work for it, can be controlled by altering the duration and frequency of the
pulse, therefore altering the intensity of the stimulus.
The effects of ICSS can be potentiated by concomitant drug administration. For
example, drugs of abuse such as cocaine, morphine, heroin, amphetamine and nicotine,
amongst others, show synergistic effects with ICSS, potentiating ICSS by lowering the
threshold for stimulation, and elevating the dopamine concentrations within the brain
(see McBride et al., 1999).Chapter 3
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The converse of reward is anhedonia – a loss of sensitivity to reward – and can be
quantified and explored using ICSS. An increase in the levels of stimulation required to
maintain a particular level of bar pressing/nose-pokes is seen as a decreased sensitivity
to brain reward. Increases in self-stimulation are also seen in drug withdrawal states,
making ICSS a useful tool for modelling for drug withdrawal symptoms in humans.
3.1.2.2.4.2 Intracranial self-administration (ICSA)
Drug administration via implantation of a cannula into brain sites has also provided
valuable insights into the actions of rewarding drugs on brain processing. ICSA studies
in rodents have shown that, like CPP and ICSS, dopaminergic signalling in the
mesolimbic pathway, originating from the ventral tegmental area, is crucial for reward
processing (see McBride et al., 1999). Also like ICPC and ICSS, ICSA has confirmed
the brain regions involved in reward processing, again mainly those linked to or
explicitly part of the mesolimbic dopaminergic pathway: the VTA (Bozarth and Wise,
1981; Devine and Wise, 1994; Wise and Hoffman, 1992), the NAcc shell (Roberts et
al., 1980; Barak Caine et al., 1995), the medial PFC (Goeders and Smith, 1993) and the
lateral hypothalamus (David and Cazala, 1994b; Olds and Williams, 1980), amongst
others. All of these regions will respond to a wide range of drugs of abuse.
3.1.2.2.5 Summary of intracranial electrical stimulation and self-
administration
Like ICPC, both ICSS and ICSA provide useful tools for understanding how rewards
are processed in the brain, as well as giving insight into the anatomical structures and
associated neurochemistry. Also, the fact that self-stimulation has been shown in
humans to demonstrate reward has proven hugely useful in drawing trans-species
parallels, a rare occurrence in many areas of research.
However, as with ICPC, self-stimulation paradigms can be problematic. Implantation of
an electrode or cannula is invasive and must be properly verified, and the situation in
itself is highly artificial – there are no natural environmental circumstances under which
an animal would experience the same events. Self-stimulation bypasses the peripheral
nervous system and the senses such as touch, smell and taste that would normally
accompany a reward (see Wise, 2002). Whilst enabling specific brain areas andChapter 3
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neurotransmitters to be identified and manipulated, it is not an ethologically valid
method of investigating reward.
3.1.3 Novelty, exploration and the approach/avoidance conflict
It is widely accepted that novelty is rewarding. In animals, novel objects are
preferentially investigated (Bevins and Besheer, 2005; Harris et al., 2007a), and novelty
preference (neophilia) for faces is apparent in young human infants (<6 months)
(Rhodes et al., 2002).
Under CPP testing conditions, Bevins and Bardo (1999) showed that conditioning with
novel objects can elicit place preference on test days, and that expression of this CPP
relied on dopaminergic signalling, as antagonism of both D1 and D2/D3 receptors
blocked the CPP. Novelty preference in animals has been argued to be a more subtle
and valid test of reward than conventional drug rewards, mimicking regular, everyday
human rewards, such as enjoying a food treat (see Bevins and Besheer, 2005).
It is suggested that intense novelty may, however, elicit avoidance rather than approach,
producing a curvilinear relationship between novelty and approach – see Figure 3-3 (see
Hughes, 2007).
Figure 3-3 – A schematic graph showing the proposed curvilinear relationship between novelty and
avoidance. High novelty can produce avoidance behaviours, whereas low novelty can result in
behavioural ‘boredom’. Curiosity is a pay-off between approach/avoidance at non-extreme levels of
novelty. Adapted from Hughes (2007).
Exploration of a novel environment will, based on the novelty-as-reward assumption, be
rewarding; however, it will be tempered by conflicting motivational drives that cause
predated animals such as rodents to exert caution in their exploration, producing anChapter 3
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approach-avoidance conflict (see Montgomery, 1955). This conflict in motivational
drives causes an anxiety state, with anxiety levels as the inverse of exploratory
behaviours (Ennaceur et al., 2006).
The innate approach-avoidance conflict is widely utilised in animal research to study the
extent to which an animal is willing to explore, and the anxiety that this produces.
Researchers looking for treatments for human anxiety syndromes have taken advantage
of conflict tasks to develop animal models of anxiety, back-validated them with current
anxiety drugs, and used these animal models for drug screening of potential therapeutic
compounds in behavioural conflict tasks.
More recently, pain researchers have begun using animal paradigms that study anxiety
to begin modelling the affective components of pain. Pain is not only a sensory
experience; the International Association for the Study of Pain defines pain as “an
unpleasant sensory and emotional experience”, and researchers have struggled to
develop affective measures of pain in animals (see Mogil, 2009). The co-morbidities
that are associated with pain, such as anxiety, depression, and anhedonia (Meyer-
Rosberg et al., 2001) make them potential behaviours to study in animals in pain states.
Some laboratories are now engaged in modelling these behaviours, in parallel with pain
behaviours (Callahan et al., 2008; Legg et al., 2009; Seminowicz et al., 2009).
3.1.3.1 Behavioural paradigms measuring anxiety-like behaviours
Many paradigms that exploit the approach/avoidance conflict are used to measure
behaviour in animal models of anxiety (see Ramos, 2008). Anxiety, as discussed, can
result from the conflict produced from being motivated to approach a novel
environment (reward) and the innate avoidance behaviours that will protect naturally
predated animals such as rodents. Therefore anxiety paradigms have components of
rewarding exploration inherent in them, which can be measured in the paradigms
described below. Indeed, this fact can confound research investigating anxiety
behaviours, as an increase in approach/exploration can either be a measure of decreased
anxiety, or increased novelty-seeking/impulsive behaviour (see Cryan and Holmes,
2005).Chapter 3
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3.1.3.1.1 Elevated plus maze
The elevated plus maze (EPM) is one of the most popular test of anxiety. It consists of a
plus-shaped maze, elevated off the floor, with two of the ‘plus’ arms being enclosed,
and the other two open (see Figure 3-4). Rodents will naturally avoid the open arms
and show general preference for closed arms, but will show exploratory behaviours by
entering the exposed arms (Rodgers, 1997). Outcome measures in this test include the
latency of entry into the open arms, number of entries into the open arms, and
percentage of time spent there versus time in the closed arms. Anxiolytics (drugs that
lower anxiety levels) will decrease the latency to enter the open arms, and increase the
number of entries and amount of time an animal spends in the open arms. Rearing
behaviour can also be scored as an index of exploratory behaviour.
Figure 3-4 – A schematic figure of the elevated plus maze for mice, showing the two open and two
closed arms. Adapted from Cryan and Holmes (2005).
3.1.3.1.2 Light/dark box test
The light/dark box, also called the black/white box, consists of two arenas connected to
each other through a small opening. One arena is large, open, brightly lit and white; the
other is smaller, covered, and black (see Figure 3-5). Rodents will tend to avoid the
aversive white environment and outcome measures can include latency to entry,
locomotive behaviour, number of entries into the light arena and number of rears. As
with the EPM, anxiolytics will decrease latency to entry and increase number of entries
into the light arena.Chapter 3
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Figure 3-5 – A schematic figure of the light/dark box test for mice. Adapted from Cryan and
Holmes (2005).
3.1.3.1.3 Open field test
First conceived in 1934, the open field test was designed to assess ‘emotional reactivity’
in rodents. Outcome measures that were regarded as indices of ‘reactivity’ were
defecation and urination (Hall, 1934). Since then, the open field test has been widely
used as a tool for assessing exploration, inquisitive behaviour, anxiety, memory and
reaction to novelty (Ennaceur et al., 2006).
Open fields consist of a large, open arena. They can be square (see Figure 3-6), circular
or rectangular; the arena can be bright or dark; the testing can be done in brightly
illuminated conditions or in the dark; and length of testing time can vary between less
than 5 minutes up to more than 30. This lack of standardisation can be problematic
when comparing results between different laboratories. Measures of central exploration
are often regarded as anxiety-related indices, where exploration into the centre will
increase as anxiety decreases. Again, rearing behaviour can be scored as an index of
exploratory behaviour.
Figure 3-6 – A schematic figure of the open field test. Adapted from Cryan and Holmes (2005).Chapter 3
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The main advantage of the open field test is its simplicity; it is not an operant task, so no
special training is required. In addition, it will always yield results of some sort,
depending on your outcome measures - although what those measures really mean can
be subject to discussion (Stanford, 2007b; Stanford, 2007a; Ramos, 2008; Walsh and
Cummins, 1976).
3.1.3.1.4 Novelty-induced hypophagia test
The inhibition of feeding produced by novelty, termed ‘hyponeophagia’, can be used to
design studies that yield anxiety-related measures, and has been used in research to
investigate the effects of chronic antidepressant treatment in both mice and rats (see
Dulawa and Hen, 2005).
Hall (1934) first described an inverse relationship between feeding and defecation in
animals exposed to a novel environment, and this fact has been exploited in the
development of hyponeophagia paradigms, resulting in conflict tasks in which an
animal has to decide between approaching and consuming a desirable food in a novel
arena, or avoiding the novel environment for safety. Assessing hyponeophagia typically
involves presenting rodents with food in a novel, and therefore anxiogenic, environment
such as an open field or unfamiliar cage, and measuring the latency to feed and the
amount consumed.
The food will either be familiar chow presented to food-deprived and therefore hungry
animals (Shephard and Broadhurst, 1982a; 1982b),or will be a highly palatable food
presented to satiated animals (Dulawa et al., 2004). The only training needed for this
task is to familiarise the animals with the highly palatable food before testing.
Experiments using the NIH task have used an open field (Bilkei-Gorzo et al., 2002;
Bodnoff et al., 1988; Britton and Britton, 1981) or a novel cage (Dulawa et al., 2004) as
the novel environment. Open field NIH paradigms expand the behaviours that can be
observed beyond measures of amount eaten and latency to eat, as other anxiety-like
behaviours such as defecation and urination, and exploratory behaviours such as
locomotion and rearing, can be scored and analysed.Chapter 3
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The use of food as a reward makes these paradigms ethologically relevant, in that it can
study animal behaviour in a situation which would be encountered in a natural habitat.
As it is a non-operant task, little or no training is required.
3.1.3.2 Impulsivity as a reward-related behavioural measure
Impulsivity refers to the inability of an organism to suppress inappropriate responses.
Definitions broadly include a lack of behavioural inhibition, including actions that are
premature, mis-timed, or difficult to suppress or control (see Dalley et al., 2008).
Impulsive behaviour is a type of reward behaviour - evidence from the addiction
literature cites impulsivity as a risk factor in addiction and relapse (Perry and Carroll,
2008), and the neural substrates linked to impulsivity are closely linked to the
mesolimbic dopaminergic system, with the fronto-striatal DA circuit suggested as a
possible locus of dysfunction in pathological impulsivity (see Dalley et al., 2008).
Clinically, impulsivity is also related to attention deficit disorders and schizophrenia
(see Robbins, 2002).
Impulsivity has been divided into two major subtypes: impulsive choice (choice of a
small, immediate reinforcer over a larger, delayed reinforcer) and inhibitory failure
(inability to stop a particular behaviour). Delay discounting tasks are used as measures
of impulsive choice, and the 5-choice serial reaction time (5CSRT) task is used to
measure inhibitory failure. Both are operant tasks that require intensive training.
3.1.3.2.1 Delay discounting task
Performed in both animals and humans, in animal experimental paradigms, animals are
trained to make a lever press/nose-poke to obtain a reward i.e. drug, food etc. One lever
will always deliver a small, immediate reward, whereas another will always deliver a
larger reward after a delay. The point at which each lever is chosen equally is called the
indifference point. As the delay becomes longer, animals that display higher impulsivity
will show a lower indifference point i.e. they will press the lever for the smaller,
immediate reward more often than they will press to wait for the larger reward.
3.1.3.2.2 5-choice serial reaction time task (5CSRTT)
This complex paradigm measures inhibitory failure. The apparatus consists of a
chamber with 5 horizontally-aligned apertures, above one of which a brief visualChapter 3
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stimulus, i.e. a light, will appear, and the animal can nose-poke to receive a reward. In
the task, a large number of consecutive trials are presented and the subjects are required
to wait during either a fixed or varied inter-trial interval (ITI). Nose-pokes that occur
prematurely are thought to reflect higher levels of impulsivity (Robbins, 2002;
Robinson et al., 2009).
Other tasks that measure inhibitory failure include the go/no-go task (subjects must
respond, or withhold a response, according to the particular stimulus presented), and the
stop signal reaction time (SSRT) task (where subjects must withhold a response already
initiated).
3.1.3.3 Summary of anxiety and impulsivity tests
One advantage of the anxiety paradigms introduced above is that they do not require
complex training schedules, unlike the tests for impulsivity. However, in the anxiety
paradigms, outcome measures in one paradigm may not tally with results from another.
For example, a meta-analysis of results from studies employing the EPM and open field
find that there is no single anxiety related factor in rats (Ramos, 2008). Outcome
measures can also be affected by other variables, i.e. time of day that testing is done,
gender and individual differences (Broadhurst, 1958).
Impulsivity tasks are sensitive to subtle reward behaviours and demand high levels of
cognitive attention, but they are complex and require long training periods, making
them labour-intensive and time-consuming.
3.1.4 Summary of reward behaviour tests
All of the research presented above shows the wide variety of reward behaviour
measurement. However, a large amount of studies have used direct drug administration
to study drug addiction. Whilst the mechanisms of addiction in animals are relevant to
the investigation of reward behaviours, it was decided that simpler general approach
behaviours towards an ethologically valid reward are a more appropriate way to begin
investigating the long-term cognitive behavioural effects of repeated early pain, which
is the central aim of this thesis.Chapter 3
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A hyponeophagia task was chosen as the paradigm for studying reward-related
behaviours – a novelty-induced hypophagia (NIH) paradigm. It uses an ethologically
relevant reward, food, and requires no further training, other than familiarising test
animals with the food prior to testing. Furthermore, a variety of behaviours can be
scored on an NIH task using an open field. This means that not only the response to
reward can be studied, but also exploratory behaviours such as central zone entries and
rearing, and classic ‘emotionality’ measures such as defecation and urination.
When designing the experiment, it was noted that previous experiments have used
albino rat strains. Hooded Lister rats were chosen for these experiments, as they have
been widely used in research investigating cognitive behaviour, for example fear-
conditioned analgesia (Butler et al., 2008) and addiction research (Tessari et al., 2007).
A square open field arena has been used in previous tests (Britton and Britton, 1981;
Bilkei-Gorzo et al., 2002). However, it was decided that the open field arena used in
these experiments would be circular. The reason for this is that a square open field
provides corners which an animal will naturally prefer to spend time in, as there are two
walls which can shelter an animal. Making a circular open field removes corners, and so
would increase the amount of exploration that an animal would be likely to engage in.
To enhance the aversive nature of the environment further, it was decided that the arena
would be bright white, and that testing would occur under full illumination (~1000 lux).
In line with much previous research showing that lab animals will work for sweet food
rewards, and on the recommendation of staff in the Biological Services Unit at UCL, a
sweet and palatable food treat was chosen that is easily quantifiable, cheap, and safe for
animal consumption – Cheerios breakfast cereal (Nestlé). Cheerios are comprised of
79.2% carbohydrates (of which 40% is sugars), 3.6% fat, 5.8% fibre and 6.6% protein
(www.cerealpartners.co.uk/brands/cheerios-honeynut.aspx) – a much higher sugar level
than standard lab chow.
3.2 Hypotheses
The hypotheses for the experiments of this chapter state that:
 Repeated early injury will alter adult nociceptive sensory thresholdsChapter 3
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 Repeated early injury will alter adult reward-related behaviour in the NIH
task
 A single adult injury to a previously uninjured animal will alter reward-
related behaviour in the NIH task
 A single adult re-injury to a previously injured animal will alter reward-
related behaviour in the NIH task
 The outcome measures being investigated are a reflection of reward-related
behaviours, exploration and emotionality.
3.3 Methods
To investigate the long-term effects of early-pain on later reward-related processing,
animals were repeatedly injured as neonates, and the long-term sensory and cognitive
effects investigated.
3.3.1 Experimental design
 All experiments were performed in accordance with the United Kingdom
Animals (Scientific Procedures) Act 1986.
 Litters of Hooded Lister rats were bred on-site from five breeding dams and two
stud rats (Charles River Laboratories, Kent, UK). Hooded Lister animals were
chosen as experimental subjects as they are widely used in cognitive tasks in the
literature, have good eyesight in comparison to albino rat strains such as
Sprague-Dawleys, and are highly inquisitive and likely to respond to
environmental stimuli. Litters ranged in number of pups from 6 to 16.
 Animals were maintained on a 12 hour light/dark cycle and had access to food
and water ad libitum.
 Males and females were used in all experiments.
Four main sets of experiments were carried out:
 The effects of repeated neonatal foot wound on nociceptive sensory processing
in the adult were investigated (Figure 3-7)
 Next, the effect of repeated neonatal foot wound on reward-related processing in
the adult, using a novelty-induced hypophagia paradigm, was investigated
(Figure 3-8).Chapter 3
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 The set of studies investigated how reward-related processing is affected by a
single adult foot wound in animals either without (experiment 3) or with
(experiment 4) a history of neonatal foot wound (Figure 3-9 and Figure 3-10 )
 The influence of Cheerios, the rewarding stimulus, was investigated by
removing the Cheerios, or moving them to an alternative place within the arena,
in animals with and without a history of foot wound after an adult re-injury.
These were control sub-experiments in experiments 3 and 4.
Figure 3-7 – A schematic diagram to show experiment number 1 – effects of repeated neonatal foot
wound on adult sensory nociceptive processing. FW = foot wound, AN = anaesthesia only.
Figure 3-8 – A schematic diagram to show experiment number 2 – the behavioural effects of
repeated neonatal foot wound on adult reward-related processing in the novelty-induced
hypophagia (NIH) task
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Figure 3-9 – A schematic diagram to show experiment number 3 – the behavioural effects of a
single adult foot wound in animals with no history of neonatal surgery.
Figure 3-10 – A schematic diagram to show experiment number 4 – the behavioural effects of a
single foot wound in animals with a history of neonatal surgery
Figure 3-11 – A schematic figure to show the sub-experiments of experiments 3 and 4 to investigate
the influence of Cheerios, where they were either absent from the central zone (upper circle), or
were moved to an alternate quadrant (lower circle).
3.3.2 Foot wound surgery – neonatal
All animals (except controls) received plantar skin incision (referred to as foot wound)
to the left (ipsilateral) hindpaw, at P3, P10 and P17. These ages were chosen for
multiple reasons. Firstly, they span important periods of development of the animals
(Walker et al., 2009b). Secondly, these ages cover a broad period of development that is
likened to the gestational period in human neonates from 26 weeks up to adolescence
(see Fitzgerald, 2005). These are ages at which is has been shown that injury affects
later sensory processing in both humans (Walker et al., 2009a) and animals (Anand et
al., 1999). Finally, these are also the time points at which the previous chapter has
shown that dopaminergic signalling is active. This is important in the context of this
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thesis in the hypothesis that early injury can interfere with reward-processing, due to
dopaminergic signalling alterations.
The plantar skin incision model of post-operative pain (Brennan et al., 1996) was used
in these experiments. It was chosen to mimic the clinical situation where premature and
full-term neonates in the neonatal intensive care unit (NICU) receive multiple heel
pricks per day. Its advantages are that it is well characterised (Brennan et al., 2005;
Hamalainen et al., 2009) and easily reproducible at all postnatal ages.
 The entire litter (n=4-15) was separated from the dam. This ensured that all pups
experienced the same amount of maternal deprivation and handling, both of
which can confound nociceptive and cognitive processing in older animals
(Walker et al., 2003a; Walker et al., 2008; de Medeiros et al., 2009; Champagne
et al., 2003). Pups were placed on a heating pad for the duration of all surgeries
and recovery periods.
 Half the litter were to receive foot wound, and half were control animals, to
receive anaesthesia only. Pups were randomly assigned at P3 to each group.
 Anaesthesia was induced with 2-5% isoflurane in 2L/min oxygen, and
maintained at 2% isoflurane for the 5-10 minutes of surgical duration.
Anaesthesia-only control animals received the same duration of anaesthesia as
surgically treated animals.
 The left hindpaw was cleaned pre-surgery with iodine solution using a cotton-
bud. Control animals’ paws were cleaned in the same manner.
 An incision was made in the paw using an 11 gauge scalpel blade, from the
midpoint of the heel to the proximal border of the first footpad, at all age points
(Figure 3-12).
Figure 3-12 – A representative picture of the
foot wound surgery in a P17 animal. The
incision was made from the midpoint of the
heel to the proximal border of the first
footpad, and two stitches sutured the
incision.Chapter 3
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 The underlying muscle and fascia were lifted and separated from surrounding
tissue using bent-tip needle-toothed forceps.
 Tissue was sutured with two stitches using 5-0 Mersilk (Ethicon, Edinburgh,
UK).
 The wound was disinfected with a cotton bud soaked in iodine to prevent
infection. Control animals’ paws were cleaned in the same manner
 Pups were returned to the holding and recovery container and recovery from
anaesthesia monitored.
 Each pup was photographed after surgery/anaesthesia. As each animal has a
specific and individual pattern of markings that is maintained throughout life
(see example photos in Figure 3-13), the treatment groups that animals were
assigned to were only revealed by comparisons between photographs (taken
after each surgery) once all treatments, testing and analysis were finalised. This
blinded the experimenter to each pup’s treatment and removed the need to mark
pups between surgeries, as well as blinding the experimenter to prior treatment
of adult animals, meaning that experimenter bias was eliminated during analysis.
 After recovery of all pups, the entire litter was returned to the home cage. At P3
and P10, all animals were rolled in sawdust litter from the cage to prevent the
dam rejecting the pups when returned.
 After the final surgery at P17, animals were weaned at P21-23 and housed 2-3
per cage, separated for gender, until behavioural testing was performed at
adulthood (>P90). The animals were undisturbed during this period except for
routine cleaning of cages.Chapter 3
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Figure 3-13 – Example photographs to show that the markings on a P3 rat, at P10, P17 and in
adulthood. The markings remain the same throughout the animal’s life.
3.3.3 Foot wound surgery - adult
 In experiments where animals were injured in adulthood, the following protocol
was employed.
 Animals were removed from their home-cages and kept in a holding box with
clean sawdust together with their cage-mates.
 Animals were removed one at a time, anaesthetised and plantar skin incision
performed as above.
 For recovery, anaesthetised animals were placed in a separate box from pre-
surgery cage-mates to prevent awake animals from interfering with recovering
animals.
 Animals were returned to their home-cage after all cage-mates had recovered
from surgery.
 Behavioural testing in the NIH paradigm was performed 2 days post-surgery.
3.3.4 Sensory testing in adulthood
Behavioural sensory testing was performed at 1 and 2 days prior to surgery to calculate
baseline responses, and 24 hours, 48 hours and 5 days post-surgery.Chapter 3
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3.3.4.1 Mechanical withdrawal thresholds
To assess the mechanical force that generated a nocifensive reflex withdrawal in
experimental animals, von Frey hairs (vFh) were used. These are fibres of differing
gauge that bend according to the force applied; the maximal force is generated at the
point at which the hair bends. The increase in force between hairs is logarithmic, rather
than linear. Table 3-1 illustrates the relationship between hair number and force (in
grams) needed to cause the hair to bend:
Hair Force (g)
10 1.95
11 3.2
12 5.9
13 10.3
14 16.3
15 24.8
16 41.7
17 65.3
18 102.4
19 156.8
20 220
Table 3-1 – a table to show the relationship between von Frey hair number and stimulus intensity
 Animals were placed into clear Plexiglas boxes elevated on a wire mesh. Before
testing, animals were placed into the testing apparatus for one hour on the 3 days
prior to testing, to habituate to the apparatus. On test days, animals were placed
into the apparatus and left to habituate for 20 minutes prior to testing.
 Von Frey hairs were applied to the point of hair bending to the plantar surface of
the left (ipsilateral) hindpaw, immediately proximal to the incision.
 6 applications of hair were performed, with an inter-stimulus interval of at least
10 seconds.
 Testing began with hair number 10 and increased until threshold was reached.
 The withdrawal threshold was determined as the force at which the animal
performed a reflex withdrawal to 3 out of the 6 stimuli.
 The right (contralateral) paw was then tested in the same manner after an
interval of at least 5 minutes.Chapter 3
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 After testing, animals were returned to their home cages and the apparatus
thoroughly cleaned with 5% Trigene (MediChem International, Kent, UK) and
70% ethanol, then thoroughly dried, in order to remove any odours.
3.3.4.2 Thermal withdrawal thresholds
To assess the thermal sensitivity of the animals, a protocol adapted from the original
described by Hargreaves et al (1988) is used.
 Animals were placed into clear Plexiglas boxes placed on a clear glass sheet.
Before testing, animals were placed into the testing apparatus for one hour on
the 3 days prior to testing, to habituate to the apparatus. On test days, animals
were placed into the apparatus and left to habituate for 20 minutes prior to
testing.
 The thermal withdrawal threshold testing apparatus (Plantar Test (Hargreaves’
Apparatus) Ugo Basile, Italy) was placed under the glass sheet, enabling access
to the plantar surface of the hindpaw without disturbance to the animal.
 A radiant beam of infra-red light was directed at the plantar surface of the
hindpaw, immediately proximal to the incision, and latency to withdrawal reflex
measured (in seconds). The latency was automatically recorded as the beam
broke. To prevent tissue damage, the test was terminated after 20 seconds if no
withdrawal had occurred.
 Three repeats were performed on each paw, with an inter-stimulus interval of at
least 2 minutes, and the mean average withdrawal latency calculated.
 After testing, animals were returned to their home cages and the apparatus
thoroughly cleaned with 5% Trigene and 70% ethanol to remove any dirt and
odours, and then thoroughly dried.
3.3.5 Novelty-induced hyponeophagia (NIH) paradigm
 Hyponeophagia refers to the inhibition of feeding produced by exposure to
novelty, and assessing it is usually done by presenting rodents with food in a
novel and thus anxiogenic environment, i.e. an open field, and measuring the
latency to eat and amount eaten. Animals are either food-deprived prior to
testing, or are trained to consume highly palatable foods which are presented
during testing (see Dulawa and Hen, 2005). In these experiments, animals wereChapter 3
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not food-deprived at any stage, eliminating the potential confound on behaviour
of hunger, and reducing ethical concerns.
 To investigate reward-related behaviours, a paradigm was developed based on
hyponeophagia principles and involving aspects of classic conflict tasks, where
the natural exploratory drive of an animal is in conflict with its fear of unfamiliar
and aversive environments. In this paradigm, the animal had to overcome a
novel, aversive environment to receive a palatable food reward that the animal
was familiar with: Cheerios breakfast cereal (Nestlé).
 To habituate animals to the palatable foodstuff, all animals received a few
Cheerios, placed onto the surface of their home-cage, for 3 days prior to testing.
All animals were checked to confirm seeking and appetitive behaviour towards
the treats in their home cage before testing in the NIH paradigm.
 All animals were tested between 10am and 12pm. Whilst this is in the sleep
phase of nocturnal rodents’ diurnal rhythms, all testing was done between these
times to minimize confounds due to sleep/awake state.
 All testing was done in minimal noise conditions, as noise levels have been
shown to affect results in open field paradigms (see Walsh and Cummins, 1976).
 On the day of testing, animals were removed singly from their home cage and
placed into a holding box with clean sawdust.
 The holding box was taken into the testing room and the animal immediately
placed into the testing arena. The experimenter then left the room immediately,
as presence of an experimenter has been shown to alter open field behaviours
(see Walsh and Cummins, 1976).
 The arena consisted of a circular, bright (>1000 lux) white open field 1.25m in
diameter (see Figure 3-14), with a wall height of 50cm to prevent escape.
 A central zone was defined as an area with a 15cm radius around the central
point of the arena (see Figure 3-14).
 A glass bowl was placed in the centre of the arena, containing 20 Cheerio food
treats.
 Animals were placed into the arena equidistant from the food bowl and the edge
of the arena and behaviour recorded using a webcam (Logitech Quickcam,
Logitech ® Inc.) suspended above the arena for a period of 15 minutes.Chapter 3
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 After the 15 minute test period, the experimenter returned to the room and
animals were removed from the arena and placed back into the holding box,
where a photograph was taken of their markings for blinding purposes. The
holding box was returned to the room containing the home cages.
 Tested animals were retained in the holding box whilst the arena was cleaned in
preparation for the next animal, and were kept separate from cage-mates
awaiting testing, to prevent the tested animal communicating any stress to the
as-yet untested animal, for example via ultra-sonic vocalisation (Litvin et al.,
2007).
 Once both/all cage-mates had been tested, all animals were returned to their
home-cages. The sawdust in the holding box was changed after each cage of
animals had been tested.
 In between testing sessions, the arena was scrubbed and disinfected with 5%
Trigene and 70% ethanol in preparation for the following animal. This was to
remove any olfactory traces of the previous animal. Any remaining Cheerios
were disposed of and the glass food bowl washed with hot water and disinfected
with 70% ethanol.
 Two hours after testing, animals were sacrificed and the animals’ brains were
utilised for the experiments in the next chapter.
1.25m
30cm
1.25m 1.25m
30cm 30cm 30cm
Figure 3-14 – An aerial photograph taken from above the modified novelty-induced hypophagia
(NIH) task. The arena is 1.25m in diameter, and the central zone was defined as a circle of 30cm
diameter, placed directly in the centre of the arena.Chapter 3
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3.3.5.1 Quantification
Behavioural videos were manually scored by a blinded experimenter on a variety of
outcome measures. These were separated for analysis purposes into anxiety-like
behaviours, exploratory behaviours, and appetitive behaviours.
3.3.5.1.1 Anxiety-like behaviours
 Number of faecal boli
 Number of urine puddles (>5mm diameter)
3.3.5.1.2 Exploratory behaviours
 Number of rears
 Number of entries into the central zone (CZ)
 Percentage of time spent in the central zone
 These outcome measures were time-binned into 5 minute periods and also
counted as total measures over the entire 15 minute recording period.
3.3.5.1.3 Reward-seeking behaviour
 Time taken to eat first Cheerio
 Number of Cheerios eaten (time-binned and total number)
3.3.6 Analysis
3.3.6.1 Sensory testing
 Percentage change from baseline after surgery was calculated. This was to
control for individual differences in variable baseline thresholds.
 Analysis of sensory testing thresholds was performed using Prism Version 4
software (GraphPad, San Diego, USA). Data was compared by 2-way repeated
measures ANOVA with day and treatment as variables and Bonferroni post-tests
 Graphs were prepared in Prism 4.
3.3.6.2 Hyponeophagia testing
 Analysis was performed using SPSS version 15.0 for Windows (SPSS Inc.,
Chicago, USA). Multiple comparisons between groups and outcome measuresChapter 3
119
were performed by multivariate analysis of variance (MANOVA), with
treatment group as the Between-subjects factor and outcome measures as the
Fixed factors. Bonferroni and Tukey’s HSD post-hoc tests were performed to
find which way any differences between groups and treatments lay.
 Analysis of time-binned data was performed by 2-way Repeated measures
ANOVA with Tukey’s Multiple Comparisons Test.
 Graphs were prepared in Prism 4.
 For both sensory and behavioural testing, results were considered statistically
significant if p<0.05.
3.4 Results
The results presented in this chapter cover both sensory and cognitive modalities and
investigate the long-term effects of a repeated early injury on adult reward-related
behaviours. To begin, the results from the sensory testing in adulthood both pre- and
post-injury are presented, followed by the results from behavioural testing in the
novelty-induced hypophagia (NIH) paradigm.
3.4.1 Sensory testing
Both mechanical and thermal thresholds of injured and control animals were measured
in adulthood (postnatal day (P)>90). This was to see what effect a repeated neonatal
foot wound (see Methods) had on sensory processing in the adult animal at baseline,
and after a single foot wound injury or re-injury in the adult animal. A reminder of the
experimental design is shown in Figure 3-15:
Figure 3-15 – A schematic diagram representing the experimental design of the sensory testing
experiments to measure mechanical and thermal withdrawal thresholds in neonatally injured or
anaesthetised animals, both at baseline and after adult surgery. FW = foot wound, AN =
anaesthesia only.
FW
X X X
Neonate
AN
Adult
Mechanical (vFh) Thermal
P3 P10 P17
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1)Chapter 3
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Mechanical and thermal withdrawal thresholds were measured at 1, 2 and 5 days post-
surgery in adulthood. Results after adult re-injury are presented below at the 2-day time
point post-surgery. This is because this is the time-point of maximal change from
baseline and so highlights treatment differences clearly. For full data for each time point
after surgery, see Appendix 2.
The ipsilateral (wounded foot) and contralateral (non-wounded) hindpaw were tested
(see Methods for experimental design and timeline). Genders were analysed separately
at baseline and pooled after adult re-injury. The treatment groups are detailed in Table
3-2:
Treatment group Number per
group
Male foot-wounded (FW) 3
Male anaesthesia control (AN) 3
Female foot-wounded (FW) 3
Female anaesthesia control (AN) 3
Table 3-2 – A table to show the treatment groups and number of animals per group for the sensory
testing experiments
3.4.1.1 Mechanical withdrawal thresholds
3.4.1.1.1 At baseline, male mechanical withdrawal thresholds do not differ
between injured and uninjured paws, or wounded and control
animals
There are no significant differences (2-way ANOVA) in mechanical withdrawal
threshold between ipsilateral and contralateral foot, nor between treatment group (foot
wounded and anaesthesia), in adult males at baseline, as shown in Graph 3-1:
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Graph 3-1 - A bar graph to show the baseline
mechanical withdrawal thresholds in male
foot wounded (FW) or anaesthesia control
(AN) animals in the ipsilateral and
contralateral paws. Thresholds were
measured in adulthood after repeated
neonatal injury or anaesthesia.Chapter 3
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3.4.1.1.2 At baseline, female mechanical withdrawal thresholds are higher in
neonatally injured animals.
At baseline, the previously injured females (FW) show a significantly increased
mechanical withdrawal threshold compared to the uninjured animals (AN), i.e. are less
sensitive to punctate mechanical stimuli (Treatment: F(1,8)= 6.544, p<0.05; 2-way
ANOVA with Bonferroni’s post-tests).
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Graph 3-2 – A bar graph to show the
baseline mechanical withdrawal thresholds in
female foot wounded (FW) or anaesthesia
control (AN) animals in the ipsilateral and
contralateral paws. Thresholds were
measured in adulthood after repeated
neonatal injury. *p<0.05; 2-way ANOVA
with Bonferroni’s post-tests.
3.4.1.1.3 Mechanical withdrawal thresholds are lower in the ipsilateral paw 2
days post-injury
After the adult animals are exposed to a single foot wound, mechanical withdrawal
thresholds are significantly lower in the ipsilateral paw of neonatally injured (FW)
animals 2 days after injury (F(1,10)=12.44, p<0.05; 2-way ANOVA with Bonferroni’s
post-tests). This decrease in baseline is not significant in the neonatally anaesthetized
(AN) control group.
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Graph 3-3 - A bar graph to show the
percentage change from baseline in
mechanical withdrawal threshold 2 days
post-injury in adulthood. The horizontal
dashed line indicates baseline. Injured (ipsi)
and uninjured (contra) paws are shown for
previously injured (FW) and uninjured (AN)
animals. The Y axis is a logarithmic scale as
the vFh increase in force (in grams) between
each hair number is logarithmic. Percentage
change from baseline was plotted to show
changes in sensitivity more clearly.Chapter 3
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3.4.1.2 Thermal withdrawal thresholds
3.4.1.2.1 Male baseline thermal withdrawal thresholds do not differ between
paw or treatment
Graph 3-4 shows that there are no differences in thermal withdrawal threshold between
ipsilateral and contralateral paws in either the injured or uninjured animals, and there
are no differences between treatment group (FW and AN) either (2-way ANOVA).
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Graph 3-4 - A bar graph to show the baseline
thermal withdrawal thresholds for male
injured and uninjured animals, in both
ipsilateral and contralateral paws.
3.4.1.2.2 Female baseline thermal withdrawal thresholds are higher in the
ipsilateral paw of the previously injured females
Graph 3-5 shows that the previously injured female rat shows a significantly higher
basal thermal withdrawal threshold in the ipsilateral paw, compared to the contralateral
paw and anaesthesia control animals (Paw F(1,8)=1.9; Treatment F(1.8)=2.65, p<0.05; 2-
way ANOVA with Bonferroni’s post-tests). This suggests that the female FW animal is
hypoalgesic (i.e. less sensitive to thermal nociceptive stimuli) at baseline, in the injured
paw only.
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) Graph 3-5 - A bar graph to show the baseline
thermal withdrawal thresholds for female
injured and uninjured animals, in both
ipsilateral and contralateral paws. *p<0.05;
2-way ANOVA with Bonferroni’s post-tests.
3.4.1.2.3 Thermal withdrawal thresholds are lower 2 days after single adult
foot wound injury in neonatally injured animals
The ipsilateral paw of the previously injured animals shows a significant decrease in
thermal withdrawal threshold 2 days post-injury (Paw: F(1,10)=28.59, p<0.001; 2-wayChapter 3
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ANOVA with Bonferroni’s post-tests). This effect is not seen in the animals that were
anaesthetised as neonates (AN).
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Graph 3-6 – A bar chart to show the
percentage change from baseline of thermal
withdrawal thresholds 2 days after adult
injury. The horizontal dashed line indicates
baseline. (***=p<0.001; 2-way ANOVA with
Bonferroni’s post-tests).
3.4.1.3 Summary of sensory threshold testing
 The results presented above show that at baseline, male animals do not show any
mechanical or thermal differences in withdrawal thresholds between ipsilateral
and contralateral paws, regardless of whether they have a history of neonatal
injury or not.
 Female animals that have been previously injured (FW) show a baseline
hypoalgesia in the ipsilateral paw for both mechanical and thermal noxious
stimuli.
 After a single adult injury, both mechanical and thermal withdrawal thresholds
are lower in the ipsilateral paw 2 days post-surgery, in the neonatally injured
animals only.
3.4.2 Repeated neonatal foot wound has little effect on adult reward-
related behaviours
The results presented in this section will describe the effect of a repeated neonatal foot
wound on adult baseline reward-related behaviours. A reminder of the experimental
design is shown in Figure 3-16:Chapter 3
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Figure 3-16 – A schematic diagram showing the experimental design for the experiments
investigating baseline adult reward behaviours in the NIH arena after repeated neonatal surgery.
The behaviours were measured during a 15 minute testing period in the novelty-induced
hypophagia (NIH) paradigm (see Methods). Outcome measures (i.e. number of rears)
that can be separated into 5 minute time bins were separated, and are presented in time
binned format in appendix 2 to show the variability of behaviours over the 15 minute
testing period. The results from the 5-10 minute time bin only are shown in this section
as many outcome measures show variable onset times; restricting the analysis to one
time bin enables treatment effects to be shown more clearly.
Outcome measures have been classified into anxiety-related measures (faeces and
urine), exploratory behaviours (rearing, central zone entries and time spent in central
zone) and appetitive behaviours (time to first Cheerio and total number of Cheerios).
Treatment groups and numbers of animals per group are described in Table 3-3 below:
Group Number of animals
Male foot wounded (M FW) 19
Male anaesthesia only (M AN) 13
Female foot wounded (F FW) 19
Female anaesthesia only (F AN) 11
Table 3-3 – a table to show the treatment groups and number of animals in each group.
NIH
FW
X X X
Neonate
AN
P P1 P1
Development
Adult
CheeriosChapter 3
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3.4.2.1 Anxiety-related measures are not affected by repeated neonatal
surgery
3.4.2.1.1 Faeces
Graph 3-7 illustrates the number of faecal boli produced by males and females over the
15 minute test period in the novelty-induced hypophagia test. There were no significant
differences between treatment groups (FW versus AN)(2-way ANOVA). There was a
significant effect of gender, showing that females produced fewer faecal boli
(F(1,58)=4.72, p<0.05; 2-way ANOVA).
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Graph 3-7 – A bar graph to show the number
of faecal boli produced by males and females
when tested for 15 minutes in the novelty-
induced hypophagia paradigm.
3.4.2.1.2 Urine
There were no differences in urination between gender or treatment group over the 15
minute test period in the NIH paradigm (2-way ANOVA).
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Graph 3-8 – A bar graph to show the number
of urine puddles (>5mm in diameter)
produced by males and females when tested
for 15 minutes in the novelty-induced
hypophagia paradigm.
3.4.2.2 Exploratory behaviours are not affected by repeated neonatal
surgery
The data presented below is for the 5-10 minute time bin only. Data showing the results
across the entire 15 minute testing period is presented in Appendix 2.Chapter 3
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3.4.2.2.1 Number of rears
The number of male and female rears decreases over the testing period (see Appendix
2). Graph 3-9 shows the number of male and female rears in the NIH paradigm in the 5-
10 minute time bin. There is no effect of treatment on the number of rears. There is a
significant effect of gender on the number of rears, showing that females rear more than
males (Gender F(1,58)=12.05, p<0.001; 2-way ANOVA with Bonferroni post-tests).
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Graph 3-9 – a bar graph to show the number
of rears that both genders, foot wounded and
anaesthesia-only, performed in the 5-10
minute time-bin.
3.4.2.2.2 Central zone entries do not differ between treatment groups or
genders
The number of entries that the anaesthesia group made into the central zone decreased
over the 15 minute time period in both males and females (see Appendix 2). Graph 3-10
shows that there is no effect of treatment or gender on the number of central zone
entries during the 5-10 minute time bin.
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Graph 3-10 – a bar graph to show the
number of central zone entries that male and
female foot wounded and anaesthesia-only
animals performed during the 5-10 minute
time bin.
3.4.2.2.3 Time spent in central zone does not differ between treatment group or
gender
The time that the animals spent in the central zone increased during the test period (see
Appendix 2). There was no significant effect of treatment or gender in the 5-10 minute
time bin (2-way ANOVA).Chapter 3
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Graph 3-11 – a bar graph to show the
percentage of time spent in the central zone
by both males and females in the 5-10 minute
time bin.
3.4.2.3 Appetitive behaviours in adulthood are altered by repeated
neonatal foot wound
Animals that did not eat any Cheerios during the entire 15 minute testing period were
excluded from this analysis. As this excluded a high number of animals, to see whether
this had arisen due to chance or was an effect of treatment, Fisher’s Exact Test was
performed to compare the groups to an expected baseline of 100% eating behaviour.
Table 3-4 shows that the M FW group, with a total of 7 animals out of 19 avoiding
Cheerios, had significantly fewer animals that ate Cheerios than was expected (p<0.008;
Fisher’s Exact Test). Therefore at baseline, male injured animals are less likely to eat
Cheerios in the NIH task.
Treatment
group
Number of non-
eaters/total
P value from Fisher’s
Exact test
M FW 7/19 0.008 **
M AN 3/13 0.22
F FW 3/19 0.12
F AN 1/11 0.5
Table 3-4 – A table to show the number of non-eating animals in each treatment group and the P
values of the Fisher’s Exact test, comparing the number of non-eating animals to an expected eating
baseline of 100%. **p<0.01.
3.4.2.3.1 The time taken to eat the first Cheerio does not differ between
treatment group or gender
Excluding the non-eaters, there are no significant differences between treatment group
or gender in the amount of time taken to eat the first Cheerio (2-way ANOVA).Chapter 3
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Graph 3-12 – a bar graph to show the time
taken to eat the first Cheerio in the male and
female foot wounded and anaesthesia-only
groups. Male FW n=12, M AN n=10, F FW
n=16, F AN n=10.
3.4.2.3.2 The number of Cheerios eaten
The number of Cheerios eaten in the 5-10 minute time bin did not differ between
treatment groups. There was a significant effect of gender, showing that females ate
fewer Cheerios during this time bin (F(1,44)=6.7, p<0.05; 2-way ANOVA).
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Graph 3-13 – A bar graph to show the
number of Cheerios eaten by males and
females in the 5-10 minute time bin.
3.4.2.4 Summary of the effect of a repeated neonatal injury on baseline
adult reward-related behaviours.
 The results from the above section show only gender differences in reward-
related behaviours at baseline in adulthood after an animal has had a repeated
foot wound as a neonate.
 Anxiety-related behaviours, in this series of experiments defined as production
of faeces and urine, show no differences between treatment groups, but show
that females produce fewer faecal boli over the total testing period than males.
 Exploratory behaviours, defined as number of rears, entries into the central zone
and time spent in the central zone, display no treatment group differences in the
5-10 minute time bin, but show that females rear more than males in the 5-10
minute time bin.
 Appetitive behaviours, in these experiments the time taken to eat the first
Cheerio and the number of Cheerios eaten, show that a male with a history of
foot wound is less likely to consume any Cheerios. Excluding non-eatingChapter 3
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animals from the analysis shows that females eat fewer Cheerios in the 5-10
minute time bin.
3.4.3 The effect of a single acute foot wound in adulthood on reward
related behaviours in animals with no prior history of injury
The results presented in this section will describe the effect that a single adult foot
wound has on behaviour in the NIH of an animal with no prior history of surgery
(anaesthesia-only animals from the above section). A reminder of the experimental
design for this experiment is shown in Figure 3-17:
Figure 3-17 – A schematic diagram to show the experimental design of the experiment to investigate
the effect of a single adult foot wound on behaviour in the NIH arena of animals with no history of
injury.
As above, the behaviours were measured during a 15 minute testing period in the NIH
paradigm; outcome measures have been classified into anxiety-related measures (faeces
and urine), exploratory behaviours (rearing, central zone entries and time spent in
central zone) and appetitive behaviours (time to first Cheerio and total number of
Cheerios); and were time-binned accordingly. Testing was performed 2 days post-
surgery. Data showing all time bins is presented in Appendix 2. The data presented
below is from the 5-10 minute time bin only to show treatment effects more clearly.
Treatment groups and numbers of animals per group are described in Table 3-5:
Group Number of
animals
Male anaesthesia only (M AN) 13
Male anaesthesia plus adult wound(M AN+FW) 14
Female anaesthesia only (F AN) 11
Female anaesthesia plus adult wound (F AN+FW) 13
Table 3-5 – A table to show the treatment groups and number of animals in each group
Neonate
P3 P10 P17
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3.4.3.1 Anxiety-related measures are not affected by a single adult foot
wound in animals with no history of injury
3.4.3.1.1 Faecal bolus production is not affected by single adult foot wound
The results show that there are no significant differences in the production of faeces due
to treatment in animals with no history of injury after a single adult foot wound. There
is a significant effect of gender, showing that females produce fewer faecal boli
(F(1,47)=5.64, p<0.05; 2-way ANOVA). There is a trend that suggests that the number of
faeces may increase in the adult injured animals, although this is not significant.
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3.4.3.1.2 Urination is not affected by a single adult foot wound
There is no significant effect of treatment group on the number of urine puddles
produced over the testing period of the NIH paradigm. There is a significant effect of
gender, showing that females urinate less frequently (F(1,47)=12.68, p<0.001; 2-way
ANOVA).
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Graph 3-15 – A bar graph to show the
number of urine puddles (>5mm in diameter)
produced during the NIH task in animals
with no history of injury, after a single adult
foot wound.
3.4.3.2 Exploratory behaviours are affected by a single adult foot
wound
3.4.3.2.1 Rearing is decreased after a single adult foot wound in animals with
no history of injuryChapter 3
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Rears are decreased in both male and female adult-injured animals compared to controls
(Treatment F(1,47)=22.4, p<0.01; 2-way ANOVA with Bonferroni’s post-tests). There
was a significant effect of gender (Gender F(1,47)=6.0, p<0.05; 2-way ANOVA). This
shows that animals with no foot wound history, injured as adults, show less rearing
exploratory behaviour.
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Graph 3-16 – A bar graph to show rearing
behaviour in the 5-10 minute time bin, in
animals with a single adult foot wound and
no history of prior injury. **p<0.05; 2-way
ANOVA with Bonferroni’s post-tests.
3.4.3.2.2 Central zone entries are not affected by a single adult foot wound
There is no effect of treatment on the number of entries into the central zone during the
5-10 minute time bin in animals with no injury history. There is an effect of gender
which shows that females enter the central zone more frequently than males
(F(1,47)=4.93, p<0.05; 2-way ANOVA).
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Graph 3-17 – A bar graph to show central
zone entries in the 5-10 minute time bin of
the testing period, in animals with no injury
history, after a single adult foot wound.
3.4.3.2.3 Time spent in the central zone increases in animals injured as adults
Percentage of time spent in central zone is increased after a single adult foot wound in
animals with no injury history. Graph 3-18 shows that the amount of time spent in the
central zone is higher during the 5-10 minute time bin in both sexes of animals
receiving a single adult foot wound, compared to those that do not (Treatment
F(1,47)=23.3, p<0.05 in males, p<0.001 in females; 2-way ANOVA with Bonferroni post-
tests).Chapter 3
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Graph 3-18 – A bar graph to show the
amount of time spent in the central zone in
the 5-10 minute time bin in animals with a
single adult foot wound. *p<0.05;
***p<0.001; 2-way ANOVA with
Bonferroni’s post-tests.
3.4.3.3 Appetitive behaviours are not affected by a single adult foot
wound in animals with no prior history of injury
As above, animals that did not eat any Cheerios during the entire 15 minute testing
period were excluded from this analysis. Fisher’s Exact test was performed to see
whether the non-consumption of Cheerios was a result of treatment or not. A table to
show the number of male and female non-eaters, and the Fisher’s Exact p value, is
shown below:
Treatment group Number of non-
eaters/total
P value from Fisher’s
Exact test
M AN 3/13 0.22
M AN+FW 2/14 0.48
F AN 1/11 0.5
F AN+FW 0/13 n/a
Table 3-6 – A table to show the number of non-eaters in each treatment group, and the P value
from Fisher’s Exact test comparing animals to an expected baseline of 100% consumption.
Table 3-6 shows that non-consumption by the animals was not due to an effect of
treatment. Excluding the non-eating animals left the following numbers in each group:
Treatment group Number of animals (excluding non-
eaters)
M AN 10
M AN+FW 12
F AN 10
F AN+FW 13
Table 3-7 – A table to show the number of animals remaining in each treatment group once non-
eaters had been excluded.Chapter 3
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3.4.3.3.1 There is no difference between treatment groups in the time taken to
eat the first Cheerio
There is no difference in the time taken to eat the first Cheerio between animals with a
single adult injury and those without (2-way ANOVA).
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Graph 3-19 – A bar graph to show the time
taken for animals with no history of foot
wound to eat the first Cheerio during the 15
minute testing period.
3.4.3.3.2 Females eat fewer Cheerios than males in the 5-10 minute time bin
Eating behaviour does not begin until 5 minutes of testing, as shown in Graph 3-20.
There were no significant treatment group differences, but a significant effect of gender,
showing that females ate fewer Cheerios than males (F(1,41)=6.26, p<0.05; 2-way
ANOVA).
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Graph 3-20 - A bar graph to show the
number of Cheerios eaten in the 5-10 minute
time bin in animals with no prior history of
foot wound, after a single adult foot wound.
3.4.3.4 Removing the food reward alters exploratory behaviours in
males and females with no history of injury
To investigate the effect that the presence of the food reward had in general on
exploratory behaviours, the Cheerios were removed from the central bowl and separate
litters of animals who received a single adult foot wound were tested. Table 3-8 shows
the number of animals in each group.Chapter 3
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Treatment Group Number of animals
M AN+FW Cheerios Present 14
M AN+FW Cheerios Absent 5
F AN+FW Cheerios Present 13
F AN+FW Cheerios Absent 4
Table 3-8 – A table to show the treatment group and numbers of animals per group in the
presence/absence of Cheerios test.
3.4.3.4.1 Anxiety measures are not significantly affected by the presence or
absence of Cheerios
Neither male nor female anxiety measures, as indexed by number of faecal boli and
urine puddles, are affected when Cheerios are removed from the NIH arena (2-way
ANOVA).
3.4.3.4.2 The absence of Cheerios causes fewer entries into the central zone
and decreases the amount of time spent there
Removing the Cheerios has the effect of decreasing the number of entries into the
central zone (Graph 3-21) and decreasing the percentage of time spent there (Treatment
F(1,32)=7.75, p<0.01; 2-way ANOVA with Bonferroni’s post-tests) as shown in Graph
3-22. These results show that the presence of Cheerios is a factor affecting exploratory
behaviours in the NIH arena.
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Graph 3-21 – A bar graph showing entries
into the central zone during the 5-10 minute
time bin in animals with no history of
neonatal injury. There is an effect of gender,
showing that females enter the central zone
more than males (F(1,32)=5.35, p<0.05; 2-way
ANOVA).
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Graph 3-22 – A bar graph to show the effect
of absence of Cheerios on percentage of time
spent in the central zone in animals with no
history of neonatal injury. **p<0.01; 2-way
ANOVA with Bonferroni’s post-tests.Chapter 3
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3.4.3.5 Moving the food-bowl within the arena alters anxiety and
approach behaviours in animals with no history of injury
The effect of moving the food-bowl from the centre to a less anxiogenic quadrant was
investigated. Litters of animals with no history of neonatal surgery, who received a
single adult foot wound, were tested with the food-bowl in an ‘alternate quadrant’ close
to the edge of the arena (see Methods) and compared to the results from litters with the
food-bowl in the centre. The central zone was defined as circling the food-bowl,
regardless of its position. The groups and numbers of animals are shown in Table 3-9.
Treatment group Number of animals
M AN+FW Centre (Central) 14
M AN+FW Alternate Quadrant (AltQuad) 3
F AN+FW Centre (Central) 13
F AN+FW Alternate Quadrant (AltQuad) 11
Table 3-9 – A table to show the treatment groups and numbers per group when the food-bowl is
moved from centre to edge (alternate quadrant).
3.4.3.5.1 Anxiety measures are changed by moving the food-bowl to an
alternate quadrant of the arena
The hypothesis that anxiety measures should be decreased when the food-bowl is
moved away from the centre is fulfilled, as for both genders, there is significantly more
urine production when the food-bowl is placed in the centre of the NIH arena (Quadrant
F(1,37)=5.22, p<0.05; Gender F(1,37)=5.45, p<0.05; 2-way ANOVA with Bonferroni’s
post-tests). This effect is not significant when measuring defecation levels (2-way
ANOVA).
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Graph 3-23 – Anxiety, as indexed by number
of faecal boli, in animals with no injury
history when the food-bowl is in the centre of
the arena or an alternate quadrant
(AltQuad).Chapter 3
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Graph 3-24 – Anxiety, as indexed by urine
puddles, in animals with no injury history,
when the food-bowl is in the centre of the
arena or an alternate quadrant. *p<0.05, 2-
way ANOVA with Bonferroni’s post-tests.
3.4.3.5.2 Exploratory behaviours are minimally affected by the alternate
placement of the food-bowl
Rearing behaviour during the 5-10 minute time bin is not affected by the placement of
the food-bowl, and the percentage of time spent in the central zone is also the same
wherever the bowl is placed (2-way ANOVA). However, entries into the central zone
by females decrease when the Cheerios are placed into the alternate quadrant (Graph
3-25)(p<0.05; 2-way ANOVA with Bonferroni’s post-tests). This is unexpected, as the
number of entries was predicted to increase when the food-bowl was placed in an
alternative, less anxiogenic, quadrant.
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Graph 3-25 – A bar graph to show the
number of central zone entries during the 5-
10 minute time bin in animals with no history
of neonatal injury. *p<0.05; 2-way ANOVA
with Bonferroni’s post-tests.
3.4.3.5.3 Appetitive behaviours are altered when Cheerios are placed in an
alternate quadrant
It was expected that the time taken to eat the first Cheerio would decrease when the
Cheerios were in the alternate quadrant. This is the case for females, as Cheerios are
eaten sooner when the food-bowl was in the alternate quadrant (p<0.01; 2-way ANOVA
with Bonferroni’s post-tests)(Graph 3-26). There was no difference in the amount of
Cheerios eaten during the 5-10 minute time bin when the Cheerios were placed in the
alternate quadrant (2-way ANOVA).Chapter 3
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Graph 3-26 – A bar graph to show the time
taken to eat the first Cheerio in both males
and females when the bowl is placed in an
alternate quadrant. **p<0.01; 2-way
ANOVA with Bonferroni’s post-tests).
3.4.3.6 Summary of the effect of a single adult foot wound on
previously uninjured animals
 The data in this section describe reward-related behaviours after a single adult
injury in animals with no prior history of surgery. Time-binned data are
presented from the 5-10 minute time bin. Data from all time-bins is presented in
Appendix 2.
 Anxiety-related measures show no differences between animals that were
injured or uninjured as adults.
 Exploratory behaviours, for both genders, show a similar pattern of results.
Animals that receive a single adult injury (compared to uninjured controls) show
decreased rearing behaviour, increased time spent in the central zone, but no
differences in the number of entries into the central zone.
 Excluding animals that did not eat, the time taken to eat the first Cheerios did
not differ between treatment groups. Females overall ate fewer Cheerios.
 Removing the Cheerios causes less time to be spent in the central zone. Placing
the Cheerios in an alternate quadrant is less anxiogenic for both genders, and
causes females to eat the Cheerios sooner. This confirms that Cheerios are
rewarding, and that the centre of the arena is an anxiogenic environment.
3.4.4 The effect of re-injury to animals with a history of repeated
neonatal foot wounds on reward-related behaviours
The results presented in this section will describe the effect that a single adult foot
wound has on an animal with a prior history of surgery. Animals all had repeated
neonatal foot wound surgery within the first 21 days of life. A reminder of the
experimental design is shown in Figure 3-18:Chapter 3
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Figure 3-18 – A schematic diagram to show the experimental design of the experiments
investigating behaviours in the NIH arena after repeated neonatal injury and re-injury in
adulthood.
As above, the behaviours were measured during a 15 minute testing period in the NIH
paradigm (see Methods); outcome measures have been classified into anxiety-related
measures (faeces and urine), exploratory behaviours (rearing, central zone entries and
time spent in central zone) and appetitive behaviours (time to first Cheerio and total
number of Cheerios); these were time-binned accordingly. Time binned data, to show
the effects of time on the outcome measures, are presented in Appendix 2. Data
presented below is from the 5-10 minute time bin. Testing was performed 2 days post-
surgery. Treatment groups and numbers of animals per group are described below:
Treatment group Number of animals
Male neonatal foot wound (M FW) 19
Male neonatal foot wound+adult foot wound
(M FW+FW) 14
Female neonatal foot wound (F FW) 19
Female neonatal foot wound+adult foot wound
(F FW+FW) 12
Table 3-10 –A table to show the treatment groups and number of animals per group in the
experiment studying animals with a history of neonatal injury.
3.4.4.1 Anxiety-related measures are affected by adult re-injury
Males with a history of foot wound defecate more after a single adult foot wound in
adulthood, compared to animals that do not receive a foot wound in adulthood (p<0.05;
2-way ANOVA with Bonferroni’s post-tests). There is a significant effect of gender,
showing that females defecate less than males (F(1,60)=14.2, p<0.001, 2-way ANOVA).
There was no effect of re-injury on urine production (2-way ANOVA).
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Graph 3-27 - A bar graph to show the
number of faecal boli produced by animals
after a single adult foot wound in animals
with a history of repeated neonatal foot
wound injury. *p<0.05; 2-way ANOVA with
Bonferroni’s post-tests.
3.4.4.2 Exploratory behaviours are significantly altered by an adult re-
injury
3.4.4.2.1 Rears are significantly decreased in animals with a history of
neonatal injury
Animals that were re-injured as adults (FW+FW) reared significantly fewer times in the
5-10 minute time bin compared to control animals (FW)(F(1,60)=49.24, p<0.001; 2-way
ANOVA with Bonferroni’s post-tests). There was a significant effect of gender,
showing that females rear more than males (F(1,60)=21.75, p<0.001; 2-way ANOVA).
Male Female
0
10
20
30
FW
FW+FW ***
***
Gender
R
e
a
r
s
Graph 3-28 – A bar graph to show the
number of rears in the 5-10 minute time bin
in animals with a history of neonatal
repeated injury. ***p<0.001; 2-way ANOVA
with Bonferroni’s post-tests.
3.4.4.2.2 Central zone entries are increased in females re-injured as adults
The number of entries into the central zone increased in females re-injured as adults
(Treatment F(1,60)=4.14, p<0.01; 2-way ANOVA with Bonferroni’s post-tests).
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number of entries into the centre during the
5-10 minute time bin by animals with a
history of repeated neonatal injury.
**p<0.01; 2-way ANOVA with Bonferroni’s
post-tests).Chapter 3
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3.4.4.2.3 Percentage of time in the central zone increases after adult re-injury.
The percentage of time spent in the central zone is higher in all animals re-injured in
adulthood (Treatment F(1,60)=22.26, p<0.01; 2-way ANOVA with Bonferroni’s post-
tests).
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Graph 3-30 – A bar graph to show the
percentage of time spent in the central zone
in the 5-10 minute time bin by animals with a
history of neonatal injury. **p<0.01; 2-way
ANOVA with Bonferroni’s post-tests.
3.4.4.3 Appetitive behaviours
As above, animals that did not eat any Cheerios during the entire 15 minute testing
period were excluded from this analysis. Fisher’s Exact test was performed to see
whether the non-consumption of Cheerios was a result of treatment or not. A table to
show the number of male and female non-eaters, and the Fisher’s Exact p value, is
shown below:
Treatment group Number of non-
eaters/total
P value from
Fisher’s Exact test
M FW 7/19 0.008**
M FW+FW 2/14 0.48
F FW 3/16 0.12
F FW+FW 1/12 0.5
Table 3-11 – A table to show the number of non-eaters in each treatment group, and the P value
from Fisher’s Exact test comparing animals to an expected baseline of 100% consumption.
**p<0.01.
Table 3-11 shows that non-consumption by the animals was due to an effect of
treatment in the M FW group – repeated neonatal injury reduces the likelihood of
consuming Cheerios during testing in adulthood. That this is not seen in the re-injured
group (M FW+FW) suggests that a re-injury increases the likelihood of Cheerio
consumption. Excluding the non-eating animals left the following numbers in each
group:Chapter 3
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Treatment group Number of animals
(excluding non-eaters)
M FW 12
M FW+FW 12
F FW 16
F FW+FW 11
Table 3-12 – A table to show the number of animals in the treatment groups, excluding non-eaters.
3.4.4.3.1 Time to eat the first Cheerio was not affected by an adult re-injury in
animals with a history of neonatal injury.
The time taken to eat the first Cheerio was not different between animals that were re-
injured as adults and those that were not (2-way ANOVA).
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Graph 3-31 –A graph showing the time in
seconds before the first Cheerio was
consumed, in animals with a history of
neonatal foot wound.
3.4.4.3.2 Cheerio consumption is affected by an adult re-injury
Cheerio consumption is increased in females re-injured as adults (Treatment
F(1,47)=6.88, p<0.01; 2-way ANOVA with Bonferroni’s post-tests). There is a significant
effect of gender, showing that females consume fewer Cheerios in the 5-10 minute time
bin (Gender F(1,47)=11.5, p<0.05; 2-way ANOVA).
Males Females
0
1
2
3
4
5
6
7
8
9
FW
FW+FW
**
Gender
C
h
e
e
r
i
o
s
e
a
t
e
n Graph 3-32 - A bar graph to show the
number of Cheerios eaten during the 5-10
minute time bin by animals with a history of
foot wound. **p<0.01; 2-way ANOVA with
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3.4.4.4 Removing the food reward alters exploratory behaviours in
males and females with a history of injury
As before, to investigate the effect that the presence of the food reward had in general
on exploratory behaviours, the Cheerios were removed from the central bowl and
separate litters of animals with a history of foot wound that were re-injured as adults
were tested. Table 3-13 shows the number of animals in each group.
Treatment Group Number of animals
M FW+FW Cheerios Present 14
M FW+FW Cheerios Absent 5
F FW+FW Cheerios Present 12
F FW+FW Cheerios Absent 4
Table 3-13 – A table to show the treatment group and numbers of animals per group in the
presence/absence of Cheerios test.
3.4.4.4.1 Anxiety measures are not affected by the absence of Cheerios in
previously injured animals
There is no effect of removing the Cheerios on the anxiety measures (faecal boli and
urine production) of males or females with a history of neonatal repeated foot wound.
There is a significant effect of gender, showing that females produce fewer faecal boli
(F(1,31)=13.21, p<0.001; 2-way ANOVA)(see Appendix 2).
3.4.4.4.2 Exploratory behaviours are affected by the presence or absence of
Cheerios in animals with a history of injury
Animals that were re-injured as adults showed an increased number of rears when the
Cheerios were absent (Treatment F(1,31)=26.9; p<0.001; 2-way ANOVA with
Bonferroni’s post-tests)
Graph 3-33). There was a significant effect of gender, showing that males rear less than
females (F(1,31)=18.42, p<0.001; 2-way ANOVA).Chapter 3
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Graph 3-33 - A graph to show the number of
rears by both genders in the 5-10 minute time
bin when Cheerios were present or absent in
animals with a history of foot wound.
*p<0.05; ***p<0.001; 2-way ANOVA with
Bonferroni’s post-tests.
The number of entries into the central zone during the 5-10 minute time bin was not
significantly affected by the presence or absence of Cheerios, although a trend suggests
fewer entries when Cheerios were absent (Graph 3-34). There was a significant effect of
gender, showing females enter the central zone more frequently (Gender F(1,31)=15.22,
p<0.001; 2-way ANOVA).
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number of central zone entries during the 5-
10 minute time bin when Cheerios are
present/absent in animals of both gender
with a history of neonatal repeated injury.
The percentage of time spent in the central zone is lower in males with a history of FW
injury when Cheerios are absent (F(1,31)=6.78, p<0.05; 2-way ANOVA with
Bonferroni’s post-tests).
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Graph 3-35 – A graph to show the percentage
of time spent in the central zone during the 5-
10 minute time bin by both genders of
animals with a history of repeated foot
wound.. *p<0.05; 2-way ANOVA with
Bonferroni’s post-tests.
3.4.4.5 Moving the food-bowl within the arena slightly alters reward-
related behaviours in animals with a history of foot wound
The effect of moving the food-bowl from the centre to a less anxiogenic quadrant was
investigated. Litters of animals with a history of foot wound that were re-injured as
adults were tested with the food-bowl in an ‘alternate quadrant’ close to the edge of theChapter 3
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arena (see Methods), and compared to results from litters with the food-bowl in the
centre. The central zone was defined as circling the food-bowl, regardless of its
position. The groups and numbers of animals are shown in Table 3-14.
Treatment group Number of animals
M FW+FW Centre (Centre) 14
M FW+FW Alternate Quadrant (AltQuad) 10
F FW+FW Centre (Centre) 12
F FW+FW Alternate Quadrant (AltQuad) 5
Table 3-14 - A table to show the treatment groups and numbers per group when the food-bowl is
moved from centre to edge (alternate quadrant).
3.4.4.5.1 Anxiety measures are affected by the position of the food-bowl in
animals with a history of injury
Unexpectedly, there is a significant effect on faecal bolus production when the bowl is
moved away from the centre in animals with a history of repeated neonatal foot wound
(Quadrant F(1,37)=4.97, p<0.05; 2-way ANOVA). This is contrary to the hypothesis that
moving the food-bowl to the edge of the NIH arena is less anxiogenic (anxiety-
inducing). There is a significant effect of gender on both faeces and urine outcome
measures, showing that males produce more faecal boli and urine over the 15 minute
NIH testing time (Gender F(1,37)=12.14 (faeces), F(1,37)=7.52 (urine), p<0.01; 2-way
ANOVA).
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Graph 3-36 – A graph to show the anxiety
measures, as indexed by number of faecal
boli produced, in animals with a history of
neonatal injury when the Cheerios are
central or placed in an alternate quadrant.Chapter 3
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Cheerios are central or placed in an alternate
quadrant.
3.4.4.5.2 Exploratory behaviours of re-injured animals are mildly affected by
placement of the food-bowl
The number of rears performed by females is significantly increased in females when
the food-bowl is moved from the centre of the NIH arena (Quadrant F(1,37)=8.78,
p<0.01; 2-way ANOVA with Bonferroni’s post-tests)(Graph 3-38).
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Graph 3-38 – A graph to show the number of
rears during the 5-10 minute time bin in
animals with a history of foot wound that
have been re-injured. **p<0.01; 2-way
ANOVA with Bonferroni’s post-tests.
There was no effect on the number of central zone entries or the amount of time spent
around the food-bowl when Cheerios were placed in the alternate quadrant (2-way
ANOVA), which was unexpected.
3.4.4.5.3 Appetitive behaviours by re-injured animals
As above, animals that did not eat any Cheerios during the entire 15 minute testing
period were excluded from this analysis. Fisher’s Exact test was performed to see
whether the non-consumption of Cheerios was a result of treatment or not. A table to
show the number of male and female non-eaters, and the Fisher’s Exact p value, is
shown below. Table 3-15 shows that non-consumption by the animals was not due to an
effect of treatment or experimental design.Chapter 3
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Treatment group Number of non-
eaters/total
P value from Fisher’s
Exact test
M FW+FW Centre 2/14 0.48
M FW+FW AltQuad 0/10 n/a
F FW+FW Centre 1/12 0.5
F FW+FW AltQuad 0/5 n/a
Table 3-15 – A table to show the number of non-eaters in each treatment group, and the P value
from Fisher’s Exact test comparing animals to an expected baseline of 100% consumption.
It was expected that the time taken to eat the first Cheerio would decrease when the
Cheerios were in the alternate quadrant. This hypothesis is not fulfilled; there are no
differences between central and alternate quadrant on the time taken to eat the first
Cheerio for either gender (2-way ANOVA). The number of Cheerios eaten during the 5-
10 minute time bin in animals with a history of foot wound was not affected by
placement of the food-bowl.
3.4.4.6 Summary of the effect of a foot wound re-injury on animals
with a history of neonatal foot wound
 The data in this section describe reward-related behaviours after an adult re-
injury in animals with a history of neonatal foot wound surgery.
 Anxiety-related measures, as indexed by defecation, are increased in males that
were re-injured as adults when they were tested in the NIH arena. Moving the
food-bowl away from the centre of the arena increased defecation, which was
unexpected, as it was hypothesised that moving the food-bowl away from the
centre of the arena would decrease the anxiogenic quality of the NIH paradigm,
and would decrease defecation accordingly.
 Exploratory behaviours, for both genders, show a similar pattern of results. In
the 5-10 minute time bin, rearing behaviour decreases, and percentage of time
spent in the central zone increases. Central zone entries increase in females only.
 Excluding animals that did not eat, the time taken to eat the first Cheerio did not
differ between treatment groups for either gender, and neither did the number of
Cheerios eaten during the 5-10 minute time bin.Chapter 3
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 Removing the Cheerios increases rearing behaviour in both genders, and
decreases the amount of time spent in the central zone in males only, showing
that Cheerios as a reward are driving central zone entries in males.
 Placing the Cheerios in an alternate quadrant increases rearing behaviour in
females only, but does not affect any other exploratory measure. This suggests
that, in animals re-injured as adults, approaching the food-bowl is anxiogenic,
regardless of its position.
3.4.5 Summary of all experiments
The results presented in this chapter have shown a variety of changes that are caused by
repeated neonatal injury, single adult injury, or a re-injury in previously injured animals.
3.4.5.1 Sensory testing
 The effect of repeated neonatal surgery on sensory nociceptive thresholds at
baseline and after an acute adult re-injury was first illustrated. Results showed
that females that have been previously injured as neonates are hypoalgesic to
mechanical and thermal stimuli at baseline. 2 days post-injury in adulthood, the
ipsilateral paw is more sensitive to mechanical and thermal stimuli compared to
contralateral paws, in neonatally injured animals in particular.
3.4.5.2 Anxiety-related measures
 When investigating animals with a history of neonatal injury at baseline, plus
animals with no history of injury but a single adult foot wound, anxiety-related
measures were not affected. However, upon testing animals re-injured as adults
in the NIH paradigm, defecation increased, suggesting that a history of neonatal
injury can increase anxiety levels after an adult re-injury.
3.4.5.3 Exploratory measures
 Exploratory measures at baseline in adulthood showed the same patterns over
the total 15 minute testing period in animals either with or without a foot wound
history – rearing and central zone entries decreased over the testing period and
percentage of time spent in the central zone increased, presumably as animals
became more familiar with their novel environment (see Appendix 2 for all
data).Chapter 3
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 Results became significantly different from controls when looking at the effects
of adult injury – either a single injury in animals with no history of neonatal foot
wound, or a re-injury in animals with a history of neonatal foot wound.
 Adult injury decreased rearing behaviour in all animals, regardless of
background, suggesting an increase in anxiety-related exploratory behaviour.
The percentage of time spent in the central zone was increased, suggesting an
increased motivation to reach the food-bowl.
 Removing the Cheerios decreased the number of entries into the central zone
and decreased the percentage of time spent there, suggesting that the Cheerios
were the factor responsible for driving approach to the food-bowl. Moving the
Cheerios to an alternate quadrant decreased anxiety measures, and decreased the
latency to eat Cheerios in females with no history of surgery only. The lack of
the same changes in animals neonatally injured and then re-injured as adults
suggests that approach of the food-bowl is anxiogenic for these animals,
regardless of its placement.
 In general, results were significant or more pronounced in females, particularly
those with a history of foot wound.
3.4.5.4 Appetitive behaviours
 Males that had a history of foot wound were less likely to consume Cheerios at
baseline in adulthood. However, upon injury in adulthood, appetitive behaviours
were virtually the same across all groups, genders and conditions. This suggests
that an adult injury increases the likelihood of eating Cheerios, regardless of the
injury background of the animal.
3.5 Discussion
Briefly, the results from the experiments presented in this chapter have shown that
repeated foot wound surgery during the first 3 weeks of an animal’s life causes long-
term changes in sensory nociceptive thresholds that persist into adulthood. Furthermore,
when testing repeatedly injured animals in a cognitive behavioural paradigm,
exploration and reward-related behaviours are subtly altered when animals are re-
injured as adults.Chapter 3
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As there were changes over time on both sensory and behavioural outcome measures,
for the purposes of presenting differences due to treatment, specific time points after
injury or time bins of the NIH task were chosen to analyse. For sensory testing, the time
point chosen was 2 days post-surgery in adulthood. On the NIH task, the 5-10 minute
time bin was chosen for data that had been split into time bins. Data presenting time
courses for all sensory changes and behavioural outcome measures is presented in
Appendix 2.
3.5.1 Sensory testing in adulthood
The results from the sensory testing experiments show that at baseline, pre-surgery in
adulthood, males do not show significant sensory changes after repeated neonatal
surgery, as measured by mechanical and thermal withdrawal thresholds. However,
females show a baseline hypoalgesia (i.e. decreased sensitivity) to both mechanical and
thermal stimuli.
After injury in adulthood, only the neonatally injured animals showed a significant drop
in mechanical and thermal withdrawal thresholds in the ipsilateral paw at two days post-
injury.
These results show that animals repeatedly injured as neonates display a baseline
hypoalgesia to punctate mechanical and thermal noxious stimulation. However, upon re-
injury in adulthood, the injured paw is made hypersensitive to mechanical and thermal
stimulation. This effect is not seen in neonatally anaesthetised control animals.
3.5.1.1 Gender differences
That male sensory withdrawal thresholds at baseline were not significantly affected by
neonatal injury is unexpected, as the literature consistently shows that male animals
show altered sensory processing after neonatal injury (Anand et al., 1999; Bhutta et al.,
2001; Lidow, 2002). The lack of significance in these results can be partially explained
by the fact that the groups tested were very small, with only 3 animals per group.
Sensory testing can be easily confounded by an animal’s state at the time of testing (i.e.
agitated, asleep), and coupled with individual differences in general reactivity to stimuli,
it is perhaps not surprising that significant differences were not found with such small
sample sizes. To clarify the effects of neonatal injury and its effect on adult baselineChapter 3
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behaviour and thresholds after adult injury, larger groups of animals would need to be
tested.
Females, however, showed significant hypoalgesia to mechanical and thermal stimuli at
baseline. This is in line with literature that has investigated the long-term effects of
neonatal inflammation of the hindpaw. LaPrairie and Murphy (2007) injected
carrageenan (an inflammatory agent) into the hindpaw on the first day of life and found
that at postnatal day (P)40 and P60, both females and males showed an increased
thermal withdrawal latency, and that the latency was 40% longer in females. This sexual
dimorphism is suggested to be due to hormonal differences between gender during
development, with female oestrogens possibly acting in a pro-nociceptive manner and
male androgens acting in a protective manner (La Prairie and Murphy, 2007; see La
Prairie and Murphy, 2010). This may help to explain the significant results seen in
females rather than males.
3.5.1.2 A critical period for sensory changes
The injuries inflicted in these experiments were performed at P3, P10 and P17.
According to various studies published, it is the injury at P3, during the ‘critical period’,
that is crucial for causing long-term changes. Studies using both the plantar incision
model and paw inflammation models have shown that long-lasting effects on sensory
thresholds are produced when the injury occurs within the first week of life, suggesting
a critical period of development during which noxious input will cause alterations in
adult sensory thresholds (Wang et al., 2004; Ren et al., 2004; Walker et al., 2009b; La
Prairie and Murphy, 2010).
During this sensitive time window, nociceptive processing is still immature. Whilst the
anatomical connections in rats are present at birth, injury can influence the postnatal
development of the sensory nociceptive system. Inflammation (induced by Complete
Freund’s adjuvant) causes an increase in primary afferent nerve input to the spinal cord
(Ruda et al., 2000) and skin wounds cause long-lasting cutaneous hypersensitivity,
increased sprouting of local sensory nerve terminals, and increased receptive field size
in the spinal cord (Torsney and Fitzgerald, 2003).Chapter 3
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3.5.1.3 Re-injury in adulthood
Previous research has shown that adult re-injury of a previously injured neonate
exacerbates the effect of injury, compared to control animals uninjured as neonates.
Coupled with an injury during the critical period for sensory development, this creates
an adult animal with baseline hypoalgesia to noxious stimuli, but an enhanced
nociceptive response to a new injury (see La Prairie and Murphy, 2010); interestingly,
this is an effect also seen anecdotally in humans (Grunau et al., 1994; Hermann et al.,
2006). The baseline hypoalgesia and exacerbated hyperalgesia after adult re-injury is
replicated in these experiments. It has been suggested that this seemingly contrary state
is mediated by a shift in the developing opioidergic tone in the brainstem of neonatally
injured animals (La Prairie and Murphy, 2009).
The authors propose a working hypothesis for the effect whereby neonatal injury during
the critical period (P0 to P8) causes increased afferent drive to central brain sites
responsible for noxious processing, including the periaqueductal grey (PAG) and
rostroventral medulla (RVM). Both these areas project directly to the spinal cord and
constitute an important anti-nociceptive circuit, modulating pain processing in a top-
down manner (Basbaum and Fields, 1984). The increased afferent drive caused by
injury induces the continued release of endogenous opioid peptides from the PAG, and
causes a long-term upregulation of these opioids. This upregulation is manifested as an
increase in opioid peptides in the PAG (La Prairie and Murphy, 2009), and is seen in the
adult rat, the upregulation of endogenous peptides lasting more than a week after
inflammation (Williams et al., 1995).
Taken together with evidence that descending inhibitory control from the brainstem
does not mature until the end of the second week of postnatal life (Boucher et al., 1998;
see Fitzgerald, 2005), LaPrairie and Murphy suggest that the delayed opioidergic
inhibitory control during the first two postnatal weeks may be the cause of the increased
vulnerability of the immature rat nociceptive processing system to noxious insult during
a critical period, a suggestion strengthened by the fact that naloxone, a mu opioid
receptor antagonist, prevented expression of the baseline hypoalgesia seen in adulthood
(La Prairie and Murphy, 2007).Chapter 3
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3.5.2 Behaviour in the NIH paradigm after a single injury in
adulthood
The results presented in this chapter explore the effect of a history of neonatal injury on
adult reward-related behaviours. However, to understand the effects upon behaviour of
a single injury in adulthood, testing in the NIH arena was performed on animals with no
history of neonatal injury who received a single foot wound in adulthood and outcome
measures were compared to animals who had received no injury at all.
The results showed that rearing behaviour, which is an index of exploratory behaviour
(see Walsh and Cummins, 1976), was decreased in animals after a single adult foot
wound. In addition to this, the amount of time these animals spent in the central zone
was increased. This is an anxiogenic (anxiety-inducing) position in which to be, as the
animal is exposed in the centre of the arena; however anxiety levels, as measured by
defecation and urination, were not affected by a single acute injury.
Therefore it is possible to speculate that animals with no history of injury but acutely
injured as adults show a reduced exploratory drive, suggesting that the rewarding effects
of exposure to novelty in the NIH arena are attenuated (Hummel et al., 2008). However,
these animals may be more motivated to seek a food reward, reflected by the increased
amount of time spent in the central zone of the NIH arena. This is supported by data
showing that removing the Cheerios from the food-bowl causes a decrease in time spent
in the central zone by these animals.
Studies from pain researchers have shown that chronic pain causes alterations in
behaviour on complex cognitive behavioural paradigms (see Mogil, 2009). This
experiment, investigating the effect of a single adult foot wound, is one of few showing
that acute pain in adulthood can also cause behavioural alterations in the same complex
paradigms (van der Kam et al., 2008; Hummel et al., 2008; LaBuda and Fuchs, 2000).
3.5.3 Behaviour in the NIH paradigm in animals injured in infancy
There was little effect on any outcome measure when animals that had been repeatedly
injured as neonates were tested at baseline on the NIH task in adulthood, with outcomeChapter 3
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measures mainly reflecting gender effects i.e. that female animals rear more than males
and defecate less.
However, when neonatally-injured animals were re-injured in adulthood and tested in
the NIH paradigm, clear behavioural differences were highlighted. Defecation was
increased, as were entries into the central zone, percentage of time spent there, and
number of Cheerios eaten. A concomitant decrease in rearing behaviour by both genders
was seen. Taken together, these results suggest that exploratory drive (as seen by
rearing behaviour) is decreased in re-injured animals, but motivational drive to reach a
palatable food reward is increased. The increase in defecation levels suggests that this
motivation to reach the Cheerios is performed despite an increase in anxiety levels
(Broadhurst, 1958).
These results suggests that early neonatal injury may not affect adult reward-related
behaviours per se, but that subtle shifts in reward processing may occur when the
animal is again placed in a pain state in adulthood. This is in line with the literature
from pain researchers showing that re-injury of a previously injured animal in adulthood
causes enhanced hyperalgesic responses (Bhutta et al., 2001; La Prairie et al., 2008).
3.5.4 Control experiments show Cheerios are rewarding
These experiments rely on the rewarding aspect of the chosen food. Therefore important
control experiments were done in the NIH arena to check that animals were responding
to the presence of food treats, and that placement of the food reward was anxiogenic
whilst in the centre of the arena.
To begin, testing animals injured as neonates on their baseline behaviour towards food
reward in the NIH arena showed an intriguing result: there were a high number of
animals that did not eat any Cheerios during the testing period. This was unexpected as
home cage behaviour had shown that all animals would universally eat the Cheerios
very shortly after their presentation. A test to see whether the lack of consumption was
due to coincidence showed that the number of non-eaters was significantly higher than
would be expected. Therefore the consumption of a food treat was less likely in animals
with a history of surgery, suggesting a possible baseline anhedonic state in these
animals.Chapter 3
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To check that the animals were responding to the presence of Cheerios, and that central
placement of the food-bowl was anxiogenic, the Cheerios were removed from the food-
bowl, or the bowl placed into an alternate, less anxiogenic quadrant of the arena.
Significant changes in behaviour were seen only in animals injured in adulthood,
particularly in those animals with a history of repeated neonatal foot wound. Taken with
the data showing a baseline decrease in Cheerio consumption by neonatally injured
males, this suggests that an adult injury increases the likelihood of Cheerio
consumption.
The appetitive aspect of the Cheerios was proven as animals spent less time in the
central zone when the Cheerios were removed, regardless of their injury background,
and the data suggests that the number of entries into the centre were also decreased by
removal of the Cheerios. In fact, in animals with no history of injury, the absence of a
food reward shows a trend for increased defecation, possibly indicating that the
presence of Cheerios may help to decrease anxiety levels in animals trained to consume
these palatable treats.
When moved to an alternate quadrant, it was expected that anxiety levels would
decrease as the approach towards the Cheerios became less aversive. This was the case
in animals with no foot wound history, as urination frequency was higher in both
genders when the food-bowl was centred in the arena. It was also expected that the
number of central zone entries and percentage of time spent there would increase, and
the latency for animals to consume their first treat would decrease. This, however, was
not seen, possibly due to the large variation in these outcome measures.
Overall, these results suggest that Cheerios are the main factor causing approach of the
food-bowl, and that approaching and spending time at the food-bowl is an anxiogenic
experience, particularly in animals with a history of neonatal injury.
3.5.5 Technical considerations
Animal behaviour is difficult to interpret due to the large variability within and between
subjects and the risk of anthropomorphism as experimenters extrapolate an animal’s
state or trait at any given time from its behaviour. Accordingly, there are many potentialChapter 3
155
variables that need to be taken into account when designing any animal experiment, and
inherent limitations in the testing methods used to measure behaviours.
3.5.5.1 Sensory testing limitations
The experiments in this chapter studying sensory withdrawal thresholds were performed
on a very small number of animals due to breeding difficulties and time constraints. In
addition, each animal will have its own method of response to a noxious stimulus, and
there are always differences in the behavioural state of each animal at the time of
testing. For example, regardless of the level of habituation to the testing apparatus, some
animals will always fall asleep after 20 minutes in the test chamber, whereas other
animals will remain wide awake. Taken together with the magnification of variance
produced by the logarithmic increase in force as von Frey hair number increases, it is
perhaps less surprising that the results from the mechanical withdrawal threshold
experiments in this chapter were not statistically significant.
3.5.5.2 Experimental design limitations
3.5.5.2.1 The novelty-induced hypophagia (NIH) paradigm
The principles of hyponeophagia, or the inhibition of feeding upon exposure to novelty,
have been useful for studying the effects of anti-depressant drugs, and the NIH
paradigm has been posited as the most valid application of hyponeophagia principles
(see Dulawa and Hen, 2005). There are numerous types of validity that define whether
a test is appropriate, including face, construct, predictive, content, criterion, internal and
external validities, amongst others. The first three on this list - face, construct and
predictive - are widely used to critically appraise behavioural tests, and are briefly
discussed below.
3.5.5.2.1.1 Face validity
Face validity is a measure of how well a test appears to measure the outcomes of
interest. The NIH task is high in face validity as it uses an ethologically relevant reward,
food, in an environment akin to something an animal would experience in its natural
habitat, and utilises inherent behaviours such as exploration as measures of interest.
Conversely, tasks such as intra-cranial self-stimulation, whilst identifying specific brainChapter 3
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regions for reward, do not take place in ethologically relevant environments or rely on
naturally occurring behaviours for measures of success.
3.5.5.2.1.2 Construct validity
Construct validity refers to the accuracy with which a test assesses the variable it is
intended to assess. That the food reward was shown to affect appetitive and exploratory
behaviours shows that the NIH task did indeed have a rewarding component, and the
significant effects of treatment further underline the construct validity of the NIH, as it
measured differences in outcome variables that were due to treatment.
3.5.5.2.1.3 Predictive validity
Predictive validity is defined as the ability of a model to make accurate predictions
about the human phenomenon of interest. Hyponeophagia tasks demonstrate strong
predictive validity for the anxiolytic effects of drug treatments (Thiébot et al., 1984;
Dulawa et al., 2004), but its predictive validity for application to pain research will
require further work i.e. validation with analgesics, anxiolytic drugs, and other pain
medications. Taken together, the face and construct validity of the NIH paradigm are
high, and confirming the predictive validity of it warrants further investigation.
Ambulation, an outcome measure that is reliably predictive of anxiety in open field
tasks (see Walsh and Cummins, 1976), was not measured in this experimental setting.
However, other parties have argued that locomotion is not a good index of emotionality
(Stanford, 2007a; Rodgers, 1997). Instead, in these experiments, defecation and
urination, also reliable outcome measures, were recorded, and yielded significant effects
of gender and treatment, in line with previous research (Broadhurst, 1958).
Animal behaviour is notoriously difficult to interpret. Animals do not have the capacity
to report back on their pain states, motivations, or internal mental state, so conclusions
are extrapolated based on often crude behavioural measures, and the danger of
anthropomorphism is clear. The best way for an experimenter to overcome these
problems is to be aware of the limitations of animal experiments, and to acknowledge
the potential variables that can confound outcome measures. Below is a brief list of
variables that were taken into account when designing the NIH paradigm:Chapter 3
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3.5.5.2.1.4 Effects of maternal care and deprivation
Maternal deprivation is a powerful factor that can affect brain development in neonatal
rat pups. Maternal style of the nursing dam i.e. licking and grooming behaviour can
interfere with brain development, affecting the stress-regulating hypothalamic-pituitary-
adrenal (HPA) axis, and epigenetic regulation of glucocorticoid receptors in the
hippocampus (Weaver et al., 2004). It can also affect pain behaviours in adulthood
(Champagne et al., 2003; Champagne and Meaney, 2006; Champagne and Meaney,
2007; Clinton et al., 2007). To decrease the impact of this between-litter variability, all
litters were to be bred from the same dams. To control for the effects of maternal
deprivation, all litters of animals experienced the same duration of deprivation and
handling during surgery, and a combination of 5 breeding dams and 2 stud males were
used for breeding, to produce a variation in maternal style.
3.5.5.2.1.5 Individual differences
A potentially major confound in all animal experimentation is the presence of individual
differences, which refers to the natural variations in response to environmental stimuli
(see Pawlak et al., 2008). High levels of individual differences cause large variation in
behavioural data. Indeed, the presence of these differences can give rise to selective
breeding whereby sub-strains of animals are created i.e. the high responding/low
responding strains of rat (see Blanchard et al., 2009).
3.5.5.2.1.6 Noise levels
High noise levels are acknowledged as a stressor in behavioural tests (see Walsh and
Cummins, 1976). To prevent this confounding the results, all testing was done in low
noise levels. However, noise levels in the corridor upon which the behavioural testing
was done were occasionally raised i.e. by the entry telephone ringing; this clearly
altered behaviour in the NIH arena, as seen by freezing behaviour from the video
recordings, but was an unavoidable confound.
3.5.5.2.1.7 Odour
Both ambient odours and urine/faecal traces left in the NIH arena could have potentially
affected behaviours i.e. conferring the anxiety status of the previously tested animal. To
control for this, the transfer box used to move animals from their home cage room to the
testing room was regularly cleaned and fresh sawdust used for every cage of animals.
The NIH arena and food-bowl was thoroughly scrubbed, cleansed and dried between theChapter 3
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testing of each animal, using disinfectant and high ethanol percentage solutions to
remove all odour traces.
3.5.5.2.1.8 Environmental conditions during development
Environmental enrichment during development affects brain development and adult
behaviour (Sale et al., 2009). To control for this variable, environmental enrichment in
the form of objects placed in the home cage that animals could interact with were
provided for all animals throughout their lifetimes.
3.5.5.2.1.9 Variations in hunger levels
Access to food and water was allowed for all animals ad libitum, in an attempt to reduce
any confounding factors of hunger. In theory, this should mean that approach to the
food in the NIH arena was due to its palatability, rather than by a motivational hunger
drive.
3.5.5.2.1.10 Social interaction
Social interactions i.e. via ultrasonic vocalisation between animals has been shown to
affect pain behaviours and outcome measures on open field tasks (see Chesler et al.,
2002; Walsh and Cummins, 1976). To limit the effects of these, animals were kept
separate after testing until all cage-mates had been testing in the NIH arena.
3.5.5.2.1.11 Gender differences
There are clear gender differences in a huge variety of animal behaviours, including
pain behaviours and behaviours in reward-related and exploratory paradigms (see Walsh
and Cummins, 1976; Bevins and Besheer, 2005; La Prairie and Murphy, 2007). For this
reason, genders were not pooled and were analysed separately.
3.5.5.3 Summary of technical considerations
With any experiment utilising laboratory animals and measuring behaviour, many
considerations regarding experimental design and potentially confounding factors have
to be taken into account. As many of these as possible were acknowledged and
controlled for in these experiments; this makes the significance of results arising from
treatment conditions more robust, and conclusions drawn firmer.Chapter 3
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3.6 Conclusions
The results presented in this chapter show that repeated plantar skin incision during the
neonatal period in rats causes sensory alterations that occur well into adulthood, and that
this model of injury affects adult reward-related behaviours on the novelty-induced
hypophagia task. To date, the literature has intensively studied the effects of this injury
model on pain behaviours (Brennan et al., 2005; Banik et al., 2006; Walker et al.,
2009b). The experiments presented above are the first to investigate the long-term
cognitive behavioural effects of the plantar skin incision model during infancy, and are
in line with the aims of pain researchers to produce pain models and outcome measures
that are more relevant to the human pain experience.
To find brain areas and processing systems that are responsible for alterations in
behaviour, it is important to help determine the neurobiological mechanisms of early
pain on later reward-related processing. The next set of experiments in this thesis
attempts to find a neurobiological correlate of the altered behaviour, investigating the
orexinergic system of the lateral hypothalamus.Chapter 4
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4 Chapter 4 – The orexin system as a neurobiological
correlate for reward behaviours
As shown in the previous chapter, a repeated injury during early neonatal life can alter
exploratory and approach behaviours towards a food reward upon re-injury in
adulthood. The aim of this chapter was to investigate whether the orexinergic system of
the lateral hypothalamus is a potential neurobiological correlate of this altered
behaviour, in an attempt to find a biomarker of the shifted reward-related behaviours.
4.1 Introduction - The orexin system
The orexin system has been the subject of much research over the past decade, and has a
suggested role in a variety of systems. For this thesis, it is its proposed role in reward
processing that is most intriguing.
4.1.1 Orexin peptides and receptors
Orexins A and B (also known as hypocretins 1 and 2) are two small peptides, 33 and 28
amino acids in length respectively. Both are produced from the same precursor peptide,
prepro-orexin, by proteolytic cleavage (de Lecea et al., 1998). They were originally
identified as ligands that bound to an orphan G-protein coupled receptor (GPCR), now
termed orexin receptor-1 (OX1R), with OX2R then identified as a receptor for orexin B
(Sakurai et al., 1998). Orexin A binds to both receptors with an equal affinity, whereas
orexin B shows higher affinity for OX2R. The OX1R couples solely to the Gq subclass
of GPCRs, whereas the OX2R couples to both the Gq and Gi/o subclasses. Activation of
both causes increased levels of intracellular calcium, resulting in the activation of the Gq
pathway to stimulate phospholipase C (PLC). Orexins A and B are unique among
hypothalamic peptides, in that they can cause release of both GABA and glutamate, and
can therefore influence both fast inhibitory and excitatory neurotransmission (van den
Pol et al., 1998). Interestingly, orexins A and B, and their receptors, show a high degree
of homology that is conserved across mammalian species, suggesting that the roles
performed by orexins may be similar across species (Tsujino and Sakurai, 2009). Figure
4-1 shows a schematic diagram of the orexin peptides and their receptors:Chapter 4
161
Figure 4-1 – A schematic representation of
the orexin system. Orexins A and B are both
produced by cleavage of prepro-orexin, and
have slightly different affinities to the OX1R
and OX2R G-protein coupled receptors. Both
GPCRs are coupled to the Gq pathway, and
OX2R is also coupled to the Gi/opathway.
Taken from Holland and Goadsby (2007).
4.1.2 Distribution and projections of orexinergic cells, peptides and
receptors
Orexins are produced exclusively by just a few thousand cells located in the perifornical
and lateral parts of the hypothalamus (PFA and LH) (see Boutrel and de Lecea, 2008).
Cells project widely throughout the entire neuraxis, sending particularly dense
connections to the paraventricular thalamic nucleus (PVN), arcuate nucleus of the
hypothalamus, and locus coeruleus (LC) (Peyron et al., 1998; Nambu et al., 1999). In
addition, orexinergic pathways from the hypothalamus project to the ventral tegmental
area (VTA) and nucleus accumbens (NAcc), and from there to prefrontal cortices (see
Figure 4-2) (Fadel and Deutch, 2002). These projections are particularly important for
the orexins’ role in reward processing (see Aston-Jones et al., 2010).
The orexinergic cells of the hypothalamus receive inputs from the parabrachial nucleus,
medial and lateral preoptic areas, basal forebrain, central amygdala, and bed nucleus of
the stria terminalis (BNST), but are also reciprocally connected with many of the LH’s
output areas i.e. the VTA and dorsal/medial parts of the hypothalamus, as well as
laminae I, II and X of the spinal cord (van den Pol, 1999).Chapter 4
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Figure 4-2 – A schematic diagram to show the orexinergic projections from the lateral (LH) and perifornical-
dorsomedial (PFA-DMH) hypothalamus, and their discrete roles. LH cells are activated by reward-predicting
stimuli and project to mesolimbic dopaminergic neurons i.e. the ventral tegmental area (VTA) and nucleus
accumbens (NAc). PFA-DMH neurons are activated by arousal-related stimuli, and project to the locus
coeruleus (LC), pedunculopontine nucleus and lateral dorsal tegmental nucleus (PPT-LDT), and
tuberomammillary nucleus (TMN), which are involved in regulation of circadian rhythms and stress. From
Harris and Aston-Jones (2006).
Orexin receptors (both 1 and 2) are found throughout the brain and spinal cord, with
higher expression in areas involved in regulation of feeding, sleep, autonomic control
and memory (Trivedi et al., 1998; Tsujino and Sakurai, 2009).
Outside of the central nervous system, orexin peptides and their receptors are also found
in the enteric nervous system, the neuroendocrine system, pancreas, stomach, heart,
kidneys, testes, and adrenal glands, suggesting a broader role of orexins in brain-gut
axis control, cardiovascular function, and reproduction (Korczynski et al., 2006).
Clearly, orexin plays an important part in a wide array of physiological functions.
Orexin peptide and receptor mRNA is present in the rat at an early stage during
development. Orexin B mRNA is present from embryonic day (E) 19, and orexin
peptide mRNA is found in the LH cells of newborn rat pups. In addition, application of
orexins to LH tissue in postnatal day (P) 1 to 14 animals shows that both orexins are
profoundly excitatory (van den Pol et al., 2001). This shows that orexins are present and
excitatory during the first few weeks of postnatal life, and therefore may be involved in
tuning the developmental control of arousal, feeding and reward processing. Research
has shown that the first few weeks of postnatal life are a critical period of developmentChapter 4
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in an organism’s life (see Fitzgerald, 2005), therefore external interference during early
postnatal development, i.e. by repeated injury, has the potential to cause imbalances in
orexin signalling that could persist into adulthood.
4.1.3 Dual roles for orexins in arousal and reward
It is generally accepted that the orexins play major roles in both reward and arousal (see
de Lecea et al., 2006; Boutrel and de Lecea, 2008). Much evidence suggests that these
functions are regulated by separate sub-divisions of the hypothalamus - the perifornical-
dorsomedial areas (PFA-DMH) and the lateral hypothalamus (LH) (Fadel and Deutch,
2002; Harris and Aston-Jones, 2006; Aston-Jones et al., 2010).
4.1.3.1 Arousal and the role of orexins
Chemelli et al (1999) first showed that orexins have a crucial role in regulating the
sleep-wake cycle by showing that mutation of the prepro-orexin gene produced mice
with a phenotype remarkably similar to that of narcolepsy in humans. Narcolepsy is a
chronic neurological disorder, characterised by sudden, intrusive episodes of sleep that
interrupt normal waking. The authors suspected that, although the hypothalamus was
classically implicated in regulation of homeostatic mechanisms (Bernardis and
Bellinger, 1993), the neuroanatomical distribution of orexins suggested a possible role
for them in the sleep-wake cycle (Peyron et al., 1998; Date et al., 1999). Indeed, the
authors found that orexin knockout (KO) mice displayed sudden episodes of REM sleep
(characterised by EEG/EMG recordings) during their awake phase. Mutations of the
OX2R gene that caused narcolepsy in dogs (Lin et al., 1999), and the discovery that
human narcoleptics have few orexin cells and negligible levels of orexin in
cerebrospinal fluid (Siegel, 2004), cemented the orexins’ roles in maintenance of the
waking state.
Narcoleptic patients are widely treated with highly addictive amphetamine-related
drugs, yet rarely become addicted (Harris and Aston-Jones, 2006). In addition, orexin
KO mice do not develop morphine dependence to the same extent as wild-type animals
(Georgescu et al., 2003), and display dopaminergic hypo-function to psychostimulants
(Mori et al., 2010). These findings suggest that orexin has a role in addiction and reward
processing – a role that has been investigated, confirmed and widely studied in the last
decade.Chapter 4
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4.1.3.2 Orexins and reward processing
The lateral hypothalamus had been known as a crucial area for reward processing for
decades before the orexins were discovered. Experiments in the 50s and 60s had shown
that self-stimulation of the lateral hypothalamus is rewarding for an animal (Olds and
Milner, 1954; Olds, 1958; Olds, 1962). Self-stimulation of the LH is more robust than
that of stimulation in other areas (see Gallistel et al., 1981), and self-administration of
opioids directly into the LH had also been shown (Cazala et al., 1987). Identification of
orexins within these cells hinted that they may have a role in reward.
4.1.3.2.1 Cue-drug association learning
The role for orexins in reward processing was firmly established by two papers using a
conditioned place preference (CPP) paradigm to investigate reward function, suggesting
that orexins are crucial for the learning involved in associating a cue (i.e. a CPP
chamber) with a drug reward.
Georgescu and colleagues (2003) showed that orexin neurons of the lateral, but not
more medial hypothalamus, contain mu opioid receptors (MORs) and respond to
chronic morphine. Using CRE-LacZ transgenic mice, increased LacZ gene expression
was seen in orexin cells after chronic morphine. In addition, orexin KO mice developed
attenuated morphine-induced CPP. The authors suggested a role for the orexin system in
molecular adaptations to morphine.
Harris et al (2005) further cemented the orexins’ role in reward processing by showing
that activation of the LH orexin cells, but not PFA-DMH orexin cells, was strongly
linked to preferences for cues associated with both drug (morphine and cocaine) and
food (i.e. natural) rewards. Using a CPP paradigm, the authors showed that the
activation of orexin cells, as shown by co-expression of Fos (a protein product of c-fos,
an immediate early gene), was strongly correlated to the strength of preference animals
displayed towards a drug or food-paired chamber.
Later studies showed again that morphine-induced CPP stimulates LH orexin neurons
during conditioning, but only when the morphine is administered in a novel drug-paired
environment – home-cage administration or a novel environment alone will not induceChapter 4
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CPP (Harris et al., 2007b). Antagonism of orexin signaling (using SB 334867 (SB), an
orexin A antagonist) in the VTA, a site receiving orexin projections, prevented learning
of morphine-induced CPP, but not expression of previously learnt associations (Narita
et al., 2006). In addition, disconnection of the LH to the VTA, by unilateral VTA lesion
and concurrent injection of SB into the opposite VTA region, showed that CPP could be
blocked (Harris et al., 2007b). Taken together, this evidence showed the importance of
the connection of the LH to the VTA, and suggested a role for orexins in learning cue-
drug associations.
4.1.3.2.2 Abstinence
Abstinence is a reward-related phenomenon in which orexins may play a role. Chronic
drug administration followed by forced abstinence causes dramatic increases in
preference for the previously administered drug, but a decrease in preference for
alternative drugs or natural rewards i.e. food, and causes long-term changes in reward
sensitivity (Markou and Koob, 1991; Epping-Jordan et al., 1998; Aston-Jones and
Harris, 2004). Regions that show increased Fos expression (i.e. increased cell
activation) during abstinence include the basolateral amygdala, shell of the nucleus
accumbens (NAcc) and LH – activation of which has been localized to the orexinergic
cells (see Aston-Jones et al., 2009). Other studies have confirmed an increase in orexin
activation and orexin mRNA levels during abstinence and withdrawal (Georgescu et al.,
2003; Zhou et al., 2008), suggesting that orexinergic signalling may be driving drug-
seeking behaviours in animals in a withdrawn state.
4.1.3.2.3 Reinstatement
A further role for orexins comes from investigating the phenomenon of reinstatement,
where an animal shows drug-seeking behaviours to previously extinguished cues.
Extinction is performed by repeatedly pairing an addicted animal to a previously drug-
paired CPP chamber, until the animal no longer displays drug-seeking behaviours.
Reinstatement is posited to model relapse in human addicts (Yahyavi-Firouz-Abadi and
See, 2009).
Harris et al (2005) showed that artificially activating the orexin neurons (using rat
pancreatic peptide (rPP) – a Y4 agonist that activates Y4 receptors on orexin cells)
reinstated an extinguished drug or food-seeking behaviour, an effect that wasChapter 4
166
completely blocked by prior administration of the orexin antagonist SB. Furthermore,
injection of orexin A directly into the VTA reinstated previously extinguished
morphine-seeking behaviours (Harris et al., 2007b). Recent studies have shown that
orexin administration causes reinstatement of nicotine-seeking behaviour (Plaza-Zabala
et al., 2010), and blockade of orexin signalling attenuates cue-induced reinstatement of
extinguished cocaine and ethanol-seeking (Smith et al., 2009; Lawrence et al., 2006),
showing that the orexins are involved in modulation of the response to a range of
addictive drugs.
4.1.3.3 Orexins strengthen the synaptic plasticity of dopamine cells in
the VTA and therefore affect the mesolimbic dopamine system
Glutamatergic transmission in the VTA (the origin of the mesolimbic dopaminergic
system) activates dopamine (DA) cells, and DA cell activation and plasticity of
neuronal output is implicated in drug reward and addiction (Hyman et al., 2006). Drugs
of abuse increase DA cell firing rates, leading to potentiation of synapses that lasts over
a long period (termed long-term potentiation – LTP). LTP is characterised by insertion
of glutamatergic NMDA (N-methyl-D-aspartic acid) and AMPA (α-amino-3-hydroxy-
5-methyl-4-isoxazole-proprionate) receptors into the post-synaptic cell membrane.
Electrophysiological studies investigating the firing properties of VTA DA cells
receiving orexin inputs have shown that orexin interacts with glutamatergic signaling in
DA cells, suggesting a potential influence on drug abuse behaviour.
Korotkova et al (2003) first showed that orexins excite DA cells in the VTA. Later,
Borgland et al (2006) co-administered the orexin antagonist SB along with cocaine, and
showed that the glutamate-dependent LTP usually seen after cocaine administration was
blocked. In addition, application of orexin A to midbrain slice preparations caused LTP
at DAergic synapses due to the insertion of postsynaptic NMDA receptors, thereby
facilitating LTP. Orexin B also potentiates NMDA receptor function postsynaptically,
as well as increasing glutamatergic transmission to VTA neurons via a PKC-dependent
mechanism (Borgland et al., 2008). Finally, orexin cells selectively promote motivation
for positive reinforcers (such as high fat food) via the strengthening of VTA synaptic
connectivity, but do not produce any synaptic strengthening after aversive stimuli such
as footshock (Borgland et al., 2009).Chapter 4
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The PFC, in particular the medial subdivision (mPFC), is an important region for
regulating goal-directed behaviours and impulse control, is linked to reward and
addictive behaviours (Kalivas and McFarland, 2003) and is strongly reciprocally
connected to the VTA. Intra-VTA infusion of orexin A caused increased extracellular
DA levels in the prefrontal cortex (PFC), indicating that orexin signalling in the VTA,
particularly the caudal subdivision, causes activation of the mesolimbic dopaminergic
system (Vittoz and Berridge, 2005; Vittoz et al., 2008).
As orexin neurons are stimulated by reward-associated cues, it is possible that orexins
and glutamate, released by the LH and mPFC respectively, may be acting upon DA
neurons in the VTA simultaneously, placing orexins in an important neuromodulatory
position to augment mPFC inputs and strengthen learning of cue-drug associations (see
Aston-Jones et al., 2010). Taken together, these data suggest that orexin neurons of the
LH are necessary for the drug-induced neuroplasticity at glutamatergic synapses in the
mesolimbic dopaminergic system.
4.1.3.4 Overlapping arousal and reward functions
Stress responses are dependent on the activation of arousal mechanisms, and studies of
orexin cells in medial hypothalamic areas have shown a role for orexins in stress-
associated reward behaviours i.e. stress-induced drug reinstatement (see Boutrel and de
Lecea, 2008). There is much reciprocal connectivity between the orexin cells spread
across the PFA-DMH and the LH, which is not surprising as the motivation to maintain
internal homeostatic states and seek reward depends heavily on the arousal state of the
animal.
When an organism is subject to a stressor, the hypothalamo-pituitary-adrenal (HPA)
axis is activated. Synthesis of corticotrophin-releasing factor (CRF) is induced in the
paraventricular nucleus (PVN) of the hypothalamus, and CRF in turn stimulates
pituitary corticotroph cells to produce adrenocorticotropic hormone (ACTH). ACTH
stimulates the adrenal glands to produce adrenaline and cortisol, causing behavioural
arousal i.e. increased heart rate and blood pressure, and increased activity levels (see
Figure 4-3).Chapter 4
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Figure 4-3 – A schematic diagram of the
HPA axis in humans. Hypothalamic cells
produce CRF in response to a stressor,
causing pituitary cells to produce and release
ACTH. This, in turn, stimulates the adrenal
glands, which secrete cortisol. Cortisol
provides negative feedback to the
hypothalamus and pituitary to decrease CRF
production and release, and terminate the
stressful response. Adapted from
http://www.montana.edu/wwwai/imsd/alcoho
l/Vanessa/vwhpa.htm.
CRF-containing terminals form synapses onto PFA-DMH orexin cells, and can directly
depolarize these cells – an effect lost in CRF-receptor KO mice (Winsky-Sommerer et
al., 2004). CRF blockade also prevents the orexin-induced reinstatement of cocaine-
seeking behaviour (Boutrel et al., 2005). Furthermore, CRF release from cells in the
PVN in response to nicotine administration, which is normally anxiogenic, was
prevented by orexin antagonism within the PVN (Plaza-Zabala et al., 2010).
Together, these results show that components of the HPA axis and orexin system are
closely linked, and may help to explain the increase in orexin mRNA seen after drug
withdrawal, as the animal is subjected to the stressful and aversive state of abstinence.
4.1.3.5 Orexins and feeding behaviour
The name ‘orexin’ arises from the term ‘orexigenic’, meaning to stimulate appetite, and
was given to the orexins due to their ability to induce feeding behaviour when injected
intracerebroventricularly (i.c.v.) or to specific hypothalamic sites in rats (Sakurai et al.,
1998; Dube et al., 1999). In addition, it was found that levels of the mRNA encoding
prepro-orexin increase during fasting, pointing to an important role in regulation of
appetite (Sakurai et al., 1998). Later studies found that orexin cell activation also drives
reward-seeking of a high fat food in satiated rats (Harris et al., 2005; Borgland et al.,
2009) and mice (Sharf et al., 2010), providing a strong suggestion that orexin cell
activation may affect the seeking and/or consumption of the food treats used as a reward
in the experiments described in this thesis.Chapter 4
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The role of orexins in feeding behaviour is mediated by the connectivity of the LH to
the NAcc (Stratford and Kelley, 1999). Orexin A injection into the NAcc shell induced
feeding behaviour (Thorpe and Kotz, 2005), and stimulation of the NAcc shell caused
high-fat feeding behaviour which depended on orexin signalling in the VTA (Zheng et
al., 2007).
Further evidence linking orexin and motivation for feeding of high fat food comes from
the study of “reward-based feeding behaviour”, or food consumption beyond
homeostatic needs. Activation of orexin cells was shown in animals that were expecting
their daily meal, and upon exposure to a cue related to a conditioned palatable food
(chocolate) in sated rats (Choi et al., 2010). In addition, Choi et al found that
administration of i.c.v. orexin A increased food intake, and caused an increase in the
progressive ratio break-point for food pellets i.e. the point at which rats discontinued
lever pressing to obtain a food reward. These effects were reversed after orexin
antagonism.
The role of orexins in feeding behaviour, particularly the motivation to obtain palatable
foods when the animal is sated, places orexin as a strong candidate to reflect the
behaviours monitored in the novelty-induced hypophagia (NIH) paradigm, which
contains a sweet, sugary foot treat at its centre.
4.1.3.6 Orexins play a role in nociception
The orexin cells of the lateral hypothalamus are reciprocally connected to areas
involved in nociceptive processing, including the periaqueductal grey (PAG),
parabrachial nucleus (PBN) and laminae I, II and X of the spinal cord (Peyron et al.,
1998; van den Pol, 1999). Lateral hypothalamic stimulation inhibits spinal cord
neuronal responses to peripheral noxious stimulation (Carstens et al., 1983; Carstens,
1986), and orexins A and B have analgesic properties in animal models of postoperative
pain (Cheng et al., 2003), neuropathic pain (Yamamoto et al., 2003a; Suyama et al.,
2004), diabetic neuropathy (Kajiyama et al., 2005), and inflammatory pain models
(Yamamoto et al., 2003b), when administered both intrathecally (i.t.) and i.c.v.
(Bingham et al., 2001; Mobarakeh et al., 2005). Orexins have also been linked to cluster
headaches and migraine (see Holland and Goadsby, 2007).Chapter 4
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Bingham et al (2001) suggest the existence of an orexinergic descending inhibitory
system, whereby orexins modulate spinal cord processing to reduce ascending
excitation. The authors suggest that this functions in a manner similar to, but
independent from, endogenous opioids, as naloxone had no effect on orexin A’s
analgesic actions. Orexins have been shown to excite both excitatory relay neurons in
the spinal cord and inhibitory GABAergic neurons in the brainstem (Siegel, 2004; Liu et
al., 2002), so to extend this theory, it is possible to speculate that orexins directly
activate ascending projection cells in the spinal cord, and simultaneously activate
inhibitory GABAergic neurons, which dampen the ascending nociceptive response.
When coupled with descending inhibition from the brainstem which utilises endogenous
opioids (Fields, 2007), this could greatly enhance inhibitory modulation. Support for
this theory comes from prepro-orexin KO mice, which show no differences in
mechanical or thermal nociceptive withdrawal thresholds at baseline, but demonstrate
greater hyperalgesia after peripheral inflammation (when descending inhibitory
mechanisms are presumably activated) compared to wild-type animals (Watanabe et al.,
2005).
The evidence suggests that orexins may play an important modulatory role in spinal
pain transmission and contribute to descending inhibitory drives, further highlighting
the potential of orexins as neurobiological correlates of behaviour in animals subjected
to repeated neonatal and adult painful stimuli.
In summary, the role of orexin cells in reward processing, stress, arousal, and
nociception places them in a strong position as candidates for reflecting the behavioural
changes seen after adult injury to neonatally-injured animals.
4.2 Hypotheses
In this chapter, I test the following hypotheses:
 That the behavioural changes seen in animals after a repeated early injury in
neonatal life will be correlated with activation of the lateral hypothalamic orexin
cells, identifying orexin as a neurobiological correlate of reward-related
behaviours in injured animals.Chapter 4
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 That, as with the behavioural changes seen, the results will be more pronounced
in neonatally-injured animals that are re-injured in adulthood.
 That orexin cell activation will be seen in relation to presentation of a food
reward, Cheerios breakfast cereal, in the NIH arena.
4.3 Methods
The experiments described in this chapter were to investigate the neurobiological
correlate of behaviour in the novelty-induced hypophagia (NIH) paradigm in animals
with a history of foot wound injury as neonates, after re-injury in adulthood. The orexin
system of the lateral hypothalamus was investigated as a potential system for reflecting
these effects. Activation of the orexin system was shown by the co-expression of c-Fos
in orexin-positive cells. C-Fos is a protein product of c-fos, an immediate early gene. It
is restricted to the nucleus, and was used in these experiments as a marker of cell
activation, with maximal expression expected at 90-120 minutes post-stimulus (see
Kovács, 2008). It has been widely used as a marker of cell activation in experiments
investigating the roles of orexins (Georgescu et al., 2003; Harris et al., 2005; Harris et
al., 2007b; Choi et al., 2010).
4.3.1 Experimental design
The tissue for the experiments in this chapter originated from the animals tested in the
novelty-induced hypophagia paradigm, as described in the previous chapter. Animals
were repeatedly injured (plantar skin incision) or anaesthetised as neonates (on postnatal
days (P)3, P10 and P17), and adult behaviour upon testing in the NIH arena was
studied. As described previously in Chapter 3, the NIH arena is a behavioural paradigm
for testing anxiety, exploratory and reward-related behaviours. Animals were tested in
the arena and then returned to their home cages before tissue collection. See Chapter 3
Methods for explanation of foot wound surgery and the NIH arena. The designs for the
experiments in this chapter are explained below:Chapter 4
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4.3.1.1 Experiment 1: Investigating activation of the orexin system
after single adult foot wound in animals with no history of
injury
To see the effect that a single adult foot wound has on orexin cell activation in animals
with no history of injury, tissue from animals that were repeatedly anaesthetised as
neonates was compared when the animals were given a single foot wound or re-
anaesthetised as adults, and tested in the NIH arena. Figure 4-4 illustrates the design of
this experiment:
Figure 4-4 – A schematic diagram to illustrate the design of Experiment 1. Animals repeatedly
anaesthetised as neonates were injured or re-anaesthetised as adults, and orexin activation after
testing in the NIH arena investigated.
4.3.1.2 Experiment 2: Investigating baseline activation of the orexin
system in animals with a history of repeated neonatal injury
To see what effect testing in the NIH arena had at baseline on the orexin system, tissue
from neonatally foot-wounded animals or anaesthesia-only controls was compared.
Figure 4-5 is a schematic diagram to illustrate the design of this experiment:
Figure 4-5 – A schematic diagram to show the design for Experiment 2. The activation of the
orexinergic system was compared after testing in the NIH arena between animals that received
repeated neonatal foot wound or anaesthesia, but received no adult treatment.
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4.3.1.3 Experiment 3: Investigating activation of the orexin system
after adult foot wound in animals repeatedly injured as
neonates
To see what effect a history of injury had on adult orexin activation after testing in the
NIH arena, tissue from animals that were repeatedly wounded as neonates was
compared when animals were re-injured or anaesthetised as adults. Figure 4-6 illustrates
the design of this experiment:
Figure 4-6 – A schematic diagram to illustrate the design of Experiment 3. Animals repeatedly
injured as neonates were re-injured or anaesthetised as adults, and orexin activation after testing in
the NIH arena investigated.
4.3.1.4 Experiment 4: Investigating the effect of Cheerio consumption
on the lateral hypothalamic orexin system.
To investigate whether consumption of Cheerios or the presence of a food reward
activates orexin cells, two additional comparisons of orexin cell activation were
performed.
4.3.1.4.1 Experiment 4a
Firstly, tissue from animals that had not consumed any Cheerios during the 15 minute
NIH testing period was compared to tissue from animals that did consume Cheerios.
Neonatally foot-wounded males, uninjured in adulthood, were used for this comparison.
Out of 19 animals in this group, 7 did not consume any Cheerios. A Fisher’s Exact test
showed that this was a significantly higher proportion of non-consuming animals than
was expected (p=0.008). Figure 4-7 is a schematic to show the design of this
experiment:
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Figure 4-7 – A schematic diagram to illustrate the design for Experiment 4a. Repeatedly
neonatally-injured males were tested in the NIH paradigm in adulthood, and the activation of the
orexin system was compared between animals that consumed Cheerios during the NIH test, and
those that did not.
4.3.1.4.2 Experiment 4b
Secondly, the activation of orexin cells was compared in tissue from animals that had
access to Cheerios in the NIH arena to tissue from animals that had no access to
Cheerios in the NIH arena. Figure 4-8 is a schematic to show the design for this
experiment:
Figure 4-8 – A schematic diagram to illustrate the experimental design for Experiment 4b. Animals
that were repeatedly injured as neonates were re-injured as adults, and tested in the NIH arena
either in the presence or absence of Cheerios in the central food bowl. Activation of the orexin
system was compared.
For all the above experiments, tissue was harvested two hours after testing in the NIH
arena. This is because it is the maximal time point of c-Fos expression and is a time
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point widely used in other experiments investigating orexin cell activation (Georgescu
et al., 2003; Harris et al., 2005; Harris et al., 2007b; Choi et al., 2010).
Animals were sacrificed by intraperitoneal (i.p.) injection of an overdose of Euthatal
(Merial Animal Health Limited, Harlow, UK), and transcardially perfused with 4%
paraformaldehyde (PFA – see Appendix 1: Solutions). Brains were dissected out, post-
fixed in 4% PFA for 4 hours, then transferred to a 30% sucrose and azide solution (see
Appendix 1) and stored at 4°C.
4.3.2 Definition of the lateral hypothalamus
The co-ordinates of the lateral hypothalamus (LH), as defined by the stereotaxic atlas of
Paxinos and Watson (2004), are as follows:
From Bregma:
Anteroposterior: -3mm to -5mm
Dorsoventral: -7mm to -9mm
Mediolateral: +1.5mm to 3mm
This is a large region, so previous studies have further defined the area as lateral to the
fornix (Harris et al., 2005; Aston-Jones et al., 2009). Figure 4-9 illustrates the definition
and localisation of the lateral hypothalamus, as used for these experiments:Chapter 4
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Figure 4-9 – A figure to show the localization and definition of the lateral hypothalamus for cell
counting purposes. The top two panels show the LH, outlined by a black rectangle, as defined by
the stereotaxic atlas of Paxinos and Watson (2004). The lower two panels show x10 and x20
magnifications of the LH. Black cytoplasmic staining shows orexin-positive cells. The dotted circle
indicates the fornix; cell counting was performed laterally to this landmark. The black rectangle in
the x20 magnification (bottom panel) represents the counting area as defined by the microscope
eyepiece.
4.3.3 Immunohistochemistry
The following protocol was used for immunostaining:
 40µm sections of the lateral hypothalamus were cut on the freezing microtome
and placed into wells containing 5% sucrose in azide (see Appendix 1:
Solutions).
 Sections were transferred to Röhren tubes (Sarstedt, Leicester, UK), 6 sections
per tube, each at a distance of 240µm from the last, and blocked in 5% horse
serum plus hydrogen peroxide for 1 hour (see Appendix 1).
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 C-Fos primary antibody (Calbiochem, Nottingham, UK) was placed onto the
sections at a 1:10,000 dilution (1µl per 10ml) in TTBS (see Appendix 1). The
tubes were incubated overnight at room temperature.
 Sections were washed with 0.1M PB (see Appendix 1), 3 times, for 10 minutes
per wash.
 The c-Fos secondary antibody was placed onto the sections. This was
biotinylated anti-rabbit, raised in goat (Vector Laboratories Inc., CA, USA), at a
1:500 dilution (2µl per ml) in TTBS. Sections were incubated for 2 hours at
room temperature.
 Sections were washed as above.
 The avidin-biotin protocol was used to amplify the signal. Using the Vectastain
ABC kit (Vector Laboratories Inc., CA, USA), 1µl of ‘A’ and 1µl of ‘B’ per ml
TTBS were stirred for 30 minutes.
 Avidin-biotin solution was placed onto the sections for 1 hour at room
temperature.
 Sections were washed, as above.
 To stain the c-Fos, brown DAB (3,3’-diaminobenzidine) staining was
performed. The DAB solution was prepared according to the kit instructions
(Vector Laboratories Inc., CA, USA). Sections were incubated for ~6 minutes in
DAB solution or until staining of nuclei was apparent, transferred to deionised
water to end the reaction, then washed with 0.01MPB and 0.1M PB, for two
minutes each.
 The orexin-A primary antibody (Santa Cruz Biotechnology Inc., CA, USA) was
placed onto the tissue at a concentration of 1:1000 (1µl per ml) in TTBS and
incubated overnight at room temperature.
 Sections were washed.
 The orexin secondary antibody was placed onto the sections. This was
biotinylated anti-goat, raised in horse (Vector Laboratories Inc., CA, USA) at a
dilution of 1:500 (2µl per ml) in TTBS for 2 hours at room temperature.
 Sections were washed.
 Avidin-biotin solution was made up as above and mixed for 30 minutes.
 The AB solution was placed onto the tissue for 1 hour at room temperature.
 Sections were washed.Chapter 4
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 To stain the orexin, blue DAB (3,3’-diaminobenzidine) staining was performed.
The DAB solution was prepared according to the kit instructions (Vector
Laboratories Inc., CA, USA). Sections were incubated for up to 2 minutes in
DAB solution or until cytoplasmic staining was apparent, transferred to PBS
(see Appendix 1), then washed in deionised water and 0.1MPB for two minutes
each.
 Sections were then placed into 0.01M PB for mounting onto gelatinised slides.
 Slides were dried in the dark overnight at room temperature, then dehydrated
and coverslipped with Histoclear (Flowgen Bioscience, Nottingham, UK).
4.3.3.1 Immunohistochemistry controls
Control tubes of sections were prepared to check for the effects of non-specific binding
of the antibodies (where the antibody binds to the tissue at random instead of to the
protein of interest). The control tubes underwent the same washing and staining as the
experimental tubes at all stages of the protocol, except the sections were not exposed to
the antibody at the relevant stage of the protocol, and were placed into 0.1M PB
instead.
Tubes were prepared under one of the four following conditions:
1. The c-Fos primary antibody was absent
2. The c-Fos secondary antibody was absent
3. The orexin primary antibody was absent
4. The orexin secondary antibody was absent
Control images are not shown, as staining was so faint that tissue could not be seen.
4.3.4 Visualisation and counting of sections
 All counting was done by a blinded experimenter. Unblinding was not
performed until all slides had been counted.
 Slides were visualised using a light microscope (Nikon E800). C-Fos staining
was seen as brown nuclear staining. Orexin staining was seen as a cytoplasmic
dark blue/black stain. Only sections that contained orexin cells were counted.
 The lateral hypothalamus was identified according to the above criteria. Sections
were counted bilaterally.Chapter 4
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 Cell counting took place at x20 magnification. The viewfinder within the
microscope eyepiece defined the area to be counted (see Figure 4-9).
 Orexin-positive cells, c-Fos positive nuclei, and the number of co-expressing
cells were counted manually.
 5 sections per animal were counted, with 5-8 animals per group. Numbers per
group are specified in the Results section.
4.3.5 Analysis of cell counts
 From raw cell counts, the percentage of orexin-positive cells that were co-
expressing c-Fos was calculated.
 Averages for each animal were calculated, and then group averages calculated.
 2-way ANOVAs were performed with GraphPad Prism version 4 software to
investigate group and gender differences. Bonferroni’s post-hoc tests were
performed to find the direction of any differences.
 Pearson’s correlation coefficient was calculated for data that was being
correlated with behavioural outcome measures.
 ANOVA and calculation of Pearson’s correlation coefficient are parametric
methods of analyses, therefore all data was checked to conform to a normal
distribution (D’Agostino and Pearson omnibus normality test) prior to analysis.
All data passed normality tests.
4.4 Results
The results from the experiments in this chapter show that the orexin system is sensitive
to a rewarding stimulus, and that an injury in adulthood, particularly if the animal has a
history of neonatal injury, alters the activation of the orexinergic system.
Immunostaining of the lateral hypothalamus was performed after animals had been
tested in the novelty-induced hypophagia (NIH) arena. C-Fos (an immediate early gene)
was used as a marker of cell activation. All cell counts were performed blind. Orexin
cells were cytoplasmically stained, and c-Fos staining was confined to nuclei (see
Figure 4-10). Percentage of orexin cells co-expressing orexin and c-Fos are therefore
said to be ‘activated’ orexin cells.Chapter 4
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Figure 4-10 – A representative image of an
orexin-positive cell co-expressing c-Fos in the
nucleus.
Representative images of lateral hypothalamic sections from male animals are presented
on the next page:
 ‘AN’ refers to an animal repeatedly anaesthetised as a neonate.
 ‘AN+FW’ refers to an animal repeatedly anaesthetised as a neonate and
receiving a single adult foot wound
 ‘FW’ refers to an animal that received a repeated neonatal foot wound.
 ‘FW+FW’ refers to an animal that received a repeated neonatal foot wound and
has been re-injured as an adult.
100µmmChapter 4
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Figure 4-11 – A representative image of the lateral hypothalamus of a control ‘AN’ animal.
Examples of c-Fos-expressing nuclei are indicated by green arrows, orexin cells by blue. Co-
expressing cells are indicated by red arrows.
Figure 4-12 - A representative image of the lateral hypothalamus of an ‘AN+ FW’ animal. Co-
expressing cells are indicated by red arrows.
Figure 4-13 - A representative image of the lateral hypothalamus of a ‘FW’ animal. Co-
expressing cells are indicated by red arrows.
Figure 4-14 - A representative image of the lateral hypothalamus of a ‘FW+FW’ animal. Co-
expressing cells are indicated by red arrows.
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4.4.1 Experiment 1: Orexin cell activation is not affected by a single
adult foot wound in animals with no history of injury, and does
not correlate with reward-related behaviours
As shown in Chapter 3, a single adult foot wound causes changes in behaviour - rearing
is decreased and the percentage of time spent in the central zone increases. The
activation of the orexin system was investigated in these animals to see if the orexin
system reflects the behavioural changes seen.
Percentage of orexin cells co-expressing c-Fos was calculated in animals that had no
history of foot wound and were either injured or re-anaesthetised as adults, after the
animals were tested in the NIH paradigm. ‘AN’ refers to animals that were repeatedly
anaesthetised as neonates. ‘AN+FW’ refers to neonatally anaesthetised animals that
received a single adult foot wound. Animals that did not eat any Cheerios were
excluded from the analysis.
Table 4-1 shows the raw data generated from this experiment. There was a significant
effect of treatment on the number of orexin cells (F(1,23)=4.89, p<0.05; 2-way ANOVA),
which showed that adult-injured animals (both genders) had more orexin cells per
section than animals with no adult injury. However, there was no significant effect of
gender or treatment on the percentage of orexin cells co-expressing c-Fos, as illustrated
in Graph 4-1. This data shows that the activation of orexin cells induced by testing in
the NIH arena is not changed by a single adult foot wound in animals with no history of
neonatal injury.
Treatment
group Number Orexin-
positive
c-Fos-
positive
Number of co-
expressing cells
% orexin cells
co-expressing c-
Fos
M AN 6 42.4±3.7 31.6±6.9 6.5±1.4 16.4±4.5
M AN+FW 7 54.6±5.2 28.1±3.2 9.8±1.3 18.4±2.8
F AN 7 40.1±3.2 44.2±7.0 9.4±2.4 22.2±4.0
F AN+FW 7 54.1±9.1 41.2±7.5 10.9±1.9 16.7±2.8
Table 4-1 – A table to show the treatment groups, number of animals per group, number of orexin-
and c-Fos-positive cells, and number and percentage of orexin-cells co-expressing c-Fos in animals
with no history of injury, injured (AN+FW) or not (AN) as adults.Chapter 4
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Graph 4-1 – A graph to show the percentage
of orexin cells co-expressing c-Fos in animals
with no history of injury (AN), compared to
those with no history of injury given a single
adult foot wound (AN+FW).
To investigate if the activation of orexin cells is correlated to the outcome measures that
were significantly affected by a single adult injury, namely rears and the percentage of
time spent in the central zone (both in the 5-10 minute time bin), Pearson’s correlation
coefficient (R) was calculated for both rears and central zone percentage, in males and
females with no history of injury, either with or without a single adult foot wound.
There were no significant correlations between activation of orexin cells and the two
chosen behavioural outcome measures in either gender or after any treatment,
suggesting that the orexin system does not reflect behavioural changes in animals with
no history of repeated neonatal injury. These data are shown in Table 4-2.
Rears Time in central zone (%)
Treatment group Pearson’s
R P value Pearson’s
R P value
M AN 0.55 0.25 (n.s.) -0.48 0.33 (n.s)
M AN+FW -0.16 0.73 (n.s.) 0.32 0.49 (n.s.)
F AN 0.25 0.59 (n.s) 0.61 0.15 (n.s.)
F AN+FW 0.22 0.64 (n.s.) -0.16 0.74 (n.s.)
Table 4-2 – A table to show Pearson’s correlation coefficient for the number of rears/percentage of
time spent in the central zone, both in the 5-10 minute time bin, correlated to the percentage of
orexin cells co-expressing c-Fos, in animals with no history of injury.
4.4.2 Experiment 2: The presence of a ‘pain history’ does not alter
baseline orexin cell activation, or correlate with reward-related
behaviours
Next, to investigate the effect a history of injury has on baseline activation of the orexin
system, the percentage of orexin cells co-expressing c-Fos was calculated in animals
that had either a history of foot wound (FW) or control animals that did not (AN), afterChapter 4
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the animals were tested in the NIH paradigm. ‘FW’ refers to animals that had a repeated
neonatal foot wound at postnatal day (P)3, P10 and P17. ‘AN’ refers to animals that
were only anaesthetised on the same days as neonates. Animals that did not eat any
Cheerios were excluded from the analysis.
Comparing the genders and treatment groups showed that the number of orexin cells per
animal did not differ (2-way ANOVA). The number of c-Fos-positive nuclei was higher
in both groups of females, possibly suggesting an effect of generalised increased arousal
in these animals (Gender F(1,24)=5.47, p<0.05; 2-way ANOVA). However, the
percentage of orexin cells co-expressing c-Fos was not different between gender or
treatment, suggesting that neither gender nor treatment affect the baseline activation of
the orexin system after testing in the NIH paradigm (see Graph 4-2). Table 4-3
illustrates the mean cell counts and calculated percentages of co-expressing cells (±
SEM).
Treatment
group Number Orexin-
positive
c-Fos-
positive
Number of
co-
expressing
cells
% orexin
cells co-
expressing
c-Fos
M FW 7 43.2±4.2 28.2±7.3 7.0±1.5 15.5±2.6
M AN 6 42.4±3.8 31.6±6.9 6.5±1.4 16.4±4.5
F FW 8 46.3±2.6 47.5±5.9 10.2±1.5 22.3±3.6
F AN 7 40.1±3.2 44.2±7.0 9.4±2.4 22.2±4.0
Table 4-3 - A table to show the treatment groups, number of animals, orexin- and c-Fos-positive cell
counts and number and percentage of orexin cells co-expressing c-Fos (± standard error) for
animals repeatedly injured (FW) or anaesthetised (AN) as neonates.
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Graph 4-2 – A bar graph to show the
percentage of orexin cells co-expressing c-Fos
in males and females injured or anaesthetised
as neonates and tested in adulthood in the
NIH arena.
To investigate whether the activation of the orexin cells is correlated to reward-related
behaviours, Pearson’s correlation coefficient was calculated in the above groups of
animals. The outcome measures used were the number of rears and percentage of timeChapter 4
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spent in the central zone (both during the 5-10 minute time bin); this was because these
are the most consistently robust outcome measures as seen in Chapter 3.
The results showed that there are no correlations between activation of orexin cells and
reward-related behaviours (rears and percentage of time spent in the central zone) in
animals of either gender, with or without a history of repeated neonatal foot wound,
when tested at baseline in the NIH arena in adulthood. These data are shown in Table
4-4.
Rears Time in central zone (%)
Treatment group Pearson’s
R P value Pearson’s R P value
M FW 0.69 0.08 (n.s.) -0.46 0.30 (n.s.)
M AN 0.55 0.25 (n.s.) -0.48 0.33 (n.s.)
F FW 0.02 0.96 (n.s.) -0.58 0.13 (n.s.)
F AN 0.25 0.59 (n.s) 0.61 0.15 (n.s.)
Table 4-4 – A table to show Pearson’s correlation coefficient for the number of rears/percentage of
time spent in the central zone, both in the 5-10 minute time bin, correlated to the percentage of
orexin cells co-expressing c-Fos, in animals with no history of injury.
4.4.3 Experiment 3: Re-injury of an animal with a history of injury
increases orexin cell activation, and correlates with rearing
behaviour
To investigate whether a re-injury in adulthood to animals with a history of neonatal
injury affected orexin cell activation, the percentage of orexin cells co-expressing c-Fos
was calculated in re-injured animals after the adult animals were tested in the NIH
paradigm. ‘FW’ refers to animals that were repeatedly injured as neonates but received
no adult injury. ‘FW+FW’ refers to neonatally injured animals that also received a
single adult foot wound. Animals that did not eat any Cheerios were excluded from the
analysis. Table 4-5 shows the cell count data from this experiment:Chapter 4
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Treatment
group Number Orexin-
positive
c-Fos-
positive
Number of
co-
expressing
cells
% orexin cells
co-
expressing c-
Fos
M FW 7 43.2±4.2 28.2±7.3 7.0±1.5 15.5±2.6
M FW+FW 7 48.2±4.9 46.8±14.4 13.7±3.1 27.2±4.1
F FW 8 46.3±2.6 47.5±5.9 10.2±1.5 22.3±3.6
F FW+FW 7 52.9±4.2 40.8±5.9 10.1±3.5 20.2±3.1
Table 4-5 – A table to show the treatment groups, number of animals, orexin- and c-Fos-positive
cell counts and number and percentage of orexin cells co-expressing c-Fos (± standard error) for
animals repeatedly injured as neonates, and re-injured (FW+FW) or not (FW) as adults.
There was no difference in orexin-positive and c-Fos positive cell numbers between
genders or treatments (2-way ANOVA).
There was, however, a significant difference in percentage of orexin cells co-expressing
c-Fos between treatment groups in the male animals (p=0.016, 1-tailed unpaired t-test).
This result shows that when an animal with a ‘pain history’ is re-injured as an adult, the
orexinergic system is more active after testing in the NIH arena, rising from ~15% of
orexin cells activated at baseline to ~27% in re-injured animals (Graph 4-3).
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Graph 4-3 – A graph to show the percentage
of orexin cells co-expressing c-Fos in animals
with a history of neonatal injury (FW),
compared to those with a history of injury
given a single adult re-injury (FW+FW).
To investigate whether the orexin cell activation correlated to the reward-related
behaviours investigated in Chapter 3, Pearson’s correlation coefficient was calculated.
The behavioural outcome measures investigated were rears and percentage of time spent
in the central zone (both during the 5-10 minute time bin), as these were the outcome
measures significantly affected by an adult re-injury in animals with a previous history
of foot wound. The data are presented in Table 4-6:Chapter 4
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Rears Time in central zone (%) Treatment group
Pearson’s R P value Pearson’s R P value
M FW 0.69 0.08 (n.s.) -0.46 0.30 (n.s.)
M FW+FW -0.83 0.04 (*) 0.02 0.96 (n.s.)
F FW 0.02 0.96 (n.s.) -0.58 0.13 (n.s.)
F FW+FW 0.42 0.35 (n.s.) 0.51 0.25 (n.s.)
Table 4-6 – A table to show Pearson’s correlation coefficient for the number of rears/percentage of
time spent in the central zone, both in the 5-10 minute time bin, correlated with the percentage of
orexin cells co-expressing c-Fos, in animals with a ‘pain history’ either with or without a re-injury
in adulthood. Significant results are shown in bold. *p<0.05.
The results show that orexin cell activation negatively correlates (r= -0.83) with the
number of rears performed in the NIH arena i.e. as the co-expression of c-Fos in orexin
cells increases, the number of rears decreases (represented in Graph 4-4). This result
proves that activation of the orexin system is sensitive to reward-related behaviours in
animals with a ‘pain history’, re-injured in adulthood.
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correlation between the percentage of orexin
cells co-expressing c-Fos and the number of
rears performed by the male FW+FW group
during the 5-10 minute testing time bin in the
NIH arena.
4.4.4 Investigating the effect of Cheerio consumption on the lateral
hypothalamic orexin system
To investigate whether consumption of Cheerios or the presence of food reward
activates orexin cells, two additional comparisons of orexin cell activation were
performed.Chapter 4
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4.4.4.1 Experiment 4a: Comparing orexin cell activation in animals
that consumed Cheerios during the NIH test period to those
that did not
It was expected that all animals would consume Cheerios during the NIH test period, as
anecdotal evidence showed that all animals rapidly consumed Cheerios when presented
with them in their home cages. However, male animals that had been repeatedly injured
as neonates produced a high number of non-eating animals when tested in the NIH
arena in adulthood. Analysis showed that there were significantly more non-eating
animals than were expected (see Chapter 3, p127). To investigate what effect Cheerio
consumption had on orexin cell activation, the percentage of orexin cells co-expressing
c-Fos was investigated in animals that consumed, or did not consume, Cheerios. Table
4-7 shows the number of eating and non-eating animals that were used for this analysis:
Eaters Non-eaters
7 5
Table 4-7 – A table to show the number of eating and non-eating animals analysed in the male
neonatally-injured group.
There was no difference in the number of orexin cells between eating or non-eating
animals, but there was significantly more c-Fos activation in the non-eating animals
(F(1,24)=7.56, p<0.05; 2-way ANOVA). This could be a reflection of increased arousal
during the test period. The data are shown in Table 4-8:
Cell type Eater Non-eater
Orexin-positive 43.2±4.2 42.2±5.7
C-Fos-positive 28.2±7.3 41.8±10.1
Co-expressing (number) 7.0±1.5 10.0±2.5
Co-expressing (%) 15.5±2.61 22.4±3.4
Table 4-8 – A table to show the mean (± standard error) number of orexin and c-Fos-positive cells,
and the percentage of cells co-expressing both, in eating and non-eating males.
When comparing the percentage of orexin cells co-expressing c-Fos between eating and
non-eating animals, there was no difference between groups (p=0.13, Unpaired t-test),
suggesting that the consumption of Cheerios does not affect orexin cell activation.Chapter 4
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Graph 4-5 – A bar graph to show the
percentage of orexin cells co-expressing c-Fos
in animals that did or did not consume
Cheerios during the NIH test period.
4.4.4.2 Experiment 4b: Orexin cell activation is significantly lower in
animals that had no access to food reward during the NIH test
period
To investigate whether the presence of Cheerios affected activation of the orexin
system, orexin cell activation was compared between animals that had Cheerios
present in the food bowl of the NIH arena (‘Present’), and those that were presented
with an empty food bowl in the centre of the NIH arena (‘Absent’).
As the re-injured male animals with a ‘pain history’ were the only group that
showed a significant effect of treatment on orexin cell activation, these animals were
compared between the ‘present’ and ‘absent’ conditions. In addition, the data was
compared to a ‘baseline’ group – animals with a history of foot wound but no adult
injury. Table 4-9 shows this data:
Treatment
group Number Orexin-
positive
c-Fos-
positive
Number co-
expressing
orexin and c-
Fos
% orexin
cells co-
expressing
c-Fos
M FW Present 7 48.2±4.5 46.8±7.5 13.7±3.1 27.2±3.1
M FW Absent 5 57.4±5.4 32.6±8.8 7.9±1.2 14.8±3.7
Baseline 7 43.2±4.2 28.2±7.3 7.0±1.5 15.5±2.6
Table 4-9 – A table to show the treatment groups, number of animals, cell counts and number and
percentage of orexin cells co-expressing c-Fos (± standard error) for animals that had access to
Cheerios in the NIH arena and those that did not have access to Cheerios, as well as a ‘baseline’
group.
Comparing the percentage of orexin cell activation between the ‘present’, ‘absent’ and
‘baseline’ conditions showed that orexin cell activation is higher in re-injured maleChapter 4
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animals when Cheerios are present in the NIH arena, and compared to baseline
activation (p<0.05; One-way ANOVA with Bonferroni’s post-tests). When Cheerios are
absent, the activation of the orexin system is the same as that at baseline:
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Graph 4-6 – A bar graph to show the
percentage of orexin cells co-expressing c-Fos
in neonatally injured animals re-injured in
adulthood, when the Cheerios were present
or absent during testing in the NIH arena.
‘Baseline’ data refers to animals with a ‘pain
history’ but no adult re-injury, tested in the
presence of Cheerios. *p<0.05; one-way
ANOVA with Bonferroni’s post-tests.
This data shows that activation of the orexin system is sensitive to food reward, but only
in male animals with a history of neonatal pain that are then re-injured in adulthood.
To see if the presence or absence of Cheerios correlated to changes in reward-related
behaviours, Pearson’s correlation coefficient was calculated for the number of rears and
the percentage of time spent in the central zone (shown in Table 4-10). Behaviourally,
the number of rears increased when the Cheerios were absent, and the percentage of
time spent in the central zone decreased.
Rears Time in central zone (%) Treatment group
Pearson’s R P value Pearson’s R P value
Present -0.83 0.04 (*) 0.02 0.96 (n.s.)
Absent 0.9 0.04 (*) -0.60 0.29 (n.s.)
Baseline 0.69 0.08 (n.s.) -0.46 0.30 (n.s.)
Table 4-10 – A table to show Pearson’s correlation coefficient for the number of rears and
percentage of time spent in the central zone (both in the 5-10 minute time bin), correlated with the
percentage of orexin cells co-expressing c-Fos at baseline and in animals with a ‘pain history’ re-
injured in adulthood, when the Cheerios are present or absent. Significant results are shown in
bold. *p<0.05.
The results show that when Cheerios are present, the number of rears is negatively
correlated (r= -0.83) to the activation of the orexin cells (see Graph 4-4). However,
when the Cheerios are absent, the number of rears is positively correlated (r=0.9) withChapter 4
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the activation of orexin cells (see Graph 4-7). There is no correlation to either
behavioural outcome measure in the Baseline group.
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Graph 4-7 – A scatterplot to show the
correlation between the percentage of orexin
cells co-expressing c-Fos and the number of
rears performed by the male FW+FW group
during the 5-10 minute testing time bin in the
NIH arena when Cheerios are absent.
Therefore, when Cheerios are absent, orexin cell activation is lower than when Cheerios
are present; and the number of rears increases as orexin cell activation increases.
However, when Cheerios are present, orexin cell activation is higher, and the higher the
activation, the fewer the number of rears.
4.4.5 Summary
 The activation of the orexin system of animals with no history of neonatal injury
is not affected by a single injury in adulthood. Furthermore, the activation of
orexin cells does not correlate to the behavioural changes seen in these animals
after a single adult injury, suggesting that the orexin system is not a sensitive
biomarker of reward-related behaviours in animals without a history of injury.
 Animals that had a history of repeated neonatal foot wound did not show any
differences in orexin cell activation when compared to anaesthesia-only controls.
Furthermore, the activation of orexin cells did not correlate to reward-related
behaviours in these animals, suggesting that the orexin system is not a sensitive
biomarker of reward-related behaviours in animals with a history of injury,
tested at baseline.
 Males with a history of repeated neonatal foot wound show an increase in the
percentage of orexin cells activated when re-injured in adulthood. In addition,
this activation of orexin cells correlates with the number of rears performed,
showing that activation of the orexin system reflects reward-related behaviours
in males with a ‘pain history’ when they are re-injured as adults.Chapter 4
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 Additional studies to investigate the effect of Cheerio consumption on orexin
cell activation showed that whether animals eat or not is irrelevant to orexin
activation. However, when comparing animals that had access to Cheerios in the
NIH arena versus those that did not, orexin activation is lower when the
Cheerios are absent. This suggests that the orexin system is sensitive to the
presence of a reward in animals with a ‘pain history’, and could be used as a
neurobiological marker of reward in animals that are tested in the NIH arena.
 In addition, when Cheerios are absent, and levels of orexin activation are low,
there is a positive correlation between cell activation and rearing behaviour.
 Taken together, these results show that the orexin system is sensitive to the
presence or absence of a food reward in animals with a history of repeated
neonatal injury. In addition, the magnitude of activation of the system correlates
with the behavioural outcome measures studied in Chapter 3.
4.5 Discussion
The results presented in this chapter show that the orexin system can reflect aspects of
reward, but only in male rats with a history of neonatal pain when re-injured in
adulthood. In these animals, orexin cell activation is sensitive to the presence or absence
of food reward and correlates to behavioural outcome measures. This suggests that the
orexin system could be a potential biomarker of reward-related behaviours in this
specific group of animals.
4.5.1 A single injury in adulthood does not influence orexin
signalling
The results showed that when an animal with no prior history of injury receives a single
foot wound in adulthood, activation of the orexin system after behavioural testing in the
novelty-induced hypophagia (NIH) paradigm is not different to that of control animals,
who received no adult injury. This suggests that orexin cells are not activated after NIH
arena testing in animals with an acute injury.
It was thought possible that an acute injury may have increased orexin activation, as the
literature has shown that orexins have analgesic effects on animal pain models of
inflammation and neuropathy and may be acting to dampen ascending nociceptive inputChapter 4
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(Bingham et al., 2001; Yamamoto et al., 2003a; Kajiyama et al., 2005). This analgesic
effect has also been shown in the plantar skin incision model of post-operative pain –
the same pain model used in these experiments (Cheng et al., 2003). However, any
potential analgesic effect, as seen by an increase in orexin signalling, was not seen in
these experiments.
This is most likely because the studies showing the orexins’ analgesic effect used very
different testing protocols to those used in these experiments. For example, Bingham et
al (2001) studied orexin A’s effect 1-5 minutes after infusion, and Cheng et al (2003)
intrathecally infused orexin beginning 20 minutes after surgery, and continued up to 180
minutes post-surgery. In the experiments presented in this chapter, orexin activation was
investigated 48 hours after surgery, meaning that any immediate inflammatory and
incision effects on orexin signalling were not measured. Perhaps if testing in the NIH
arena had been performed at a time closer to injury i.e. 20 minute post-surgery, changes
in orexin activation may have been evident. This, however, was not the aim of these
experiments, which was to see how early injury affects adult reward-related behaviours,
and whether orexins are linked to these changes.
In addition to the testing time point differences, the NIH arena is not a test of acute
nociception and is not designed as such. Unlike the papers investigating orexin
analgesia, which included utilisation of the Hargreaves hotplate apparatus to test
thermal hyperalgesia, von Frey hairs to study mechanical hypersensitivity, and
abdominal acid injection to test visceral pain responses (Bingham et al., 2001;
Yamamoto et al., 2003b; Suyama et al., 2004), the NIH arena was designed to measure
exploratory behaviours and approach to a reward. This would further explain why a
single acute adult injury did not affect orexin cell activation after NIH testing, 2 days
after surgery.
4.5.2 Animals with a history of neonatal injury do not show altered
orexin activation after reward testing in adulthood
To investigate the effect of a ‘pain history’ on reward-related behaviours, animals that
were repeatedly injured as neonates (or repeatedly anaesthetised control animals) were
tested in the NIH arena in adulthood at baseline i.e. with no further injury/anaesthesia.Chapter 4
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The previous chapter has shown that there were no behavioural differences between
these groups of animals, and the results from this chapter show that there was no
difference in orexin cell activation either.
Baseline activation of orexin cells (i.e. percentage of orexin cells co-expressing c-Fos)
was around 15-22% in all groups, both male and female. This is in line with the
literature on orexin cell activation, which also shows control/baseline LH orexin cell
activation at around 10-20% (Harris et al., 2005; Harris et al., 2007b; Aston-Jones et al.,
2009).
4.5.3 Orexin cell activation does not reflect whether an animal
consumes a food reward or not
Increases of c-Fos expression in orexin cells have been shown when animals are
exposed to a cue previously linked to a high-fat food reward (Harris et al., 2005), and
upon anticipation and consumption of a palatable foodstuff i.e. chocolate (Choi et al.,
2010). Orexin antagonism has shown decreases in the self-administration of high-fat
food (Nair et al., 2008) and prevention of the feeding induced by nucleus accumbens
stimulation (Zheng et al., 2007). Recent work has suggested that orexin is responsible
for signalling positive reinforcers and rewarding stimuli, in particular high-fat foods as
well as drugs of abuse, but not aversive stimuli (Borgland et al., 2009). For these
reasons, one hypothesis of these experiments was that consumption of Cheerios, acting
as a food reward, would be related to orexin cell activation. However, when comparing
activation in animals that voluntarily consumed Cheerios during the NIH test to those
that did not, no differences were seen.
One explanation for this may be that the group of animals within which this
consummatory behaviour was investigated were males with a history of neonatal injury,
with no further adult injury. Whilst this group displayed a significantly higher number
of non-eating animals than was expected (see page 127, Chapter 3), the animals that ate
Cheerios showed no differences in any behavioural outcome measure (compared to
controls) when tested in the NIH arena in adulthood. This result suggests that a neonatal
foot wound, which decreases the likelihood of eating Cheerios in the NIH, is not linkedChapter 4
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to orexin cell activation, and does not support the hypothesis that consumption of a food
reward is linked to orexin cell activation in animals repeatedly injured as neonates.
4.5.4 Animals with a history of neonatal injury show increased
orexin activation after re-injury in adulthood
When males with a history of neonatal foot wound were re-injured in adulthood and
tested in the NIH arena, the percentage of orexin cells co-expressing c-Fos was
significantly increased (27%) compared to males with a similar history but no adult re-
injury (15%). This result, unlike the previous result, supports hypotheses 1 and 2 of this
chapter - that early neonatal injury affects orexin cell activation upon reward testing in
adulthood, but similar to the behavioural results, it is upon re-injury in adulthood that
differences become apparent.
The increase in percentage of orexin cells co-expressing c-Fos seen between males with
a ‘pain history’, and those with the same history plus an adult re-injury, is around 10%.
This is not as large as increases elsewhere in the literature that investigate orexin cell
activation in food-cued conditioned place preference (CPP) tasks, which record
percentage increases of 20-40%, similar to that induced by morphine and cocaine-
conditioned protocols (Harris et al., 2005). Choi et al (2010) showed overall activation
of orexin cells within the LH as reaching up to 80%, which is much higher than the
highest activation of orexin cells seen in these experiments, at 27%.
However, the studies above utilise conditioning tasks to investigate reward behaviours,
where the animal has learnt to associate a particular reward with a specific environment
or operative response i.e. lever press. The NIH arena does not require any pre-training,
and does not rely on conditioned learning or cues. The only training performed before
NIH arena testing was familiarisation of animals with Cheerios presented in their home
cages. Therefore it could be argued that animals had learnt to associate the smell of
Cheerios with the motivation to consume them, and that this odour was acting as a
conditioned cue. However, the lack of training to pair the odour ‘cue’ to any specific
novel environment would preclude this type of classical conditioning, and indeed Harris
et al (2007b) showed that it was the pairing of the food/drug to a novel environment
which specifically activates orexin cells and led to suggestions that orexins are criticallyChapter 4
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involved in learning drug-cue associations. Therefore the data presented in this chapter
are the first to date to show that orexin cell activation is possible after testing in a non-
conditioned behavioural paradigm.
In addition to increased orexin cell activation seen in males re-injured in adulthood, the
percentage of orexin cell activation was correlated to a behavioural outcome measure -
specifically, the number of rears performed during the 5-10 minute time bin. Rears were
negatively correlated to percentage of orexin cells co-expressing c-Fos. This fulfils the
hypothesis that orexin cell activation is linked to behavioural outcome measures from
NIH testing, and is in line with published literature showing correlations of orexin cell
activation to preference scores in CPP testing paradigms (Harris et al., 2005; Harris et
al., 2007b; Smith et al., 2010). It is unusual however that, as orexin cell activation
increases, rearing decreases, as it would be expected that increased activation would be
associated with increased rearing, due to the rewarding aspect of exploration of a novel
environment (see Bevins and Besheer, 2005). However, Li et al (2010a) found that
microinjections of orexin into the paraventricular nucleus (PVN) (which receives orexin
innervation from the hypothalamus) reduced rearing behaviour in the open field. The
PVN produces corticotrophin-releasing factor (CRF) under conditions of stress and
arousal, so it is possible that the increased orexin cell activation seen when animals
were tested in the NIH arena is linked to activation of arousal mechanisms (see de
Lecea et al., 2006; Boutrel and de Lecea, 2008).
The increase in orexin cell activation after adult re-injury and correlation to rearing
behaviour was not seen in females, which could perhaps be due to hormonal confounds.
The fact that behavioural outcome measures were altered in females (see Chapter 3), but
there were no significant differences in orexin cell activation, suggests that the orexin
system may be vulnerable to hormonal interference during the oestrus cycle. This is the
case with stress regulation via the HPA axis (see Kudielka and Kirschbaum, 2005) and
with nociceptive processing (La Prairie and Murphy, 2007). As the oestrus cycle was
not monitored in these experiments, this could explain variance within results from the
female animals, and a lack of significant differences in orexin cell activation between
treatment groups.Chapter 4
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4.5.5 Animals with a history of neonatal injury display an orexin
system sensitive to the presence or absence of a food reward
To investigate whether the orexin system is sensitive to the presence of Cheerios as a
food reward in the NIH arena, activation (i.e. co-expression of c-Fos in orexin-positive
cells) was investigated when Cheerios were present or absent from the food bowl at the
centre of the NIH arena. The results showed that the presence of Cheerios produced an
increase in orexin cell activation relative to activation in the absence of Cheerios, in the
neonatally-injured males re-injured in adulthood (‘FW+FW’ animals). The level of
activation in the absence of Cheerios was the same as that of baseline levels of
activation (~15%). This result suggests that the orexin system is activated in the
presence of a food reward, which is in line with literature showing that cues associated
with, and motivation to seek, a food reward are linked to orexin signalling (Borgland et
al., 2009; Choi et al., 2010; Sharf et al., 2010).
Behavioural results from the previous chapter showed that FW+FW animals spent less
time in the centre of the NIH arena, and reared more, during the 5-10 minute time bin
when Cheerios were absent. Correlating the behavioural outcome measures with the
percentage of orexin cells co-expressing c-Fos showed that rearing behaviour was
positively correlated, i.e. as orexin cell activation increased, so did the number of rears.
This is in direct contrast to the correlation seen in the same group of animals when the
Cheerios are present (see section 4.5.4).
This result was intriguing, as it shows that, despite the orexin system being insensitive
to whether an animal eats or not (see section 4.5.3), it is sensitive to the presence or
absence of a reward in the NIH arena. Furthermore, the positive and negative
correlations seen between orexin cell activation and rearing behaviour when the
Cheerios are absent or present suggests that the presence of a food reward is impacting
upon the orexin system. When Cheerios are absent, the orexin system may be reflecting
exploratory drive as seen by increased rearing behaviours. However, when Cheerios are
present, exploratory drive may be confounded by the motivational aspect of the
presence of a food reward, hence the decrease in rears as orexin cell activation
increases.Chapter 4
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4.5.6 Significant results are seen in male FW+FW animals only
As in the previous chapter investigating reward-related behaviours in the NIH arena, it
is after an animal receives an injury in adulthood that behavioural differences are
highlighted between treatment groups. Orexin cell activation changes were only seen in
neonatally-injured males, re-injured as adults. Why is it that only these animals display
alterations in orexin signalling?
It has already been shown that these ‘FW+FW’ animals are subjected to injury during a
developmental time point when interference can cause long-term changes in nociceptive
processing (see La Prairie and Murphy, 2010) and development of the HPA axis (Nunez
et al., 1996). The long-term changes in nociceptive sensitivity caused by repeated
neonatal surgery have been confirmed within this thesis, as the previous chapter showed
sensory withdrawal thresholds were altered in neonatally-injured animals. Long-term
changes in nociceptive processing have been linked to baseline hypoactivity of the
endogenous opioid system, which becomes hyper-responsive after an adult injury (La
Prairie and Murphy, 2009). Perhaps noxious interference during a critical period of
development is causing a similar shift in responsiveness of the orexin system, leading to
hyper-responsiveness of the system after adult re-injury and driving increased reward-
motivated behaviours. ‘Critical periods’, during which interference with a developing
system causes long-term changes, have been shown in the nociceptive system (Walker
et al., 2009b), the stress-responsivity system (Enthoven et al., 2008), and the visual
system (Wiesel, 1982). Furthermore, evidence that the orexin system is present and
functional from birth (van den Pol et al., 2001) places it in a position whereby its
development could be affected by outside interference.
This proposed model of shifted orexinergic tone after neonatal injury could explain why
increased activation of the orexin system after NIH exposure is only seen in neonatally-
injured animals when they are re-injured as adults, much like the enhanced hyperalgesia
seen in neonatally-injured animals following re-injury (see La Prairie and Murphy,
2010). Further experiments would be needed to investigate the effect of orexin
antagonism during development, and any resulting long-lasting changes on reward
function.Chapter 4
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An alternative theory to explain why a re-injury in adulthood causes an increase in
orexin cell activation is explained by a speculative argument that links drug withdrawal
to pain states.
Orexin mRNA is increased when an animal enters into a drug-withdrawal state, and c-
Fos expression is seen in LH orexin cells in this state (Georgescu et al., 2003; Zhou et
al., 2006; Zhou et al., 2008). Morphine withdrawal also results in increased c-Fos
expression in the orexin cells of the PFA-DMH region in mice (Sharf et al., 2008), most
likely as withdrawal is aversive and arousing for an animal, and the stress of withdrawal
activates the HPA axis (Zhou et al., 2006; Corominas et al., 2010). The resulting CRF
release will activate medial hypothalamic structures, as CRF-containing fibres synapse
directly onto orexin cells (Winsky-Sommerer et al., 2005).
Withdrawal in humans induces states of dysphoria, irritability, anxiety, and anhedonia,
in addition to physiological symptoms (see Koob and Volkow, 2009). Animal models of
withdrawal have tried to model the psychological effects seen in humans, using
behavioural paradigms such as the elevated plus maze and forced swim tests to measure
anxiety-like and depression-like behaviours (Castilho et al., 2008; Perrine et al., 2008).
Interestingly, chronic pain states in humans can produce symptoms similar to those of
withdrawal i.e. anxiety and anhedonia (Meyer-Rosberg et al., 2001) and treatments
include anxiolytics and antidepressants (Dworkin et al., 2007), linking reward
withdrawal and pain states.
It is possible to speculate that neonatally-injured animals are being placed in an
anhedonic, withdrawal-like state by re-injury during adulthood, and this state causes
increases in orexin cell activation similar to those seen during withdrawal, leading to
increased reward-seeking motivational drive to explore the novel NIH arena (as seen by
increased rearing behaviour) and approach a food reward (as seen by increased time
spent around the food-bowl). To confirm this speculation, it would be interesting to
block orexin signalling with an antagonist administered prior to NIH testing, and see if
behaviour was unaltered, and orexin signalling unchanged in this situation.Chapter 4
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4.5.7 Technical considerations
In the experiments in this chapter, expression of c-Fos protein within orexin-positive
cells was used as a marker of cell activation. C-Fos is the protein product of the
immediate early gene c-fos, and has become one of the most widely used functional
anatomical markers of activated neurons for a number of reasons. It shows low basal
expression levels, is induced by a variety of signals including ions, neurotransmitters,
growth factors and drugs, shows a transient response, and can be easily combined with
markers for other things (see Kovács, 2008). Presence of c-Fos protein has been widely
used in the central nervous system as a marker of system activation (Herrera and
Robertson, 1996) as well as in the reward literature to study motivation, addiction, and
withdrawal (Georges et al., 2000; Georgescu et al., 2003; Aston-Jones et al., 2010).
However, c-Fos is not a perfect marker of cell activation in these studies. The DAB
reaction is performed during immunostaining to visualise c-Fos protein, and strength of
staining relies on the length of time the tissue is left in the DAB solution by the
experimenter. This can vary each time it is done, depending on the rapidity of the DAB
reaction. Faint staining over the whole section can result from poor quality perfusions,
degradation of the quality of the c-Fos primary antibody (as multiple freezing and
thawing of the stored antibody can have a detrimental effect on its binding), or the
freshness of the DAB solution. All of these will require a longer period in the DAB
solution. To minimise the risk of false negative cell counts due to faint staining, tissue
was preferentially stained more darkly. However, this in turn increases background
staining, and could have potentially led to false positives in some instances.
In addition, orexin is located in the cytoplasm, so the orexin stain occasionally occluded
the c-Fos nuclear stain, especially when the nucleus was in a focal plane lower than, and
behind, the cytoplasm. Whilst special attention was paid to cells in these circumstances,
it was not always clear whether the nucleus of an orexinergic cell was stained for c-Fos,
again potentially leading to false positive or false negative cell counts. Whilst efforts
were made to minimise these confounds and produce clearly stained tissue, there will be
inherent variability within the cell counts due to these issues.Chapter 4
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4.6 Summary
Differences in activation of orexin cells were only seen between groups of animals in
which behavioural differences in the NIH arena were also seen, in particular the
neonatally-injured males re-injured in adulthood. Correlations between activation and
behavioural outcome measures were also only seen in groups of animals that showed
altered behaviour compared to controls, suggesting that orexin is a neurobiological
correlate of reward-related behaviours. This shows that orexin is a potential biomarker
of animal reward behaviour in a specific subset of animals, and that orexin system
activation is seen in groups of animals that showed shifted behaviour in the NIH
paradigm, fulfilling the hypotheses of this chapter.
Two possible explanations are presented to explain why orexin cell activation is only
shifted in neonatally-injured animals, re-injured as adults. One states that the neonatal
injuries occurred during a critical period of development, causing a long-term shift in
orexin system reactivity, and the other suggests that animals may be in a state similar to
drug withdrawal. In both cases, activation of the orexin system is proposed to be driving
motivation to seek a reward.
The correlations between cell activation and behaviour do not confer any information on
cause. It is unclear from these experiments whether orexin activation is driving
behaviour, or whether orexin cells are activated in response to behaviour. To answer
this question, further experiments would need to be done that interfere with orexin
function, i.e. via administration of the orexin antagonist SB. Decreases in orexin cell
activation, coupled with behavioural alterations towards a food reward, would help
determine whether orexin is driving, or reflecting, animal behaviour in the NIH arena.Discussion
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5 Discussion
This thesis has aimed to test the hypothesis that repeated early pain altered adult reward-
related processing in the rat. To do this, I first tested the functionality of the reward
pathways of the neonatal rat with morphine (Chapter 2), then tested the long-term effect
of a repeated neonatal foot wound upon reward behaviours in the adult (Chapter 3), and
finally investigated the orexin system as a potential neurobiological correlate of reward
behaviours (Chapter 4).
5.1 Chapter 2 – Activation of neonatal reward pathways
Activation of reward pathways by morphine was measured using induction of pERK, a
marker of cell activation, within the dopaminergic (tyrosine hydroxylase-positive) cells
of the ventral tegmental area (VTA). Projections from the VTA form the basis of the
mesolimbic dopaminergic pathway, heavily implicated in reward processing (Wise,
2004).
The experiments in Chapter 2 showed that a single systemic morphine injection
activates the reward pathways of the P7, P21 and adult rat to the same extent, such that
the percentage of dopaminergic (DAergic) cells co-expressing pERK was increased
from ~10% to ~30%, relative to control groups, at all three ages. This result proves that
the neonatal reward pathways are functional within the first week of life, and that
morphine will activate these pathways.
Systemic morphine injections repeated over 5 days produced an age-dependent response
in activation of dopamine cells. In the adult, the percentage of DA cells activated after
the 5
th injection was decreased to baseline/control levels, suggesting that the adults
develop cellular tolerance after repeated morphine challenge. However, the preweanling
animals continued to show increased DA cell activation in comparison with
baseline/control groups, suggesting that these young animals do not develop the same
level of cellular tolerance to morphine as the adult.
Analgesic tolerance, widely documented in the literature as a decrease in the effects of
morphine upon repeat administration (see Christie, 2008), was not measured in theseDiscussion
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experiments, although general sedation and analgesia were observed and recorded in
each age group after the final morphine dose.
Potential explanations for the different response to repeated morphine in preweanling
animals include suggestions that the young animal has immature tolerance systems
compared to those of the adult. For example, younger animals may not display
‘superactivation’ of the adenylyl cyclase signalling cascade after chronic morphine
(Avidor-Reiss et al., 1996), or may not have mature ‘anti-opioid’ systems that
downregulate opioid response in the adults (see Mao, 1999; Christie, 2008). A further
explanation suggests that the young animals have yet to develop mature functional
connectivity to prefrontal cortical areas, which can regulate the activation of the VTA in
the adult (see McCutcheon and Marinelli, 2009).
In summary, these results showed that rat pups have functional reward pathways in the
first week of life. As noxious stimulation during this time has lasting effects in the rat,
and nociception and reward processing are closely linked, this provides a strong
framework for the hypothesis that early pain will cause long-lasting shifts in reward
processing in the rat.
5.2 Chapter 3 – Early pain affects adult reward-related
behaviours
To investigate the long-term effects of neonatal pain on adult reward behaviours, rat
pups were subject to a repeated foot wound within the first three weeks of life. This is a
time window of rapid functional maturation in the pain system and a critical period
within which noxious stimulation causes long-lasting effects (see Fitzgerald, 2005;
Walker et al., 2009b). Adult reward behaviours were investigated using a novelty-
induced hypophagia (NIH) paradigm. Novelty-induced hypophagia refers to the
inhibition of feeding in the rodent resulting from exposure to a novel environment, and
the NIH arena designed for these investigations was a classic conflict paradigm, where
the animal had to overcome the inherent behavioural drive to stay ‘safe’ near the edges
of an aversive bright circular arena, in order to reach a palatable food treat placed in the
centre of the arena. Control experiments removing the food treats from the centre of the
arena confirmed that the treats were encouraging approach behaviours.Discussion
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Results showed that neonatally-injured females displayed a baseline decrease in
sensitivity to noxious stimulation, i.e. hypoalgesia, which is consistent with literature
showing that females are more vulnerable to the long-term effects of neonatal injury (La
Prairie and Murphy, 2007). However, at baseline NIH testing in adulthood, neither
males nor females displayed any altered exploratory behaviours in comparison to
anaesthetised controls. Neonatally-injured males were less likely to consume food
treats, suggesting that motivational drives, mediated by reward pathway activation, were
shifted in these animals. Overall, these experiments showed that early pain experience
did not alter baseline activity in reward pathways.
Re-injury in adulthood of a previously injured animal highlighted differences in reward
approach behaviours. Animals with a prior history of injury showed increased anxiety-
like behaviours in the NIH arena, as indexed by defecation and decreased rearing
behaviour. In addition, the number of approaches to the food treats and time spent
around them increased, suggesting that the motivational drive to approach the food
reward was higher in animals with a history of prior injury, despite the approach
inducing an anxiogenic state. These results are consistent with literature from animal
and human studies showing that the effects of neonatal injury are most pronounced after
a re-injury later in life (Bhutta et al., 2001; Peters et al., 2005; La Prairie and Murphy,
2009).
Furthermore, these results show that a repeated neonatal injury can cause long-lasting
alterations in behaviour towards a reward in adulthood. This is, to date, the first
experimental data to explicitly investigate the effect of early pain on later reward
behaviours. Bhutta et al (2001) investigated the long-term effects of repeated formalin
injection upon adult pain thresholds, and found that alcohol preference and
amphetamine response was decreased in neonatally-inflamed animals, however, this
study did not investigate the effect of adult re-inflammation.Discussion
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5.3 Chapter 4 – A neurobiological correlate of reward-related
behaviours
The orexin system, originating in the lateral hypothalamus, has been heavily implicated
in reward and addiction due to its direct influence on the mesolimbic dopamine pathway
(Fadel and Deutch, 2002; Narita et al., 2006; see Aston-Jones et al., 2010). In Chapter 4,
the orexin system was identified as a candidate system to reflect the behavioural
changes seen in Chapter 3, and activation of orexin cells (seen via c-Fos expression)
was studied in animals after testing in the NIH arena.
Results showed that, in line with the behavioural results from Chapter 3, orexin cell
activation was the same as control activation levels in animals with a history of neonatal
foot wound when tested at baseline, but that this changed when the animals were re-
injured as adults. In re-injured adults, orexin cell activation upon NIH testing was
increased to around ~30%, doubling the activation. Furthermore, cell activation
correlated with behavioural outcome measures – rearing behaviour was negatively
correlated to orexin cell activation. This is consistent with literature investigating the
role of orexin in reward and addiction, showing the same correlative phenomenon
(Harris et al., 2005; Harris et al., 2007b; Aston-Jones et al., 2009).
Control experiments in the absence of food treats confirmed orexin signalling as
sensitive to food reward, as cell activation was decreased to baseline levels when food
treats were absent from the food bowl. Again, this decrease was correlated with
behavioural outcome measures, as rearing behaviour was positively correlated with
orexin cell activation, further confirming the orexin system as a neurobiological
substrate capable of reflecting reward behaviours. Other outcome measures such as
approach to the food reward and time spent around it did not show any correlations with
cell activation. Whilst Meaney et al (2001) showed that repeated maternal deprivation
as a neonate could cause increases in drug responses in the adult, this is some of the first
data to explicitly link repeated neonatal pain to shifts in adult reward seeking.
5.4 Discussion of possible mechanisms
The results described above show that a repeated injury during the neonatal period
causes changes in reward-related behaviours in adulthood, and that these alteredDiscussion
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behaviours are correlated with changes in activation of neurobiological systems
involved in processing reward and addiction. Possible mechanisms involved in
mediating these changes are presented below.
To begin, repeated injury within the neonatal period results in excessive afferent input
from the periphery to the brain, through pathways that are not yet fully mature (see
Fitzgerald, 2005). This excessive nociceptive input causes long-term alterations in pain
sensitivity (see Grunau et al., 2006) by a variety of potential mechanisms. Neonatal skin
wounds and inflammation cause excessive sprouting of nociceptor nerve terminals in
the dorsal horn of the spinal cord, both of which contribute to enhanced excitability of
spinal nociceptive circuits and therefore an increased pain response upon re-injury
(Ruda et al., 2000; Walker et al., 2003b). Neonatal injury also causes changes in adult
spinal cord gene expression (Ren et al., 2005), developmentally-mediated shifts in
excitatory spinal cord transmission (Li et al., 2009), and expansion of receptive field
size of dorsal horn neurons (Ririe et al., 2008), all of which could lead to enhanced
neuronal excitability in neonatally injured adult animals that would help to explain the
hypersensitivity of the nociceptive system to painful stimuli.
Central sensitisation may be initiated by neonatal inflammation, whereby spinal
nociceptive neurons are sensitised by peripheral tissue damage, leading to continued and
enhanced spinal pain transmission. This is suggested to share similar mechanisms to
long-term potentiation (LTP) in higher brain regions, in that insertion of AMPA
receptors and ‘unmasking’ of previously ‘silent’ NMDA synapses strengthens synaptic
connectivity and could in turn further increase nociceptor excitability (see Ji et al.,
2003). In addition to the immature balance between excitatory and inhibitory spinal
processing (see Fitzgerald, 2005) and immature descending inhibitory pathways before
three weeks of life in the neonatal rat (Fitzgerald and Koltzenburg, 1986; Hathway et
al., 2009), all of these factors could strongly influence developing nociceptive circuitry
and cause the changes in pain response seen in these experiments that persist well into
adulthood.
Alterations in pain sensitivity in adulthood after neonatal injury are also speculated to
involve upregulation of endogenous opioidergic tone in areas involved in descending
modulation of pain – La Prairie and Murphy (2009) suggest that repeated injury may beDiscussion
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causing tonic opioid release within the PAG, aimed at dampening consistent spinal
nociceptive signalling. The complex link between opioid and dopamine signalling could
therefore mean that chronic increases in opioid release affect dopamine signalling. For
example, the balance of tonic and phasic dopamine release can be altered by stress,
meaning that subsequent phasic dopamine release upon rewarding stimuli is attenuated
and dopaminergic responses altered (see Wood, 2006). It is possible that repeated
neonatal surgery, which is inherently stressful, is also altering dopaminergic tone in the
developing organism.
The upregulation of endogenous opioids, produced by repeated neonatal surgery, could
‘reset’ the level of descending control during a critical period of development, and is
suggested to persist into adulthood (La Prairie and Murphy, 2009). This resetting could
explain the baseline decreases in sensitivity i.e. hypoalgesia seen in both animals and
humans with a history of injury (Ren et al., 2004; Hermann et al., 2006; see La Prairie
and Murphy, 2010) - as endogenous opioid levels are raised, a net overall inhibition of
spinal nociceptive processing results. In addition, a blunted stress response within the
hypothalamic-pituitary-adrenal (HPA) axis is seen in the adult after neonatal stress,
which could contribute to decreased baseline pain sensitivity (Nunez et al., 1996).
Furthermore, the stress of early injury could cause increases in tonic dopamine release,
which inhibit phasic dopamine responses to external stimuli, producing a dampened
dopaminergic response system.
Changes in nociceptive circuitry (such as increased afferent input to the dorsal horn of
the spinal cord and hyperinnervation of wounded skin, described above) induced by
repeated neonatal injury lead to a system that is sensitised to respond when a new insult
occurs, resulting in exaggerated hyperalgesic behavioural responses to a new injury (see
Fitzgerald, 2005). Excessive hyperalgesia is seen in both animals and humans upon a
later re-injury (Peters et al., 2005; Walker et al., 2009b; Taddio et al., 2009). In addition,
if phasic dopamine release is decreased in neonatally injured animals due to tonic stress-
related dopamine release during infancy, then it is possible to speculate that
motivational drives for reward will be increased in these animals, in order to
compensate for a dampened phasic dopaminergic response to reward. This speculation
is supported by evidence from this thesis that orexin cell activation upon presence of a
food reward is greater in previously injured animals when re-injured as adults, as wellDiscussion
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as evidence that the orexin system is directly linked to reward motivation and activation
of the dopaminergic system (Narita et al., 2006; Borgland et al., 2009).
Figure 5-1 – A schematic diagram to represent possible mechanisms of the long-term effects of
repeated neonatal foot wound (FW x 3) on adult behaviours. Repeated injury causes changes in
spinal nociceptive circuitry, alterations in endogenous descending control, and a possible stress-
induced imbalance in tonic/phasic dopamine release. At baseline in adulthood, hypoalgesia results
due to increased circulating opioids, a blunted HPA response, and higher tonic levels of dopamine,
leading to net decrease in spinal excitability. Upon re-injury, increased spinal afferent input leads
to behavioural hyperalgesia. In addition, decreased phasic DA release, in turn caused by enhanced
tonic release, causes an increase in compensatory motivational drives, reflected in increased reward
drives in previously injured animals.
5.5 Speculating on the link between reward behaviours and
orexin activation
Whilst the mechanisms that could be involved in causing altered reward behaviours are
outlined above, the precise linkage between behavioural results and activation of the
orexin system observed in this thesis remain unclear at this point. In this section, I
speculate as to how the results presented in chapters 3 and 4 are related and how they fit
into a model of early pain experience-dependent reward behaviours.
Cheerios have been shown to be driving behaviour, as removing them decreases
approach behaviours (fewer central zone entries and less time spent around the food
bowl) compared to when Cheerios are present. That the most obvious behavioural
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differences are seen in the neonatally-injured animals when re-injured as adults
(‘FW+FW’ animals) suggests that these animals have, as described above, alterations in
spinal and supraspinal nociceptive processing that influences adult responses to pain.
These animals may also show disturbed HPA axis regulation (see Grunau et al., 2006)
and therefore be more anxious, as indexed by increased defecation and decreased
rearing behaviours. However, these animals also display increased time spent around
the central food bowl which could explain the decrease in rearing behaviours, as
animals are engaged in contemplating the consumption of the palatable food reward
instead of exploring the arena. The fact that animals do not eat more Cheerios than
controls during NIH testing is puzzling.
Another possibility is that these FW+FW animals are incapable of making clear
decisions regarding a reward. In the presence of Cheerios, the animal is exposed to a
true conflict situation - to avoid the open, aversive environment, or to approach the
palatable reward. This faulty decision-making could be related to the shifted nociceptive
processing seen, and is based upon the linkage of the pain and reward networks and the
possible concept of an overlap in the critical period in development of reward pathways
and of nociceptive pathways such that early nociceptive interference affects both later
pain and reward processing. The results from Chapter 2 showing a lack of tolerance to
morphine in young animals supports the suggestion of immature prefrontal connectivity
at this age, as does research showing that medial prefrontal cortical connectivity, which
is crucial for decision-making, is immature in preweanling animals (see McCutcheon
and Marinelli, 2009), which matches the critical period suggested for pain processing
(La Prairie and Murphy, 2009; Walker et al., 2009b).
The correlations between rearing and orexin cell activation are intriguing and not easily
explained. When the Cheerios were present, a negative correlation was seen i.e. the
greater the rearing, the less the orexin cell activation. It could be that the less anxious
animals are rearing more frequently and therefore their motivational drives lie with
exploration of the aversive environment rather than contemplation of the food reward.
Rearing in this cohort of FW+FW animals was generally decreased compared to
controls which suggests that under normal circumstances (i.e. non re-injured animals)
rearing and exploration is inherently rewarding, which is in line with literature on
exploration as rewarding for an animal (see Hughes, 2007) and supports the speculationDiscussion
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that these animals display faulty reward-related decision-making. The lack of
correlations between orexin activation and any other outcome measure was unexpected,
and could be due to small group numbers, large variability within groups, and the
inherent difficulties in interpreting the meaning of behavioural outcome measures in
animal experiments (Stanford, 2007b).
When Cheerios were absent, rearing behaviour was generally increased in the
‘FW+FW’ group, as animals engaged in more exploratory behaviours and spent less
time around the central zone. Under these circumstances, the greater the orexin cell
activation the greater the rearing behaviour, so it could be argued that when the food
reward was absent, exploration was in itself rewarding. This provides further support
that animals within the FW+FW cohort are less capable of making decisions relating to
a specific palatable reward, as the presence of Cheerios reward showed an inverse
correlation to rearing behaviour.
However, at this point, these suggestions are speculative only, and would need further
investigation and careful experimental design to fully elucidate the links between
reward behaviours and neurobiological activation in the adult after repeated neonatal
injury.
5.6 The Motivation-Decision model
The behavioural results can also be viewed in the light of Fields’ Motivation-Decision
model (2006). The motivation-decision model states that the decision to respond to a
stimulus is based upon the premise that anything that is potentially more important for
survival than pain should exert anti-nociceptive effects. In the case of testing in the NIH
arena, animals that have been injured as adults display anti-nociceptive effects, as they
show greater behavioural responses to reward than animals with no adult injury, despite
a recent foot wound. This suggests that nociceptive events (i.e. ongoing input from
primary afferent nociceptors) are being ignored, and the more salient event (i.e.
presence of the food treats) is being attended to. In the absence of food, the motivation
to explore becomes the more salient behavioural drive.
The motivation-decision model is based on the reward/cost decision by classic brain
‘reward’ associated areas, and the resulting behaviour to pain dictated by opioidergicDiscussion
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descending modulation (Fields, 2004; 2006). Results from the literature and from the
experiments presented in this thesis suggest that early repeated injury affects
opioidergic tone (La Prairie and Murphy, 2009) and shifts orexin-mediated reward
pathway activation (Chapter 4), resulting in altered behaviours towards reward in
adulthood and a system primed to respond to further painful stimuli (Chapter 3; Walker
et al (2009b)). This data extends the motivation-decision model, as pain experienced
during vulnerable periods of development takes on a more salient motivating role in
adulthood, in order to promote survival. The increased saliency of nociceptive input is
reflected in the enhanced hyperalgesia to an adult injury. Motivation for a reward
becomes accordingly increased when pain becomes more salient, and is reflected here in
an increased motivational drive to approach food reward, decrease in exploratory
rearing, plus corresponding orexin system activation, seen in the previously injured
animals.
Interestingly, evidence to support the motivation-decision model is found in work on rat
pups younger than ten days old, as Kehoe and Blass (1986d) found that distress upon
maternal separation produced analgesia to a noxious stimulus, suggesting that the
motivating survival drive of behavioural distress i.e. ultrasonic vocalisation, over-rides
pain responses, as the model predicts. This also supports Fields’ assumption that the
‘decision’ to respond to stimuli is mainly unconscious (Fields, 2004; 2006), as rat pups
in the first week of life do not have functionally mature prefrontal connectivity (see
McCutcheon and Marinelli, 2009) and are arguably not conscious of their behavioural
drives. This in turn fits with data showing that sucrose ‘analgesia’ in young rats is
mediated by the brainstem i.e. does not require a cerebral cortex (Anseloni et al., 2005).
5.7 Further work
The results from the experiments in this thesis provide intriguing evidence on the long-
term effects of repeated early pain on reward function in the adult. However, further
work is necessary to confirm these results and to clearly elucidate the mechanisms
causing these results.
Firstly, it would be interesting to repeat the experiments using a classical reward
paradigm, such as conditioned place preference, as competing motivational drives (i.e.
approach/avoidance of the food reward) add complexity to the interpretation ofDiscussion
212
behaviour within the NIH arena. It would also be interesting to see if repeated neonatal
pain affected intracranial self-stimulation and/or intracranial self-administration of drug
in a part of the brain critical for reward processing, for example the nucleus accumbens.
These experiments could provide robust evidence for the effect of early pain on reward
processing. In addition, the effect of repeated morphine administration during infancy
upon adult reward behaviours would be an interesting avenue of research, to model the
clinical situation where morphine is routinely used as an analgesic and for sedation
(Anand, 2007).
Ultimately, basic pain research is aimed at reducing pain in humans. To transfer the
research described in this thesis to the clinic, longitudinal studies of human infants and
the long-term consequences of neonatal pain on attitude towards a reward would be
necessary. Currently, much research is underway to study neonatal pain mechanisms,
but longitudinal research on children and adults with prior pain history is still relatively
rare. Difficulties with longitudinal studies include the fact that clinical records from
infancy are incomplete, or not available. However, newer cohorts of post-NICU
children such as the UK EpiCure cohort come complete with more comprehensive
clinical notes, and therefore provide the basis for helpful epidemiological studies in the
future (Wood et al., 2005; Walker et al., 2009a). Over the years, it would be interesting
to monitor children in these cohorts for drug abuse and/or addiction problems, and more
subtle reward-related dopaminergic personality traits such as sensation-seeking and
extroversion. In addition, existence of these cohorts provides researchers with many
potential candidates for imaging studies, using techniques such as fMRI to investigate
BOLD responses to pain and reward, or positron emission tomography (PET) to
investigate dopamine receptor binding in adulthood. Both of these have been used to
study adult pain and reward responses, but have not yet investigated the consequences
of pain during childhood (see Leknes and Tracey, 2008; Volkow et al., 2009).
A major challenge if these results are to be tested in infants would be to find an outcome
measure of reward in young infants. The question of how to measure a subjective
‘reward’ in young infants is confounded by both technical and ethical difficulties, but
the quality of the infant-caregiver bond might provide insights into reward processing in
young children. Infant attachment i.e. the bond between offspring and primary caregiver
(usually the mother) is rewarding for both child and mother (Bowlby, 1978; Insel,Discussion
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2003). Animal studies have shown that separation causes distress in young rat pups and
is mediated by opioid signalling (Kehoe and Blass, 1986d; Blass et al., 1987). Mu
opioid receptor knock-out mouse pups develop disordered attachment to the dam
(Moles et al., 2004), and mice lacking the dopamine β-hydroxylase gene fail to nurture 
their offspring (see Palmiter, 2008). In humans, activation of the mesolimbic dopamine
pathway from the VTA is seen in mothers when viewing their infants (Noriuchi et al.,
2008), and human imaging studies have begun to identify a neurobiological substrate
for infant attachment, based in reward processing areas such as the nucleus accumbens,
VTA and medial prefrontal cortices (see Parsons et al (2010) for a comprehensive
review). The attachment of infant to mother lasts throughout life, and can affect adult
relationships, self-esteem, response to stress and mental health in later life (see Rees,
2005).
Attachment style and quality have been linked to pain experience in humans, with
disordered attachment styles linked to chronic pain and problems in coping with pain
(Porter et al., 2007). For example, chronic pain patients with high levels of avoidant
attachment self-scored pain intensity more highly, and patients with fearful attachment
styles displayed increased levels of pain catastrophising (Ciechanowski et al., 2003;
Meredith et al., 2006a). In volunteers with no history of chronic pain, acute pain
induced by the cold-pressor test (which involves holding the arm in iced water for as
long as possible) was scored as less intense, less anxiogenic and more personally
controllable in subjects with secure attachment styles (Meredith et al., 2006b).
The suggestion of attachment as rewarding, together with evidence on the effect of
attachment style on pain experience, produced the idea that monitoring the infant-
caregiver attachment upon a painful stimulus (i.e. routine immunisation), information
regarding reward processing in young children could be gleaned.
5.8 Summary and conclusions
To summarise, this thesis aimed to test the hypothesis that repeated pain during early
infancy can cause long-term changes in adult reward sensitivity. Studies that performed
repeated foot wound surgery to neonatal rat pups showed that reward behaviours were
different in the adult animal when the animals received a new injury. These behaviouralDiscussion
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differences were reflected in activation of the orexin system, providing a neural
substrate for reward behaviours. Testing the integrity of early reward pathways with
morphine showed the functionality of reward signalling in the first week of the rat’s life,
but illustrated quantitatively different responses after repeated morphine in comparison
to the adult, suggesting that, similar to nociceptive processing, reward processing does
not reach maturity until the third week of postnatal life.
The existence of a critical period of nociceptive development, plus the extensive overlap
between reward and pain processing, suggests that reward pathways may also be
vulnerable to interference during this period. In turn, this could inform clinical practice,
enabling more appropriate treatment of infants exposed to repeated painful procedures
during early life, and helping to minimise the long-term consequences of early pain on
both later pain sensation and reward processing.Appendix 1
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6 Appendix 1 - SOLUTIONS
6.1.1 Phosphate buffers
All are based on dilutions of 0.2M phosphate buffer (pH 7.4), made in the following
manner (for a 5L yield):
4,050ml 0.2M Na2HPO4 (28.4g/L dH2O)
950ml 0.2M NaH2PO4 (27.6g/L dH2O)
6.1.1.1 0.1M
1:1 dilution with dH2O of 0.2M phosphate buffer - i.e. for 1L, add 500ml dH2O to
500ml 0.2M PB.
6.1.1.2 0.01M
Dilution of 0.1M PB - i.e. for 1L, add 100ml 0.1M PB to 900ml dH2O.
6.1.1.3 0.6M PB (for perfusions)
For 5L stock:
1.2L NaH2PO4(dissolve 99.34g in 1.2L dH2O)
4.2L Na2HPO4(dissolve 357.7g in 4.2 dH2O)
6.1.2 TTBS
To make 1L:
3ml Triton X100 (Sigma Aldrich, Steinheim, Germany)
50ml 1M Tris solution (Sigma Aldrich, Steinheim, Germany)
8.7g NaCl (Fisher Scientific, Leicester, UK)
6.1.3 PFA
To make 5L stock 12% PFA:
500g PFA powder (Fisher Scientific)
4.166L dH2O
~few ml NaOHAppendix 1
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To make 1L 4% PFA immediately prior to perfusion:
333ml 12% stock PFA
167ml 0.6M PB
500ml dH2O
Add 50ml NaF if staining for pERK.
6.1.4 Sucrose and azide
Add 5% or 30% (w/v) to 0.1M PB. Add 1μl/ml 20% sodium azide. For example: 
6.1.4.1 30%
1L 0.1MPB
300g saccharose (VWR, Leuven, Belgium)
1ml azide
6.1.4.2 5%
1L 0.1MPB
50g sucrose
1ml azide
6.1.5 Blocking serum
300µl serum i.e. horse, goat, etc
300µl 10% Triton X-100
both per ml 0.1M PB
For DAB staining, add 200µl hydrogen peroxide ~30% solution (VWR, Leuven,
Belgium) per ml 0.1M PB.Appendix 2
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7 Appendix 2 - Chapter 2: Graphing the time course of
reward behaviours
The results presented below describe the time course of behaviours either over the
course of 5 days post-surgery (sensory testing), or during the 15 minute testing period in
the NIH arena, split for gender.
Sensory testing
Mechanical withdrawal thresholds – 5 day time course
Male
There are no significant differences (2-way ANOVA) in mechanical withdrawal
threshold between ipsilateral and contralateral foot, nor between treatment group (foot
wounded and anaesthesia), in adult males at baseline.
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Graph 7-1– A line graph to show how male mechanical withdrawal thresholds change from
baseline at 1, 2 and 5 days after a single adult foot wound. Both injured (ipsi) and uninjured
(contra) paws are shown for previously injured (M FW) and uninjured (M AN) animals. The Y
axis is a logarithmic scale as the vFh increase in force (in grams) between each hair number is
logarithmic. Percentage change from baseline was plotted to show changes in sensitivity more
clearly. M FW n=3, M AN n=3.
Female
After the adult females are exposed to a single foot wound, mechanical withdrawal
thresholds do not change significantly over the course of 5 days post-injury (2-way
Repeated measures ANOVA). However, Graph 7-2 shows a trend for the ipsilateral paw
in the FW animal to decrease from baseline, i.e. withdrawal threshold to decrease; and
the contralateral paw to increase from baseline i.e. withdrawal threshold to increase.
Both paws in the AN animals appear to stay around baseline levels.Appendix 2
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Graph 7-2 - A line graph to show how female mechanical withdrawal thresholds change from
baseline at 1, 2 and 5 days after a single adult foot wound. Both injured (ipsi) and uninjured
(contra) paws are shown for previously injured (M FW) and uninjured (M AN) animals. The Y
axis is a logarithmic scale as the increase in force (in grams) between each von Frey hair is
logarithmic. Percentage change from baseline was plotted to show changes in sensitivity more
clearly. F FW n=3, F AN n=3.
Thermal withdrawal thresholds – 5 day time course
Male
Graph 7-3 shows the time course of changes in thermal withdrawal thresholds after a
single adult foot wound. General trends show that the ipsilateral paws of both
previously injured and uninjured animals show a drop in threshold, i.e. their sensitivity
increases, until the thresholds return towards baseline levels at day 5 post-surgery.
Baseline Day1 Day2 Day5
0
50
100
150
200
M FW ipsi
M FW contra
M AN ipsi
M AN contra
1) p<0.05
3) p<0.05
2) p<0.05
%
c
h
a
n
g
e
f
r
o
m
b
a
s
e
l
i
n
e
Graph 7-3 – A line graph to show that thermal withdrawal thresholds change after single adult
injury. 1) There is a significant decrease in threshold in the AN animal’s ipsilateral paw one day
after injury; 2) There is a significant increase between days 2 and 5 in the AN contralateral paw’s
threshold and 3) there is a significant increase between days 2 and 5 in the FW ipsilateral paw’s
threshold (p<0.05 for all; 2-way Repeated measures ANOVA with Bonferroni’s post-tests). M FW
n=3, M AN n=3.Appendix 2
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Female
General trends show that the FW ipsilateral paw shows a drop in threshold i.e. an
increase in sensitivity after adult foot wound that begins to return to baseline by 5 days
post-injury. The contralateral paw and both paws in the AN animals show a significant
increase in threshold over 5 days (p<0.05; 2-way Repeated measures ANOVA with
Bonferroni’s post-tests).
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Graph 7-4 – A line graph to show that thermal withdrawal thresholds change after single adult
injury. The arrow indicates that the AN ipsilateral paw’s threshold is significantly higher at day 5
than at all other time points (p<0.05; 2-way Repeated measures ANOVA with Bonferroni’s post-
tests). The lower line and asterisk show that the FW ipsilateral paw’s threshold is significantly
lower at day 2 than at baseline (p<0.05; 2-way Repeated measures ANOVA with Bonferroni’s post-
tests). F FW n=3, F AN n=3.
Baseline behavioural testing
The graphs below describe behaviour in the novelty-induced hypophagia test in animals
with or without a history of neonatal injury. Graphs describe the time course of
behaviours during the 15 minute test period, separated into 5 minute time bins. M FW
group n=19, M AN group n=13, F FW group n=19, F AN group n=11.
Exploratory behaviours: Rearing, central zone entries, and
percentage of time spent in the central zone
Number of rears decrease over the testing period
Males
Graph 7-5 shows how rearing significantly decreases over the 15 minute testing period
(p=0.028; 2-way Repeated measures ANOVA with Bonferroni’s post-tests). There wereAppendix 2
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no differences at any time point between the injured and uninjured groups at any time
point (Multivariate ANOVA).
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Graph 7-5 – a line graph to show the number of rears that male foot wounded and anaesthesia-only
animals performed, time-binned into 5 minutes bins. *p=0.028; 2-way Repeated measures ANOVA
with Bonferroni’s post-tests.
Females
The number of rears that injured females made significantly decreased over the testing
period (p=0.006; 2-way Repeated measures ANOVA with Bonferroni’s post-tests).
There were no significant differences between treatment groups (Multivariate
ANOVA). Graph 7-6 illustrates this data:
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Graph 7-6 – A line graph to show the number of rears that female foot wounded and anaesthesia-
only animals performed, time-binned into 5 minutes bins. **p=0.006; Repeated measures ANOVA
with Bonferroni’s post-test.
Central zone entries decrease over the testing period
Males
The number of entries that the anaesthesia group made into the central zone decreased
significantly over the 15 minute time period (p=0.009; 2-way Repeated measures
ANOVA with Bonferroni’s post-tests). There is a trend for the injured group to showAppendix 2
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fewer entries, but this was not significant. There were no significant differences
between injured and uninjured animals (Multivariate ANOVA).
0-5 5-10 10-15
0
2
4
6
8
10
12
M FW
M AN
**
Time bins (minutes)
C
e
n
t
r
a
l
z
o
n
e
e
n
t
r
i
e
s
Graph 7-7 – a line graph to show the number of central zone entries that male foot wounded and
anaesthesia-only animals performed, time-binned into 5 minute bins. **p=0.009; 2-way Repeated
measures ANOVA with Bonferroni’s post-tests.
Females
The number of central zone entries drops over the testing period in both injured and
uninjured females (F FW: p=0.001, F AN: p=0.009; 2-way Repeated measures ANOVA
with Bonferroni’s post-tests). There were no differences between treatment group
(Multivariate ANOVA).
0-5 5-10 10-15
0
2
4
6
8
10
12
F FW
F AN
**
Time bin (minutes)
C
e
n
t
r
a
l
z
o
n
e
e
n
t
r
i
e
s
Graph 7-8 – A line graph to show the number of central zone entries that female foot wounded and
anaesthesia-only animals performed, time-binned into 5 minute bins. **p=0.009; 2-way Repeated
measures ANOVA with Bonferroni’s post-tests.
Time spent in central zone increases over the testing period
Males
The time that the injured animals spent in the central zone increased between the first
and last time bins (p=0.037; 2-way Repeated measures ANOVA with Bonferroni’s post-
tests). There was no significant difference between treatment groups (Multivariate
ANOVA).Appendix 2
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Graph 7-9 – a line graph to show how male injured and anaesthesia-only animals increase their
percentage of time spent in the central zone of the NIH arena over the 15 minute testing period.
*p=0.037; 2-way Repeated measures ANOVA with Bonferroni’s post-tests.
Females
The time that the injured females spent in the central zone does not significantly
increase over the testing period (2-way Repeated measures ANOVA). There was no
significant difference between treatment groups (Multivariate ANOVA).
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Graph 7-10 – A line graph to show the percentage of time spent female animals spent in the central
zone of the NIH arena in each time bin of the 15 minute testing period.
Appetitive behaviour
The number of Cheerios eaten differs between time bin
Males
The number of Cheerios eaten was time-binned. The results show that there is a
difference between FW (n= 12) and AN (n=10) groups in the 10-15 minute time bin
(p<0.05, 2-way Repeated measures ANOVA with Bonferroni’s post-tests).
Graph 7-11 also shows that there is a difference in the number of Cheerios eaten
between the 0-5 and both 5-10 and 10-15 time bins for both injured and uninjured
animals (M FW: 0-5 vs. 5-10, p<0.001, 0-5 vs. 10-15, p<0.01; M AN 0-5 vs. 5-10,Appendix 2
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p<0.01, 0-5 vs. 10-15, p<0.001; 2-way Repeated measures ANOVA with Bonferroni’s
post-tests).
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Graph 7-11 – A line graph to show how the number of Cheerios eaten differs between time bins.
The lines above the graph show the data from the male FW group only, although the AN group also
show similar differences. *p<0.05; **p<0.01; ***p<0.001; 2-way Repeated measures ANOVA with
Bonferroni’s post-tests
Females
The time that the injured females (n=16, F AN n=10) spent in the central zone does not
significantly increase over the testing period (2-way Repeated measures ANOVA).
There was no significant difference between treatment groups (Multivariate ANOVA).
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Graph 7-12 – A line graph to show the percentage of time spent female animals spent in the central
zone of the NIH arena in each time bin of the 15 minute testing period.
The effect of single acute foot wound in adulthood on reward
related behaviours in animals with no prior history of injury
The graphs below describe behaviour in the novelty-induced hypophagia test in animals
with or without a history of neonatal injury. Graphs describe the time course of
behaviours during the 15 minute test period, separated into 5 minute time bins.Appendix 2
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Exploratory behaviours – rearing, central zone entries, and
percentage of time spent in the central zone
Rears are decreased in adult-injured animals compared to controls
Males
Graph 7-13 illustrates how male animals that receive a single adult foot wound (n=14)
rear less than those with a similar background (repeated neonatal anaesthesia, n=13).
This effect is significant in the 5-10 minute time-bin (p=0.016; Multivariate ANOVA
with Tukey’s HSD post-tests). Animals that are acutely injured in adulthood show a
drop in rearing over the first ten minutes (as shown by the arrow, p<0.01) that is still
significantly lower by 15 minutes (indicated by the line and asterisk at the bottom,
p<0.05; both from Repeated measures ANOVA with Tukey’s Multiple Comparison
Test).
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Graph 7-13 – A line graph to show rearing behaviour in each time bin, in males after a single adult
foot wound in animals with no history of prior injury. The arrow and line below the graph are
explained in the text. *p<0.05; **p<0.01; Repeated measures ANOVA with Tukey’s Multiple
Comparison Test
Females
Graph 7-14 illustrates how female animals that receive an adult foot wound (n=13) rear
less than those with a similar background (repeated neonatal anaesthesia, n=11). This
effect is significant in the 0-5 and 10-15 minute time-bins (0-5: p=0.002; 10-15:
p=0.013; Multivariate ANOVA with Tukey’s HSD post-tests).Appendix 2
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Graph 7-14 - A line graph to show rearing behaviour in each time bin, in females after a single
adult foot wound in animals with no history of prior injury. *p<0.05; **p<0.01. Multivariate
ANOVA with Tukey’s HSD post-tests.
Central zone entries decrease over the testing period
Males
Graph 7-15 shows how rearing behaviour decreases over the 15 minute testing period in
males with no history of injury (p<0.05 to p<0.001; Repeated measures ANOVA with
Tukey’s Multiple Comparisons Test). There were no differences between treatment
groups (Multivariate ANOVA).
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Graph 7-15 – A line graph to show central zone entries in each time bin of the testing period, in
males after a single adult foot wound. *p<0.05; **p<0.01; ***p<0.001; Repeated measures ANOVA
with Tukey’s Multiple Comparison Test.
Females
Central zone entries decrease between time bins over the testing period. This is a
significant decrease (p<0.05 to p<0.001; Repeated measures ANOVA with Tukey’s
Multiple Comparisons test). There were no differences between treatment groups
(Multivariate ANOVA).Appendix 2
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Graph 7-16 - A line graph to show central zone entries in each time bin of the testing period, in
females after a single adult foot wound. Significant differences are shown for the F AN+FW group
only, although the F AN group showed a similar significant decrease over the total 15 minute test
session (*p<0.05; **p<0.01; ***p<0.001. Repeated measures ANOVA with Tukey’s Multiple
Comparison Test).
Percentage of time spent in central zone increases during the testing
period
Males
Graph 7-17 shows that the amount of time spent in the central zone increases after the
first 5 minute time bin, but this is only a significant increase in the AN+FW group
(p<0.01; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test). There
were no significant differences between treatment groups (Multivariate ANOVA).
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Graph 7-17 – A line graph to show the amount of time males spent in the central zone in each time
bin of the testing period, in males after a single adult foot wound. **p<0.01; Repeated measures
ANOVA with Tukey’s Multiple Comparison Test.
Females
Female animals that received a single adult foot wound spend more time in the central
zone, in comparison to animals with the same background (repeated neonatal
anaesthesia) that were not injured as adults (5-10 minute time bin: p=0.007; 10-15Appendix 2
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minute time bin: p=0.001; Multivariate ANOVA with Tukey’s HSD post-tests). The
females that were injured as adults (F AN+FW) show an increased amount of time in
the central zone over the 15 minute testing period (p<0.05 to p<0.001; Repeated
Measures ANOVA with Tukey’s Multiple Comparisons Test), which was not seen in
the uninjured control group (F AN).
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Graph 7-18 – A line graph to show the amount of time females spent in the central zone in each
time bin of the testing period, in females after a single adult foot wound. Lines above the graph
indicate *p<0.05; **p<0.01; ***p<0.001; Repeated Measures ANOVA with Tukey’s Multiple
Comparisons Test. Asterisks above the F AN+FW triangles indicate **p=0.007; ***p=0.001;
Multivariate ANOVA with Tukey’s HSD post-tests.
Appetitive behaviours
Cheerios are eaten after the first 5 minutes of the testing period
Males
Eating behaviour does not begin until 5 minutes of testing, as shown in Graph 7-19.
There were no significant treatment group differences (M AN n=10, M AN+FW n=12;
Multivariate ANOVA).
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Graph 7-19 - A line graph to show the Cheerios eaten per time bin in males with no prior history of
foot wound, after a single adult foot wound. Significant data shown for M AN+FW group only for
clarity, although the M AN group showed similar differences (***p<0.001.; Repeated measures
ANOVA with Tukey’s Multiple Comparisons Test).Appendix 2
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Females
Eating behaviour begins after 5 minutes, and increases over the 15 minute time period
in the adult injured females (F AN+FW: p<0.001; Repeated measures ANOVA with
Tukey’s Multiple Comparisons Test). Injured females (n=10) eat significantly fewer
Cheerios than uninjured controls (n=13) in the 10-15 minute time bin (p<0.01; 2-way
Repeated measures ANOVA with Bonferroni post-tests).
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Graph 7-20 – A line graph to show the Cheerios eaten per time bin in females with no prior history
of foot wound, after a single adult foot wound. Lines above the graph indicate ***p<0.001;
Repeated measures ANOVA with Tukey’s Multiple Comparisons Test. Asterisks above the F
AN+FW triangle indicate **p<0.01; 2-way Repeated measures ANOVA with Bonferroni post-tests.
Removing the food reward alters exploratory behaviours in males
and females with no history of injury
To investigate the effect that the presence of the food reward had in general on
exploratory behaviours, the Cheerios were removed from the central bowl and separate
litters of animals who received a single adult foot wound were tested. Genders are
grouped in the following results. M AN+FW Present n=14; M AN+FW Absent n=5; F
AN+FW Present n=13; F AN+FW Absent n=4.
Exploratory behaviours do not show the same increases or decreases in
frequency when the Cheerios are absent.
Rearing behaviour is affected by the absence of Cheerios in females
As already reported, rearing in males decreases between time bins over the testing
period. This decrease is lost when the Cheerios are removed.Appendix 2
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Removing the Cheerios has the effect of increasing rearing in the female animals at the
5-10 minute time bin (see Graph 7-21 – p=0.003; Multivariate ANOVA with Tukey’s
HSD post-tests).
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Graph 7-21 – A line graph showing rearing behaviour in animals with no history of injury, when
Cheerios are either present of absent. Rearing behaviour is increased in females when the Cheerios
are absent. (M) and (F) refer to the gender of the effect, for both Present and Absent groups. (M)
*p<0.05; **p<0.01; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test. (F)
**p=0.003; Multivariate ANOVA with Tukey’s HSD post-tests.
Entries into the central zone do not decrease significantly when Cheerios are
absent.
As already reported, the number of entries by males and females into the central zone
decreases between time bins over the course of the testing period. This decrease is not
significant when the Cheerios are absent.
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Graph 7-22 – A line graph showing that entries into the central zone decrease over the testing
period in animals with no history of neonatal injury. (P) refers to the significant results in the
presence of Cheerios. *p<0.05; **p<0.01; ***p<0.001; Repeated measures ANOVA with Tukey’s
Multiple Comparisons Test.
Percentage of time spent in the central zone does not increase over the testing
period, and is lower in females when Cheerios are absent.Appendix 2
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There are significantly fewer central zone entries by females in the final 5 minute time
bin when Cheerios are absent (p=0.031; Multivariate ANOVA with Tukey’s HSD post-
tests). As previously reported, the number of entries into the central zone increases
between the first and last time bins when Cheerios are present. This is not the case when
the Cheerios are absent (see Graph 7-23 )
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Graph 7-23 – A line graph to show the effect of absence of Cheerios on percentage of time spent in
the central zone. (F) refers to significance in female animals only. (P) refers to significant results in
the presence of Cheerios. (P) *p<0.05; **p<0.01; ***p<0.001; Repeated measures ANOVA with
Tukey’s Multiple Comparisons Test; (F)*p=0.031; Multivariate ANOVA with Tukey’s HSD post-
tests.
Moving the food-bowl within the arena does not alter reward-related
behaviours in animals with no history of injury
The effect of moving the food-bowl from the centre to a less anxiogenic quadrant was
investigated. Litters of animals who received a single adult foot wound were tested with
the food-bowl in an ‘alternate quadrant’ close to the edge of the arena (see Methods)
and compared to the results from litters with the food-bowl in the centre. The central
zone was defined as circling the food-bowl, regardless of its position. M AN+FW
Central group, n=14; M AN+FW AltQuad group, n=3; F AN+FW Central group, n=13;
F AN+FW AltQuad group, n=11.
Exploratory behaviours are minimally affected by the alternate
placement of the food-bowl
Rearing behaviour is not affected by the placement of the Cheerios
As previously shown, the number of male rears decreases over the recording period.
This is not significant in females, nor for groups where the food-bowl is in the alternate
quadrant.Appendix 2
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Graph 7-24 - A line graph showing rearing behaviour in animals with no history of injury, when
the Cheerios are moved to an alternate quadrant. (C) denotes significant results when the Cheerios
are centrally placed. *p<0.05; **p<0.01; Repeated measures ANOVA with Tukey’s Multiple
Comparisons Test)
Central zone entries do not differ when the food-bowl is alternatively placed
As previously shown, the number of central zone entries decreases between time bins
over the total testing time for both genders. This trend is similar when the food-bowl is
in the alternate quadrant, but is only significant in females (p<0.01; Repeated measures
ANOVA with Tukey’s Multiple Comparisons Tests).
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Graph 7-25 – A line graph to show the number of central zone entries in each time bin over the 15
minute testing period. (MC) refers to male results when the food-bowl was centrally placed; (FC)
refers to females results when the food-bowl was centrally placed; (FAlt) refers to female results
when the food-bowl was in the alternate quadrant. *p<0.05; **p<0.01; ***p<0.001; Repeated
measures ANOVA with Tukey’s Multiple Comparisons Test.
Percentage of central zone time is the same wherever the food-bowl is placed
The percentage of time spent in the central zone increases during the testing period.
This trend is not significant (except for females between the first 2 time bins) when the
food-bowl is in the alternate quadrant.Appendix 2
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Graph 7-26 – A line graph to show the percentage of time spent in the central zone when the
Cheerios are moved to an alternate quadrant. (MC) refers to male results when the Cheerios are
centrally placed; (FC) refers to female results when the Cheerios are centrally placed; (FAlt) refers
to female results when the food-bowl was in the alternate quadrant. *p<0.05; **p<0.01;
***p<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test.
Appetitive behaviours
Cheerios eaten
The number of Cheerios eaten peaks in the 5-10 minute time bin, as previously shown.
This trend is the same when the Cheerios are moved within the arena, and there are no
significant differences between Cheerio placement groups (Multivariate ANOVA).
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Graph 7-27 – A line graph to show the number of Cheerios eaten per time bin over the test period.
(MC) refers to male results when the Cheerios are centrally placed; (FC) refers to female results
when the Cheerios are centrally placed; (FAlt) refers to female results when the food-bowl was in
the alternate quadrant. *p<0.05; **p<0.01; ***p<0.001; Repeated measures ANOVA with Tukey’s
Multiple Comparisons Test.
The effect of re-injury to animals with a history of repeated
neonatal foot wounds on reward-related behaviours
The results presented in this section will describe the effect that a single adult foot
wound has on an animal with a prior history of surgery. Animals all had repeated
neonatal foot wound surgery within the first 21 days of life.Appendix 2
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As above, the behaviours were measured during a 15 minute testing period in the
novelty-induced hypophagia paradigm (see Methods); outcome measures have been
classified into anxiety-related measures (faeces and urine), exploratory behaviours
(rearing, central zone entries and time spent in central zone) and appetitive behaviours
(time to first Cheerio and total number of Cheerios); and were time-binned accordingly.
Genders have been analysed separately. M FW group, n=19; MFW+FW group, n=14; F
FW group, n=19, F FW+FW group, n=12.
Exploratory behaviours – rearing, central zone entries, and
percentage of time spent in the central zone
Rears are near-significantly decreased in males with a history of
neonatal injury
Males
Number of rears decreases over the testing period in the re-injured animals only
(p<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test).
Males that were re-injured as adults (M FW+FW) reared near-significantly fewer times
in the 5-10 minute time bin compared to control animals (M FW) – p=0.06; Multivariate
ANOVA with Tukey’s HSD post-tests.
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Graph 7-28 – A line graph to show the number of rears per time bin in males with a history of
neonatal repeated injury. ***p<0.001; Repeated measures ANOVA with Tukey’s Multiple
Comparisons Test.
Females
Number of rears decreases over the testing period in the uninjured-as-adult animals only
(p<0.01; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test).
Females that were re-injured as adults (F FW+FW) reared significantly fewer times inAppendix 2
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the first two time bins compared to control animals (0-5: p=0.016; 5-10: p=0.000;
Multivariate ANOVA with Tukey’s HSD post-tests).
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Graph 7-29 - A line graph to show the number of rears per time bin in females with a history of
neonatal repeated injury. **(FW) refers to results in the FW group. **p<0.01; Repeated measures
ANOVA with Tukey’s Multiple Comparisons Test. Larger asterisks indicate treatment group
differences. *p=0.016; **p=0.000; Multivariate ANOVA with Tukey’s HSD post-tests.
Central zone entries decrease during the testing period, regardless of
adult treatment
Males
The number of entries into the central zone decreased between time bins in re-injured
males only (p<0.05 to p<0.001; Repeated measures ANOVA with Tukey’s Multiple
Comparisons Test). There were no differences between treatment groups at any time
point (Multivariate ANOVA).
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Graph 7-30 – A line graph to show the number of entries into the central zone per time bin in males
with a history of repeated neonatal injury. *p<0.05; **p<0.01; ***p<0.001; Repeated measures
ANOVA with Tukey’s Multiple Comparisons Test.Appendix 2
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Females
The number of entries in the central zone was significantly higher in the first two time
bins in females that were re-injured as adults (p=0.000 and p=0.012; Multivariate
ANOVA with Tukey’s HSD post-tests).
Central zone entries also decreased significantly over the testing period for both adult
uninjured and adult re-injured animals (p<0.05 to p<0.001; Repeated measures ANOVA
with Tukey’s Multiple Comparisons Test).
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Graph 7-31 – A line graph to show the number of entries into the central zone per time bin in
females with a history of repeated neonatal injury. (FW) and (FW+FW) refer to the treatment
group. *p<0.05; **p<0.01; ***p<0.001; Repeated measures ANOVA with Tukey’s Multiple
Comparisons Test. The larger asterisks denote treatment group differences: ***p=0.000; *p=0.012;
Multivariate ANOVA with Tukey’s HSD post-tests.
Percentage of time in the central zone increases further in re-injured
animals than controls.
Males
The percentage of time spent in the central zone increase between time bins, particularly
in males that were re-injured as adults (see Graph 3-30). There was a near-significant
treatment effect of adult re-injury on the central zone time percentage in the final 10-15
minute time bin (p=0.073; Multivariate ANOVA with Tukey’s HSD).Appendix 2
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Graph 7-32 – A line graph to show the percentage of time spent in the central zone in each time bin
for males with a history of neonatal injury. (FW) refers to adult-uninjured animals. (FW+FW)
refers to animals that were re-injured as adults. *p<0.05; **p<0.01; Repeated measures ANOVA
with Tukey’s Multiple Comparisons Test).
Females
Females that were re-injured as adults spent significantly more time in the central zone
in the final time bin (p=0.007; Multivariate ANOVA with Tukey’s HSD).
The percentage of time spent in the central zone significantly increases between time
bins in females that were re-injured as adults.
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Graph 7-33 - A line graph to show the percentage of time spent in the central zone in each time bin
for females with a history of neonatal injury. (FW+FW) refers to animals that were re-injured as
adults. *p<0.05; ***p<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons
Test. The larger asterisk denotes a significant effect of treatment group. P=0.007; Multivariate
ANOVA with Tukey’s HSD.
Appetitive behaviours
Cheerio consumption is not affected by an adult re-injury
Males
Cheerio consumption does not begin until the second time bin, and peaks in the 5-10
minute time bin. For both the uninjured (n=12) and injured (n=12) adults, there was aAppendix 2
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significant increase in Cheerio consumption after the first time bin and over the total
period (p<0.001 and p<0.01; Repeated measures ANOVA with Tukey’s Multiple
Comparisons Test).
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Graph 7-34 – A line graph to show the number of Cheerios eaten per time bin in males with a
history of foot wound. ***p<0.001; **p<0.01; Repeated measures ANOVA with Tukey’s Multiple
Comparisons Test.
Females
Cheerio consumption significantly increases between time bins and over the total period
in both uninjured (n=13) and adult re-injured (n=11) females (p<0.01; Repeated
measures ANOVA with Tukey’s Multiple Comparisons Test). There was no significant
effect of treatment (Multivariate ANOVA).
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Graph 7-35 – A line graph to show the number of Cheerios eaten per time bin in females with a
history of foot wound. **p<0.01; Repeated measures ANOVA with Tukey’s Multiple Comparisons
Test.
Removing the food reward does not alter exploratory behaviours in
males and females with a history of injury
To investigate the effect that the presence of the food reward had in general on
exploratory behaviours, the Cheerios were removed from the central bowl and separate
litters of animals with a history of foot wound that were re-injured as adults were tested.Appendix 2
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M FW+FW Present group, n=19; M FW+FW Absent group, n=5; F FW+FW Present
group, n=12; F FW+FW Absent group, n=4.
Exploratory behaviours – rearing, central zone entries and percentage
of time spent in central zone
Rearing behaviour is affected by the presence of Cheerios in females with a
history of injury
Females that were re-injured as adults showed an increased number of rears when the
Cheerios were absent (p=0.045; Multivariate ANOVA with Tukey’s HSD post-tests).
The number of rears decreased over the testing period for both groups of males (p<0.01
to p<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test).
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Graph 7-36 – A graph to show the number of rears of both genders per time bin when Cheerios
were present or absent in animals with a history of foot wound. (M) refers to results that were
significant in males only **p<0.01; **p<0.001; Repeated measures ANOVA with Tukey’s Multiple
Comparisons Test. The larger asterisk refers to results for females only (F)*p=0.045; Multivariate
ANOVA with Tukey’s HSD post-tests.
Central zone entries are not affected by the presence or absence of Cheerios in
animals with a history of injury.
The number of entries into the central zone decreased between time bins. This effect
was similar for all groups, regardless of the presence of Cheerios.
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Graph 7-37 – A line graph to show the number of central zone entries per time bin when Cheerios
are present/absent in animals of both gender with a history of neonatal repeated injury. (M) or (F)
refer to gender, (Pr or Ab) refer to presence of absence of Cheerios. *p<0.05; **p<0.01;
***p<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test).
Percentage of time spent in the central zone does not show any increase over
the testing period when the Cheerios are removed
The percentage of time spent in the central zone increases in both genders during the
testing period, as previously shown. This effect is lost in both genders when the
Cheerios are removed.
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Graph 7-38 – A graph to show the percentage of time spent in the central zone per time bin for both
genders in animals with a history of repeated foot wound. (M) and (F) refers to the gender of the
result. (Pr) refers to the result in the presence of Cheerios. **p<0.01; ***p<0.001; Repeated
measures ANOVA with Tukey’s Multiple Comparisons Test).
Moving the food-bowl within the arena slightly alters reward-related
behaviours in animals with a history of foot wound
The effect of moving the food-bowl from the centre to a less anxiogenic quadrant was
investigated. Litters of animals with a history of foot wound that were re-injured as
adults were tested with the food-bowl in an ‘alternate quadrant’ close to the edge of the
arena (see Methods), and compared to results from litters with the food-bowl in the
centre. The central zone was defined as circling the food-bowl, regardless of its
position. Genders are grouped in the following results. MFW+FW Centre n=14;
MFW+FW AltQuad n=10; F FW+FW Centre n=12; F FW+FW AltQuad n=5.
Exploratory behaviours – rearing, central zone entries and percentage
of time spent in central zone
Rears are not affected by the placement of the food-bowl in animals re-injured
as adultsAppendix 2
240
As described previously, the number of rears that males perform decreases over the 15
minute testing period. This trend is the same for males when the bowl is in the alternate
quadrant (p<0.05; Repeated measures ANOVA with Tukey’s Multiple Comparisons
Test). There is no effect on female rearing behaviour.
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Graph 7-39 – A graph to show the number of rears per time bin in animals of both gender with a
history of foot wound that have been re-injured. (M C) refers to male results from Cheerios
centrally placed, (M Alt) refers to male results from Cheerios in the alternate quadrant. *p<0.05;
***p<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test.
Central zone entries are not affected by the placement of the Cheerios in re-
injured animals with a history of injury.
As shown previously, males and females that are re-injured as adults show a decrease in
central zone entries over successive time bins. This effect is replicated in situations
where the Cheerios are absent. There are no effects of placement of the Cheerios.
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Graph 7-40 – A graph to show the number of central zone entries per time bin for males and
females that are re-injured as adults, when the Cheerios are present or absent. (M) or (F) refers to
the gender within which the results are seen. (C) or (Alt) refers to whether the Cheerios were
placed centrally or in the alternate quadrant. *p<0.05; **p<0.01;***P<0.001; Repeated measures
ANOVA with Tukey’s Multiple Comparisons Test.Appendix 2
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The increase in percentage of time spent in the central zone is lost in females
re-injured as adults when the food-bowl is moved from the centre
As previously shown, the percentage of time spent in the central zone increased between
time bins, for both males and females re-injured as adults. This result is lost in females
re-injured as adults when Cheerios are moved to an alternate quadrant.
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Graph 7-41 – A graph to show the percentage of time spent in the central zone per time bin for
animals that are re-injured as adults. (M) and (F) refer to the gender in which the results are seen.
(C) and (Alt) refers to whether the Cheerios were placed centrally or in the alternate quadrant.
*p<0.05; **p<0.01;***P<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons
Test.
Appetitive behaviours
Number of Cheerios eaten is unaffected by the placement of the food-bowl in
re-injured animals
As previously shown, Cheerio consumption begins after the first time bin (see Graph
7-34 and Graph 7-35). This pattern is the same when the Cheerios are moved from the
centre of the arena to the edge (alternate quadrant).
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Graph 7-42 – A graph to show the number of Cheerios eaten per time bin by animals of both
gender re-injured as adults. (M) and (F) refer to the gender in which the results are seen. (C) and
(Alt) refers to whether the Cheerios were placed centrally or in the alternate quadrant.
**p<0.01;***P<0.001; Repeated measures ANOVA with Tukey’s Multiple Comparisons Test.242
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